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SUMMARY 
Atherosclerosis is an inflammatory disease which develops focally in regions of 
the vasculature where there is dysfunction of endothelial cells modulated in part by shear 
stress from flowing blood.  To address the clinical crisis of atherosclerosis, tissue 
engineering has focused on development of a living blood vessel substitute for use as a 
vascular graft in bypass surgery.  Despite substantial progress in understanding the 
biological basis and developing clinical treatments for cardiovascular disease, critical 
challenges remain.  As a novel strategy to improve understanding of basic human 
vascular biology and develop superior tissue engineered grafts, this dissertation combines 
the scientific and clinical approaches by using a tissue engineered blood vessel as a more 
physiologic in vitro model to study endothelial cell biology.  Through the use of 
transcriptional profiling, results demonstrate significant changes in endothelial cell gene 
expression using the tissue engineered blood vessel model.  Furthermore, the presence of 
a more physiologic substrate alters the cellular response to shear stress which is a critical 
mediator of vascular pathology.  A case study of endothelial cell function in this system 
focuses on cell-cell communication through gap junctions.  Endothelial cell connexins 
which form gap junctions are shown to be differentially regulated by substrate and shear 
stress.  Moreover, gap junction communication between endothelial cells is modulated by 
the mechanical environment.  Studies using RNA interference to knockdown expression 
of individual connexin isotypes demonstrate integrated regulation of connexins yet 
unique roles in endothelial cell function.  Collectively, results exemplify the sensitivity of 
endothelial cell phenotype to substrate and shear stress and underline the importance of 
using more physiologic models in the study of basic cell biology.
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CHAPTER ONE: Introduction 
 
 One-third of American adults suffer from at least one form of cardiovascular 
disease thus generating a patient population of over 71 million.  Widespread prevalence 
of cardiovascular disease results in one death every 35 seconds and is responsible for 
shortening the American life expectancy by seven years. (1)  Atherosclerosis is one major 
type of cardiovascular disease and involves the development of plaque in the innermost 
lining of blood vessels which can lead to stroke or myocardial infarction.  To address the 
crisis of atherosclerosis, development of clinical treatments and understanding through 
research have been aggressively pursued. 
 Endothelial cells which line the inner surface of blood vessels have been the focus 
of research into both physiologic and pathologic mechanisms.  The endothelium serves 
multiple purposes including barrier formation between blood and tissue, control of blood 
coagulation and regulation of vascular tone. (2)  One critical discovery is the link 
between mechanical forces and endothelial cell behavior, especially the influence of 
shear forces from flowing blood which can render the vessel resistant or susceptible to 
atherosclerosis. (3)  Multifaceted dysfunction of endothelial cells from increased 
permeability to altered cell adhesion is involved in progression of atherosclerosis, 
however despite decades of investigation; a comprehensive understanding of mechanisms 
underlying this disease is still elusive. (4, 5) 
 While research into endothelial cells and atherosclerosis continues, clinical 
treatment to prevent plaque rupture and possible stroke or myocardial infarction often 
requires bypass surgery.  This procedure uses a graft to provide an alternate route for 
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blood flow thus avoiding passage through the diseased vessel.  Although grafts of 
synthetic material remain patent in large arteries, small diameter vessels can occlude thus 
requiring harvest of vessel segments from another region of the patient’s body for use as 
a conduit.  Due to the pain of two procedures and the lack of healthy vessel available in 
many patients, alternative graft sources are being investigated.   
The goal of tissue engineering is the development of living substitutes to repair, 
replace or enhance tissue function.  Tissue engineered substitutes are an attractive 
solution to many diseases because of the opportunity to use healthy, normal tissue as a 
therapy. (6)  Strategies to generate engineered cardiovascular tissues have incorporated 
synthetic and biological matrices, multiple cell types and bioreactors for application of 
chemical, electrical and mechanical stimuli.  While development of tissue engineered 
blood vessels as a source of small diameter vascular grafts has made significant advances, 
numerous challenges remain prior to their widespread use in a clinical setting. (7, 8) 
 Despite years of significant effort in biology of endothelial cells to understand 
their roles in maintenance of healthy vessels and progression of disease, a myriad of 
questions remain.  While studies conducted using both in vitro and in vivo experimental 
settings have provided valuable scientific insight and aided in the advancement of clinical 
therapies, results from these two environments have not always been predictive of each 
other or the human body.  Understanding the disconnect between in vitro experiments, in 
vivo animal studies and human patients will lead to a further scientific understanding of 
endothelial cell biology and impact treatment of vascular disease.  This opportunity is 
provided by the field of tissue engineering where technology is used to recreate the native 
cellular environment in a controlled and reproducible manner resulting in more 
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physiologic models for the study of basic biology.  Use of engineered human tissue will 
lead to an improved understanding of basic biology as well as an emergence of superior 
tissue engineered substitutes.  Therefore this dissertation uses a tissue engineered blood 
vessel to model the vascular wall microenvironment for study of basic human endothelial 
cell biology. 
 Within the context of endothelial cell biology, numerous areas are under 
investigation for their roles in vascular development and disease.  Studies presented here 
focus on endothelial cell communication through gap junctions.  Communication 
between cells is critical to normal function and disease progression because cells do not 
function in isolation, but coordinate to generate a tissue-level response to stimuli. (9, 10)  
Endothelial gap junctions, which provide direct communication between cells, have been 
implicated in multiple vascular diseases including atherosclerosis and hypertension. (11, 
12)  While evidence is building regarding endothelial gap junction sensitivity to 
mechanical forces, growth factors and cytokines, substantial questions remain regarding 
their roles in physiologic and pathologic processes. (13, 14)  Furthermore, preliminary 
data gathered in this study using the tissue engineered blood vessel model indicated 
differential expression of endothelial connexins which are the building blocks of gap 
junctions.  Therefore this dissertation evaluates the response of endothelial gap junctions 
to substrate and shear stress and investigates the unique functions of the three endothelial 
connexin isotypes. 
 The central hypothesis of this dissertation is that endothelial cell behavior is 
altered by the presence of smooth muscle cells, extracellular matrix and fluid flow.  
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Investigation of the central hypothesis is achieved through the following specific aims 
and corresponding hypotheses. 
 
Specific Aim 1 
Hypothesis:  Exposure of endothelial cells to a tissue engineered blood vessel 
substrate alters gene expression in response to static and shear mechanical 
environments. 
Specific Aim:  Compare transcriptional profiles of endothelial cells on a collagen 
coated slide to cells on a tissue engineered blood vessel under laminar shear stress 
and static conditions. 
Specific Aim 2 
Hypothesis:  Endothelial cell gap junction expression and function will be 
influenced by substrate and mechanical environment. 
Specific Aim:  Compare endothelial cell connexin expression and gap junction 
communication on a collagen coated slide and tissue engineered blood vessel 
under laminar shear stress and static conditions. 
Specific Aim 3 
Hypothesis:  Three connexin isotypes (Cx37, Cx40, Cx43) have unique functions 
in endothelial cell biology and response to shear stress. 
Specific Aim:  Knockdown expression of individual connexins to determine their 




 CHAPTER TWO: Background 
 
Introduction 
To address the clinical crisis of atherosclerosis, both the study of basic vascular 
biology and the development of novel therapies will be required.  While substantial 
progress has been made in understanding the physiology and pathology of endothelial 
cell, new strategies are needed for advancement.  Furthermore, great strides have been 
made in the development of tissue engineered vascular grafts but clinical application of 
this therapy has not yet been realized.  This dissertation combines the efforts to 
understand and treat cardiovascular disease by using a tissue engineered blood vessel as a 
more physiologic in vitro model for the study of basic human endothelial cell biology. 
 Atherosclerosis is a disease of the blood vessel wall that was originally identified 
by hard lesions which appeared to have composition similar to gruel.  It is now 
recognized to be a progressive, inflammatory disease of the vasculature which results 
from a combination of genetic predisposition and lifestyle risk factors. (15)  While high 
cholesterol and inflammatory cytokines are systemic in nature, atherosclerotic plaque 
develops focally in regions of the vascular tree where the endothelium is dysfunctional. 
(16)  Endothelial dysfunction is clinically characterized by a loss of nitric oxide 
production and therefore reduced endothelium-dependent vasodilation. (17)  The shift in 
phenotype to a state of dysfunction is also characterized by increases in endothelial 
adhesiveness, permeability, proliferation and thrombogenesis. (18)  Atherosclerosis 
begins as a fatty streak with the accumulation of lipid-laden macrophages known as foam 
cells in the vascular wall beneath the endothelium.  Dysfunction of endothelial cells and 
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inflammation lead to increased uptake of lipids which are then scavenged by recruited 
monocytes in the subendothelial space.  Fatty streaks progress to form intermediate then 
advanced lesions which are accelerated by other conditions such as hypertension, 
diabetes, high cholesterol and various inflammatory triggers.  The major steps involved in 
atherosclerotic plaque development and progression to advanced stages include 
endothelial injury, monocyte recruitment, macrophage development, foam cell formation, 
lipid deposition, platelet activation, smooth muscle cell migration and proliferation, and 
synthesis and deposition of extracellular matrix. (19)  Much is known about factors 
contributing to development of atherosclerosis, however a comprehensive understanding 
of underlying mechanisms has not yet been achieved. 
The dangers of atherosclerosis are in the downstream consequences of plaque 
expansion or rupture and the currently unpredictable nature of these events.  While 
plaques can grow to block the lumen thus preventing blood flow, the vessel most often 
compensates through positively remodeling to maintain the lumenal opening.  In the 
event of plaque rupture, release of the contents leads to thrombosis which blocks the 
lumen  and prevents blood from flowing.  Loss of blood flow to the heart results in 
myocardial infarction, loss of blood flow to the brain results in stroke, and loss of blood 
flow in the peripheral vasculature can lead to limb amputation due to tissue death.  
Efforts are currently underway to understand what causes plaque rupture and how to 
predict this clinical event prior to major complications.  Vulnerability of plaque appears 
to be dependent not only on external factors such as mechanical forces and circulating 
inflammatory stimuli, but also on the composition of the plaque itself. (20) 
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As the pathology of atherosclerosis continues to be studied and methods for 
reliably predicting clinical events are being developed, treatment of patients is ongoing.  
Management of risk factors through diet, exercise and treatment of high blood pressure 
and high cholesterol aims to slow the progression of atherosclerosis.  For patients whose 
vascular disease is deemed a current threat or those who have experienced a major 
cardiac event, treatment is by stent or bypass surgery. (21)  Treatment by balloon 
angioplasty and stenting serves to reopen a vessel where plaque is encroaching into the 
lumen and hold it open with structural support.  Treatment with bypass surgery involves 
placing an alternative conduit, either a synthetic graft, vein graft or arterial graft, around 
the diseased vessel to divert blood flow and ensure perfusion to downstream tissue. 
With the increasing number of patients requiring bypass surgery due to 
atherosclerotic lesions and the failure of synthetic grafts to replace small diameter 
arteries, clinicians and researchers began investigating methods for improving synthetic 
grafts.  Failure of small diameter synthetic vascular grafts was most often due to 
thrombosis which is not seen in replacement of larger diameter vessels.  Initial 
approaches included coating the graft lumen with proteins such as albumin, collagen or 
heparin in attempts to reduce the thrombogenicity. (22, 23)  The next step in improving 
synthetic graft success was to line the lumen with endothelial cells prior to implantation 
to provide a natural non-thrombogenic surface. (24, 25)  While limited success was 
achieved, expansion of endothelial cells in culture is required and mixed results have 
prevented widespread adoption of this technique.  Since synthetic small diameter grafts 
result in thrombosis, vein grafting is often used to bypass diseased arterial conduits.  
Although vein grafts provide a living tissue replacement, their properties differ from 
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arteries and therefore failure and re-operation can be a consequence. (26)  Modification 
of vein grafts through genetic engineering has been extensively investigated however a 
viable therapeutic strategy has not been developed. (27)  When failure of synthetic grafts 
and vein grafts presented numerous challenges, clinicians turned to arterial grafting and 
the development of new options promised by the field of tissue engineering. (28) 
 Cellular and tissue engineering are multi-disciplinary fields which apply the 
principles of engineering to the problems of biology and medicine to create new scientific 
understanding and clinical therapies. (29, 30)  The goal of tissue engineering is to 
develop living tissue substitutes which can repair, replace or enhance native tissue 
function.  Tissue engineering offers the clinical world the option of treating patients with 
normal, healthy tissue to restore health due to any number of diseases.  While great 
progress has been made, numerous challenges have arisen which have increased our 
appreciation for the complexity of tissue development and function.  Current work in the 
field of tissue engineering is focused on almost every tissue imaginable; however we will 
focus this discussion on development of the blood vessel.  Recent progress and new 
challenges in the area of cardiovascular tissue engineering have been recently reviewed 
by several groups. (6-8) 
 An early strategy in tissue engineering of blood vessels was to remove all cellular 
material from existing vessels and implant the acellular tissue since it possesses adequate 
strength as well as biological properties. (31, 32)  The next step was to seed this acellular 
matrix with cells which could interact with the biological matrix and develop a living 
tissue. (33)  As development of engineered substitutes progressed, it became apparent 
that presence of cells and extracellular matrix was not sufficient to develop tissue but that 
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additional stimuli such as mechanical forces and specific nutrients were required. (34)  
With the increasing appreciation of biological complexity in the development of tissue 
engineered substitutes, native development of the vasculature was closely examined for 
clues. (35) 
 Although numerous approaches have been taken, early development of tissue 
engineered vascular grafts focused on mimicking the structure and function of native 
vessels.  One early strategy used smooth muscle cells dispersed in a tubular collagen gel 
to mimic the medial layer and then lined this tube with endothelial cells to create an 
intimal layer.  While biological in nature, this early blood vessel construct required an 
exterior synthetic graft to provide adequate strength for in vivo implantation. (36)  A 
second in vitro biological approach involves long term culture of smooth muscle cells 
with numerous growth factors to induce generation of extensive extracellular matrix.  
Smooth muscle cell-matrix sheets are then rolled into a tubular shape, the lumen is 
seeded with endothelial cells and the exterior is wrapped with a fibroblast-matrix sheet 
for additional strength. (37)  Several biomaterials-based approaches have been pursued 
where living cells are seeded onto a synthetic material which provides structural integrity 
while cells develop their own extracellular matrix environment.  One example of this 
strategy involved seeding smooth muscle cells onto tubular polymeric scaffolds and 
culturing them in bioreactors applying mechanical force prior to seeding the lumen with 
endothelial cells. (38, 39)  Finally, a novel in vivo approach was taken to generate a small 
diameter vascular graft which would provide an autologous tissue source and therefore 
avoid complications due to immune rejection.  Silastic tubing was inserted into the 
peritoneal cavity of multiple animal models and following several weeks of implantation, 
 10
the tubing/tissue structure was harvested and the artificial material removed leaving a 
biological conduit with a medial-like layer and a nonthrombogenic inner lining. (40) 
 The primary focus of tissue engineering has been the development of living 
tissues to repair, replace or enhance tissue function in a clinical setting.  However, a 
potentially untapped result of advances in tissue engineering is the use of engineered 
substitutes as more physiologic in vitro models.  This approach combines the control of 
in vitro systems with the complexity of in vivo systems to generate new insight into cell 
biology.  Furthermore, a unique advantage of tissue engineering is the ability to use 
human cells to generate human tissue for experimentation without a danger to patients.  
Our laboratory recently combined the development of tissue engineered vascular grafts 
with the study of endothelial mechanotransduction by using the tissue engineered blood 
vessel as a model substrate during endothelial cell exposure to fluid flow.  Early studies 
examined porcine endothelial cell morphology and proliferation under the combined 
influences of extracellular matrix, smooth muscle cells and shear stress.(41)  More recent 
work has incorporated human endothelial and smooth muscle cells in studying 
morphology, proliferation and migration of endothelial cells in this more physiologic 
model.(42, 43) 
 
Endothelial Cell Biology 
 Endothelial cells line all the blood vessels of the body and have numerous critical 
functions due to their presence at the interface of blood and tissue.  Their primary 
functions include barrier formation, regulation of blood coagulation and control of 
vascular tone. (2)  As mediators between blood and tissue, endothelial cells are involved 
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in numerous systemic and cardiovascular diseases. (4, 5)  For the purpose of this 
dissertation, the review of endothelial cell function will be restricted to interactions with 
shear stress, extracellular matrix and smooth muscle cells. 
Endothelial cell behavior in response to shear stress has been extensively studied 
since the observation that regions of the arterial tree where flow is unidirectional and 
axially aligned have no intimal thickening whereas regions of low shear stress and flow 
separation exhibit intimal thickening and correspond with the presence of 
atherosclerosis.(44)  Early in vivo studies of endothelial function in these regions 
demonstrated altered cell morphology as well as proliferation rates.(45-47)  More recent 
in vivo investigations have demonstrated distinct and highly complex transcriptional 
profiles of cells in disturbed and undisturbed flow regions.(48) 
To better understand the relationship between endothelial cells and fluid shear 
stress, extensive investigations have been conducted in vitro due to development of the 
cone-plate viscometer and parallel plate flow chamber.(49, 50)  These early systems 
applied a steady, laminar shear stress to a monolayer of endothelial cells to mimic athero-
protective regions of the vasculature and later oscillatory, pulsatile and re-created human 
vascular waveforms were added to the repertoire.(51-53)  Early in vitro studies confirmed 
in vivo observations regarding the influence of shear stress on endothelial morphology 
and proliferation.(54-56) The apparent complexity of endothelial behavior began to build 
as studies investigated endothelial cell functions which are altered by shear stress and the 
mechanisms underlying this mechanical influence.   
Potassium ion channels and calcium signaling are sensitive not only to presence 
of flow but also type of shear stress. (57-59)  With respect to the specific pathogenesis of 
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atherosclerosis, shear stress affects endothelial uptake of LDL as well as chemotactic 
molecules involved in recruitment of monocytes into the vascular wall. (60-62)  In 
addition to chemotactic signals to cells in flowing blood, endothelial cells modulate 
expression of surface adhesion molecules in response to shear stress. (63, 64)  With 
respect to endothelial-blood interactions, numerous coagulation molecules including 
thrombomodulin and the plasminogen activators (tissue and urokinase) are affected by 
fluid flow. (65-67)  Multiple mediators of inflammation and the reduction-oxidation 
balance in endothelial cells are also affected by the nature of the mechanical environment 
imparted by flowing blood. (68-70)   
With so many cell functions affected by shear stress, it became clear that the 
major signal transduction pathways must also be affected.  Studies identified shear-
induced changes in the mitogen-activated protein kinases, protein kinase C and NF-kappa 
B. (71-74)  The question of mechanisms behind endothelial cell response to shear stress 
and the “mechanosensors” involved in transducing these signal became hotly debated.  
Discovery of a shear stress response element in the promoter region of several genes 
confirmed a direct influence of fluid flow on transcription. (75, 76)  Additional 
mechanosensors including ion channels, caveolae, G proteins and integrins were quickly 
added to the list. (77, 78)   
Widespread belief in broad endothelial gene expression changes induced by 
mechanical environment was confirmed in multiple studies. (79)  More recently, 
transcriptional profiling has demonstrated the extent of changes in endothelial gene 
expression and the cell’s ability to distinguish between different types of shear stress.  
Microarray analysis of cells exposed to steady laminar shear and arterial waveforms from 
 13
athero-susceptible and athero-resistant regions of the vasculature have provided valuable 
insight. (80-83)  The endothelial cell sensitivity to shear stress and relationship to 
atherosclerosis presented here is merely the tip of the iceberg.  Recent reviews provide an 
excellent picture of the links between disease, cell biology and mechanical forces. (3, 84, 
85) 
While not as heavily investigated as the role of shear stress in modulating 
endothelial phenotype, research has also been conducted into the effects of other 
environmental components such as extracellular matrix and smooth muscle cells on 
endothelial function.  Investigations were launched into the role of extracellular matrix 
and endothelial function with specific focus on angiogenesis, vascular migration and 
vascular patterning as motivated by the field of cancer biology.  Different basement 
membrane proteins appear in a spatially and temporally regulated manner during 
angiogenesis in vivo and also control cell proliferation in vitro.(86)  Further sensitivity of 
endothelial cells to extracellular matrix was demonstrated in studies showing differential 
regulation between assembled, solid forms and degraded, soluble forms with influence 
being determined by composition, structural integrity as well as exposure of various 
degradation sites.(87)  Over the course of angiogenesis, extracellular matrix proteins 
were shown to both stabilize the vessel as well as promote migration and 
proliferation.(88)  The mechanisms by which extracellular matrix controls vessel 
patterning including the binding and display of growth factors, chemo-attractant and 
chemo-repellant molecules.(89)  
 Beyond studies of the microvasculature, endothelial cells in culture are both 
affected by extracellular matrix substrates provided and are involved in secreting their 
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own basement membrane. (90, 91)  Not only do endothelial cells generate extracellular 
matrix but they also degrade it as needed thus implying a highly interactive relationship. 
(92)  With regard to specific endothelial functions, matrix is also known to control 
growth and differentiation as well as production of molecules including 
glycosaminoglycans and prostaglandin.(93, 94)  A naturally-derived complex 
extracellular matrix often used in studies of endothelial cell biology is a reconstituted 
basement membrane secreted by the EHS mouse sarcoma.  Commercially known as 
Matrigel, the presence of numerous basement membrane proteins in defined proportions 
has significantly contributed to the understanding of vascular network formation.(95) 
 Investigations of shear stress and extracellular matrix influence on endothelial cell 
behavior converged with the study of integrin signaling.  Endothelial adhesion to specific 
extracellular matrix proteins through members of the integrin family alters cellular 
response via specific signal transduction pathways.(96, 97) These same integrin signaling 
pathways are critical in transmitting signals induced by shear stress.(98)  Thus we are 
reminded that endothelial cells in vivo are exposed not only to shear stress or only 
extracellular matrix but both stimuli concurrently. 
 The in vivo endothelial cell environment also includes a number of other cell 
types in both the blood and the vascular wall.  Smooth muscle cells underlying the 
endothelium in large conduits and pericytes wrapping the microvasculature have been 
studied extensively in their own right as well as in conjuction with endothelial cells.(99, 
100)  With a focus on atherosclerosis, this discussion will be limited to endothelial-
smooth muscle interactions of the arteries. 
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 To study the relationship between endothelial and smooth muscle cells in vitro, a 
number of co-culture systems were developed.  Soluble, unidirectional communication 
has been investigated using conditioned medium or cell homogenate applied from one 
cell type to the other.(101)  Soluble, bidirectional communication thus including 
feedback mechanisms is examined using co-cultures of the two cell types separated by a 
porous membrane.(102-104)  Finally, contact-mediated communication has been studied 
using bilayer or spheroid culture methods.(105, 106)  Initial studies focused on 
endothelial control of smooth muscle cell function including growth factor production, 
migration and proliferation.(101, 103, 107)  Later studies recognized the corresponding 
influence of smooth muscle cells on endothelial cell function.  Smooth muscle cells were 
shown to influence endothelial proliferation, cytokine secretion and growth factor 
production as well as endothelial quiescence and response to external growth 
factors.(106, 108) 
 With the development of models demonstrating endothelial response to shear 
stress and resulting smooth muscle vasoactivity, the concurrent presence of shear stress 
and smooth muscle cells in the in vivo endothelial environment was underlined.  One 
elegant system to evaluate simultaneous presence of smooth muscle cells and shear stress 
on endothelial cells involved co-culture of the two cell types of opposite sides of 
polypropylene capillary tubes which were then bundled together and fluid flowed through 
the lumens thus shearing the endothelial cells.(109)  The dual influence of smooth muscle 
cells and shear stress was then shown to influence endothelial nitric oxide synthase 
(eNOS) and cyclooxygenase (Cox) expression, both of which have an established role in 
vascular disease.(110)  Another approach uses endothelial and smooth muscle cells co-
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cultured on opposite sides of a permeable membrane and a modified parallel plate flow 
chamber to shear the endothelial surface.  Results demonstrated that smooth muscle cell 
contact induced endothelial cell adhesion molecule expression under static conditions 
however the presence of shear stress would counteract this effect.(111)  Thus we 
conclude not only are shear stress and smooth muscle cells both regulators of endothelial 
behavior; they have influence over similar pathways. 
 
Cell Communication: Connexins & Gap Junctions 
 In studying endothelial cell function in physiologic and pathologic processes, it is 
clear that each does not act independently but instead there is a coordinated response.  
Communication between endothelial cells is critical to numerous functions and occurs 
through soluble factors, binding of cell surface receptors and even transmission of 
physical forces. (10)  One method of cell-cell communication in the endothelium is by 
the most direct pathway: an open pore between two cells for the instant sharing of 
information.  This pore is created by gap junctions which are the focus of several studies 
in this dissertation and will thus be reviewed in detail. 
 A gap junction forms when a hemichannel from one cell docks with a 
hemichannel from a neighboring cell to create a pore connecting the two cells together.  
Hemichannels, also called connexons, are an array of six connexin proteins which bond 
to form a single unit which is inserted into the plasma membrane.  The gap junction 
channel opens and closes to allow the flow of electrical and chemical information in the 
form of ions, second messengers and metabolites smaller than 1000Da.  Figure 2.1 






















Figure 2.1 Connexin, Hemichannel, Gap Junction and Gap Junction Plaque 
Hierarchy 
A single connexin protein (of which there are over 20 isotypes) clusters with five other connexins in a 
hexameric array to form a connexon (hemichannel).  One hemichannel from each of two neighboring cells 
docks together to form a gap junction and then multiple gap junctions cluster together in the membrane to 














Currently over twenty isotypes of connexin have been identified and are named by their 
molecular weight.  Figure 2.2 shows the structure of a connexin protein in the cell 
membrane.  The protein contains four transmembrane regions along with two 
extracellular domains and one cytoplasmic loop.  The N-terminus and C-terminus are 
both located within the cytoplasm.  While the majority of the connexin protein structure 
is conserved amongst the different isotypes, unique characteristics are usually found in 
the C-terminus which is thought to potentially be involved in gating and giving the 
channel particular charge and size characteristics. (112) 
Gap junctions cluster in the membrane at regions of cell-cell contact to form a gap 
junction plaque and regulate flow of chemical and electrical information through their 
pores.  While classically connexins and hemichannels were thought to only function 
when assembled into gap junctions, new evidence demonstrates otherwise.  
Hemichannels are routinely identified in the cell membrane but it has been assumed that 
their pores were closed and they were simply moving towards a gap junction plaque. 
(113)  Data now shows that hemichannels do open with functions including release of 
ATP and propagation of calcium waves.  Furthermore, their open/closed state is highly 
regulated by membrane voltage and pH. (114-116)  There is also new evidence 
supporting functions for connexins which are independent of hemichannels or gap 
junctions.  Connexins are often seen in the nucleus or cytoplasm and studies have shown 
they play roles in controlling cell growth and tumorigenicity as well as cell 
differentiation. (117)  While knowledge regarding connexin and hemichannel functions is 


















Figure 2.2 General Connexin Protein Structure 
Connexin protein structure is conserved across multiple isotypes and contains four transmembrane regions, 
two extracellular domains, one cytoplasmic loop.  The N-terminus and C-terminus are located within the 












Connexins and gap junctions in the cardiovascular system were first studied in the 
heart for their roles in connecting cells of the myocardium and propagating electrical 
signals regulating heart beat.  Changes in levels of connexin expression or alterations in 
pattern of connexin expression are known to lead to numerous cardiac rhythm 
abnormalities. (118)  Recently interest in the role of connexins in the vascular wall has 
begun to build with evidence that they play critical and poorly understood roles in 
vascular development and disease.  Endothelial cells are known to express Connexin 37, 
Connexin 40 and Connexin 43 while smooth muscle cells express Connexin 40, 
Connexin 43 and Connexin 45. (13, 119)  Distribution of these connexins varies amongst 
vascular beds and in different species as well as between in vivo and in vitro experimental 
settings. (120, 121)  It is thought that the heterogeneity in cellular and vascular bed 
distribution is linked to specialized functions of the connexin isotypes and needs for 
cellular communication that are not yet understood. (122)  Gap junctions coordinate 
cellular responses within the endothelium and also within the layers of smooth muscle 
cells in the vascular media.  In addition to homocellular connections, heterocellular 
connections also exist.  Most notably, there are myoendothelial gap junctions (MEGJ) 
which link endothelial cells and smooth muscle cells together. (120, 123)  While their 
existence was only recently confirmed, it is believed that signals passed through 
myoendothelial gap junctions function to control vascular tone. (124).   
 
Properties and Regulation of Gap Junctions 
 The life cycle of a gap junction is usually rapid with half-lives documented 
starting at 1 hour and regulation occuring at numerous points.  Connexins are transcribed 
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from the DNA into mRNA and then translated into protein in the rough endoplasmic 
reticulum (ER).  Connexin proteins oligomerize into hemichannels in the rough ER or in 
the trans Golgi network.  They are trafficked to the cell surface in vesicles and inserted 
into the plasma membrane where they travel to the periphery of a gap junction plaque to 
dock with hemichannels from a neighboring cell. (113, 125)  Connexins which are 
misfolded do not get incorporated into the membrane but are degraded in the proteosome.  
Gap junctions are removed from the center of the plaque in annular gap junctions, which 
contains hemichannels and membrane from both cells, and are trafficked to lysosomes 
where they are degraded.  Degradation is not an all or none phenomenon as there are 
documented cases of partial truncation and diversion to the proteosome rather than the 
lysosome. (126, 127) 
While much regulation of gap junction function is related to the open/closed state 
of the pore and trafficking of channels to and from the membrane, it is increasingly clear 
that connexins are highly regulated.  A widespread trend of mismatched levels of mRNA 
and protein for connexins in the literature is noted in multiple recent reviews. (128-130)  
Explanations for this phenomenon may lie in the complex processes used by cells to 
control connexin expression, gap junction formation and cell communication; however 
the mechanisms underlying these processes are largely unknown.  Initial investigations of 
gene structure and mRNA translation provide some insight into potential mechanisms 
however studies in these areas are ongoing. 
At the transcriptional level, mouse genes for Cx37, Cx40 and Cx43 have been 
analyzed to evaluate structure and potential regulatory mechanisms.  All three genes 
contain a TATA box and numerous putative transcription factor sites.  Cx37 is known to 
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also contain a GC box and a CCAAT box which may be involved in its regulation. (130)  
Cx40 and Cx43 both contain transcription factor binding sites for SP-1, AP-1 and AP-2 
as well as several other sites unique to each gene. (131, 132)  Human connexin sequences 
are similar to the mouse although some differences have been noted and future studies 
based on the sequencing of the human genome are sure to provide additional information. 
(133-135) 
At the post-transcriptional level, multiple mechanisms are thought to be involved 
in connexin regulation including mRNA stability, mRNA localization, rate of translation, 
efficiency of translation, and translation in the absence of normal machinery.  Specific 
mechanisms of control for connexins which are currently being investigated include 
sequences in the 5’UTR (untranslated region) and uORF (upstream open reading frame) 
as well as the presence of an IRES (internal ribosome entry sequence).   
Cx37 is the least investigated of the vascular connexins due to its relatively recent 
identification and restricted expression in the body.  Post-transcriptional control has not 
been specifically investigated for Cx37 although differing levels of mRNA and protein 
have been commonly seen. (130)  Additionally, all connexin genes have a 5’UTR longer 
than the normal length for cellular mRNAs (>50 nucleotides) which has been suggested 
to include a mechanism of regulation which requires a longer sequence. (136)  Mouse 
Cx40 was shown to contain a number of alternative promoters which result in multiple 
mRNA transcripts which contain identical coding regions but varied 5’UTR. (128)  It is 
currently unknown if this influences the translatability of the Cx40 message but similar 
structures in Cx32 and Cx43 have just such an effect.  Additionally, some Cx40 mRNA 
transcripts contain an extra noncoding exon whose function is currently unknown but has 
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been hypothesized to be involved in translataional control, mRNA localization or mRNA 
stability. 
Due to the early identification and widespread importance of Cx43, it is the most 
heavily investigated of the vascular connexins.  Analysis of Cx43 structure has identified 
mechanisms of post-transcriptional control involving an IRES and additional exons for 
alternative 5’UTRs. (129, 137)  An internal ribosome entry sequence (IRES) as detected 
in Cx43 is relatively uncommon in cellular mRNA because it allows the ribosome to 
translate the mRNA into protein from a point inside the sequence rather than at the 5’ cap 
which is normally required to start translation machinery.  The advantage of this system 
is that translation can occur under cellular conditions where the 5’ cap may be 
unavailable thus allowing the cell to maintain production of critical proteins. (136)  
Furthermore, it has been shown that IRES activity in cellular mRNAs can be modulated 
by mitotic stimuli, hypoxia and other stresses which adds an additional level of control. 
(138)  Finally, analysis of mouse Cx43 structure has shown the presence of four 
additional exons encoding for different 5’untranslated regions (UTR). (129)  Using 
different promoters and alternative splicing there are nine different mouse Cx43 mRNA 
transcripts which vary only in non-coding regions and have been demonstrated to exhibit 
a range of translational efficiencies.  It is unknown at this time if the human Cx43 
sequence also contains multiple additional 5’UTRs and if so, whether they play a role in 
mRNA stability and translation. 
Along with regulation of mRNA and protein expression, connexin function is also 
modulated through phosphorylation sites.  All connexins except Cx26 are 
phosphoproteins although the precise interacting partners and downstream functions for 
 24
each connexin isotype are not fully known.  Phosphorylation has been implicated in 
connexin biosynthesis, trafficking, assembly, membrane insertion, channel gating, 
internalization and degradation. (113, 114, 126, 139)  Connexin 43 is most extensively 
studied for its phosphorylation properties with several known consensus sites identified 
in the carboxy terminus which is located in the cytoplasm during membrane insertion.  
Several of these phosphorylation sites are known targets of protein kinases including 
protein kinase C and MAPK. (140)  Both mouse and human Connexin 37 are thought to 
be phosphorylated mainly on their serine residues, however interacting proteins have not 
be definitively determined. (141, 142) 
Six individual connexin proteins assemble together to form one hemichannel and 
two hemichannels form one gap junction, thus twelve connexin proteins are involved in 
creation of one gap junction.  It was originally believed that only connexins of one 
isotype could interact to form a hemichannel or gap junction, however the ability of 
certain connexins to mix and match has now been demonstrated. (112, 143)  Three types 
of gap junction channels are possible: i) homomeric/homotypic ii) 
homomeric/heterotypic iii) heteromeric/heterotypic.  Homomeric or heteromeric refers to 
the connexins which make up a hemichannel and homotypic or heterotypic refers to the 
hemichannels which make up a gap junction.  Homomeric/Homotypic (HoM/HoT) gap 
junctions are assembled from one type of connexin making up the hemichannel in one 
cell binding to a hemichannel from another cell made of the same connexins.  
Homomeric/Heterotypic (HoM/HeT) gap junctions are assembled from two 
hemichannels where the connexins in each hemichannel are the same but the 
hemichannels from the two cells are of different connexins.  Heteromeric/Heterotypic 
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(HeM/HeT) gap junctions are assembled from hemichannels with more than one type of 
connexin.  If two connexins are expressed in a given cell population, then 14 
hemichannel combinations are possible resulting in 196 possible gap junction 
combinations.  If three connexins are expressed in a given cell population, then 21 
hemichannel combinations are possible resulting in 441 possible gap junction 
combinations. 
To further complicate matters, mixed gap junctions have properties of voltage-
dependent gating, chemical gating, permeability and selectivity which are different from 
their single-connexin counterparts. (144-146)  Gating of gap junction channels is often 
regulated by membrane voltage and different connexin isotypes are sensitive to different 
voltage ranges.  Compared to HoM/HoT junctions, HoM/HeT junctions exhibit a variable 
degree of asymmetry in voltage gating rather than an average of the two connexins 
involved.  This may be explained by multiple voltage-sensitive gates or modification of 
gating behavior in docking of the two different hemichannels.  In HeM/HeT junctions, 
one might assume that the overall channel gating behavior would arise from the relative 
contributions of each connexin involved.  While this is sometimes the case, studies have 
demonstrated behaviors not predicted solely by composition.  This may be explained by 
some connexins dominating over others, interactions amongst connexins within the 
hemichannel and interactions between the two hemichannels. 
Gap junction gating is also influenced by chemical environment and most notably 
the pH.  Data suggest that connexin-connexin and hemichannel-hemichannel interactions 
combine to influence the sensitivity and kinetics of the pH-sensitive gating response.  A 
similar phenomenon is seen in channel permeability and selectivity.  While these 
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characteristics are predominantly determined by the size of the channel pore, there are 
also electrostatic charges lining the pore and charges lining the vestibule region which 
contribute to specificity.  It appears that some connexins dominate over each other, 
similar to a “limiting reagent” phenomenon, however the numerous combinations of 
HeM/HeT channels in addition to the multiple dyes with various characteristics make a 
thorough characterization of these properties very difficult. 
Of the vascular connexins, Cx37 and Cx40 are known to form HoM/HeT junction 
with conductance properties different from homotypic Cx37 or Cx40 junctions. (147)  
Heteromeric mixing of Cx37 and Cx40 is certainly possible but has not been investigated 
to date.  Cx37 and Cx43 form both HoM/HeT and HeM/HeT junctions.  Heterotypic cell 
pairs display asymmetric voltage dependence and the HeM/HeT cell pairs have 
characteristics distinct from HoM/HoT and HoM/HeT combinations indicating 
interactions between the connexin isotypes. (142, 148)  Connexins 40 and 43 have also 
been demonstrated to form HoM/HeT and HeM/HeT gap junctions.  Each combination 
has properties which are distinct from other permutations indicating both connexin-
connexin and hemichannel-hemichannel interactions. (149-151) 
 
Vascular Connexins 
With a focus on endothelial cell biology, it is most intriguing to note that while 
gap junctions form between endothelial cells, they also form between endothelial cells 
and smooth muscle cells, pericytes and neutrophils.  Investigating these heterocellular  
gap junctions is important in understanding the roles they play in normal vascular 
function and disease.  It is widely believed that the direct communication between 
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endothelial cells and smooth muscle cells, in addition to the connections which exist 
among each cell type, allow the vascular wall to act as a unit in response to a stimulus. 
(122)  Early studies of conductivity in arterioles first suggested that endothelial and 
smooth muscle cells are electrically coupled in both a homocellular and heterocellular 
manner. (152)  Subsequently, multiple dyes were used to trace the patterns of the 
potential endothelial-smooth muscle cell coupling units. (153)  Anatomical evidence for 
myoendothelial gap junctions was then uncovered along with studies identifying 
movement of calcium and endothelial-derived hyperpolarizing factor directly between the 
two cell types. (154-156)  The first in vitro study of myoendothelial gap junctions was 
recently reported where an endothelial-smooth muscle cell co-culture system was 
developed to better understand the role of specific connexin isotypes in their formation. 
(157) 
Similar to smooth muscle cells, gap junctions between pericytes and endothelial 
cells have been detected in vivo. (158)  In vitro investigations have shown gap junctions 
between microvascular endothelial cells, between pericytes and in co-culture models, 
transfer of dye and nucleotides between the two cell types. (159)  More recently it was 
discovered that endothelial cells communicate directly with cells present in blood.  
Neutrophils couple to endothelial cells through gap junctions during transmigration into 
the vascular wall. (160) 
Gap junctions in the vascular system are responsible for communication between 
cells and coordinating signals for a tissue-level response.  However, as with most 
biological systems critical to normal function, alterations in the system can lead to 
disease and disease in turn can impact the system.  While roles for connexins have been 
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identified in both cardiac dysfunction and angiogenesis, we will focus on the evidence 
linking gap junctions to hypertension and atherosclerosis. (11, 118, 161, 162)  In a recent 
study, the Cx43 gene was knocked out only in vascular endothelial cells therefore 
providing a model in which the role of connexins in the vascular wall can be studied 
without the confounding influence of perinatal death or impaired fertility of mice. Of 
particular interest is the finding that the VEC Cx43-/- mice exhibit hypotension and 
bradycardia compare to heterozygous littermates indicating a role for endothelial cell 
Cx43 in maintaining normal vascular function.(163)  Further demonstrating the link 
between connexins and hypertension are results from spontaneously hypertensive rats 
which show reduced connexin expression compared to normal controls. (164)  Rats 
induced for hypertension also show reduced Cx37 and Cx43 expression but no change in 
Cx40 expression in endothelial cells compared to normotensive animals.  This reduction 
can be partially recovered by one drug treatment and completely restored by another drug 
treatment. (165) 
Connexins in the vascular wall have also been linked to the prevalence of 
atherosclerosis and have been shown to vary in expression with the progression of 
plaques.  Heterozygous Cx43+/- mice exhibit a 50% decrease in atherosclerotic plaques 
in vivo and in vitro experiments have shown that statins reduce the Cx43 expression in 
endothelial and smooth muscle cell cultures. (166)  Cx37 and Cx40 expression is reduced 
in endothelial cells of hyperlipidemic mice and only Cx37 levels recover with lipid-
lowering drug treatment. (167)  An altered pattern of connexin expression in endothelial 
and smooth muscle cells is seen in non-diseased arteries, early atheromas and advanced 
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atheromas. (168)  Finally, naturally occurring Cx37 variants have also been implicated in 
the prevalence of atherosclerosis in human populations. (169)  
With their primary function being to promote communication between cells, gap 
junctions are critical in development of many tissues.  There are four connexins 
expressed in the developing mouse heart: Cx37, Cx40, Cx43 and Cx45.  Cx37 is 
expressed in endothelial cells of blood vessels and in the endocardium, Cx40 is expressed 
in myocytes and appears to be regionally controlled while Cx43 often has either 
overlapping or complementary expression to Cx40 depending on the tissue region. (170)  
Knockout connexin models elucidate functions in development but attempts to study 
connexin influence on vascular wall biology have been hampered by the widespread 
expression of these molecules in other tissues and the drastic influence of knocking out 
the gene in all tissues.  Cx37-/- mice are viable but females are infertile because of 
abnormal development of both oocytes and ovarian follicles. (171)  Cx40-/- mice are 
viable but have prolonged atrioventricular conduction, right bundle branch block and a 
predisposition for arrhythmias. Furthermore, Cx40-/- mice have diminished conduction 
of arteriolar dilatation in response to acetylcholine and bradykinin and are hypertensive 
but have no other obvious blood vessel abnormalities. (172)  Cx43-/- mice die perinatally 
due to abnormal development of the pulmonary outflow tract from atypical migration of 
cardiac neural crest cells. (173)  Single knockout connexin mice have characterized 
phenotypes which are largely non-blood vessel related because of the widespread 
expression of these molecules and their presumed functional overlap within the vessel 
wall. When in vivo expression of connexins is reduced further using a multiple knockout 
strategy, there are severe blood vessel abnormalities indicating an important interplay 
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between the functions of connexins.  Cx37-/- Cx40-/- mice die perinatally with 
hemorrhages and severe blood vessel dilatation. (174)  Cx40-/- Cx43-/- have also been 
reported to die at E12.5 with malformed hearts including abnormally rotated 
ventricles.(175) 
While knockout models provide valuable information regarding the missing gene, 
several reports have identified effects on non-ablated connexins.  Evaluation of Cx40-/- 
mice found expression of Cx37 protein upregulated three-fold and redistributed in a more 
homogeneous manner. (176)  In a separate study of Cx37-/- and Cx40-/- mice, data 
showed a drop in endothelial Cx40 protein in Cx37-/- animals and a drop in endothelial 
Cx37 protein in Cx40-/- animals however no changes in mRNA levels were detected. 
(177, 178)  An additional evaluation of Cx40-/- animals showed reduced staining of 
endothelial Cx43 at the cell membrane and reduced expression of smooth muscle cell 
Cx43. (179)  Evidence of reduced Cx43 expression in smooth muscle cells of animals 
where Cx43 was knocked out only in endothelial cells (VEC Cx43-/-) supports the 
hypothesis that effects on non-ablated connexins are not restricted to one cell type. (163)  
Following a complementary approach, a study which transfected endothelial cells with an 
adenovirus for Cx37 demonstrated no change in Cx43 mRNA but a substantial drop in 
Cx43 protein. (180)   
While effects on non-targeted connexins in knockout models suggest overlapping 
functions of connexin isotypes, differential responses to chemical and pathologic stimuli 
have been demonstrated.  In endothelial cells, Cx43 is highly expressed in subconfluent 
cultures and levels decrease at confluence while Cx37 levels are minimal at 
subconfluence and rise when cells contact.  Furthering this polarity in behavior of 
 31
connexin isotypes is response to TGF-β1 where Cx43 levels increase and Cx37 levels 
decrease. (181)  Nitric oxide has also been shown to differentially affect endothelial 
connexin isotypes by decreasing coupling of gap junctions which contain Cx37 and 
increasing new formation of gap junctions which contain Cx40. (182, 183)  In response to 
injury in vivo, rat endothelial connexin expression drops initially and then over time Cx40 
expression returns to normal while Cx37 and Cx43 are expressed at higher levels than 
uninjured artery. (162)  In response to injury in vitro, wounding of an endothelial 
monolayer results in upregulation of Cx43 at the wounded edge, decrease in Cx37 at the 
injury site and no change in Cx40. (184)  Exposure of human endothelial cells to TNF-α 
resulted in a downregulation of Cx37 and Cx40 mRNA while Cx43 mRNA was 
unaffected. (185)  Finally, sepsis induced in a rat model increased Cx40 mRNA but did 
not alter expression of endothelial Cx37 or Cx43. (186) 
Of particular interest in the cardiovascular system where mechanical forces are 
known regulators of cell function, is the response of connexins and gap junctions to 
physical stimuli.  The first insight into the potential regulation of gap junctions by 
mechanical forces grew out of a study focused on mapping the regional distribution of 
Cx37, Cx40 and Cx43 in rat endothelium. (187)  While the distribution of Cx37 and 
Cx40 appeared in similar widespread patterns, it was noted that Cx43 expression was 
found mainly in regions near aortic branches where blood flow is disturbed.  Introduction 
of a flow disturbance into this model resulted in a strong upregulation of Cx43 in areas 
not previously showing high levels of expression.  An in vitro study of vascular cells and 
mechanical forces found a sustained upregulation of Cx43 protein in rat aortic smooth 
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muscle cells exposed to 20% stretch for 24 hours and a transient upregulation in Cx43 
mRNA in endothelial cells exposed to laminar shear stress. (188)   
Further investigation of endothelial cell Cx43 regulation by shear stress was 
conducted using an in vitro parallel plate flow chamber system which exposed cells to 
four types of fluid shear from recirculating to fully developed laminar flow. (189)  It was 
found that Cx43 mRNA was transiently upregulated by all flow patterns however 
upregulation was only sustained after 30 hours in areas of disturbed, recirculating flow.  
Furthermore, Cx43 protein appeared disorganized in regions of disturbed flow and cells 
showed little coupling as assessed by dye transfer indicating limited gap junction 
communication.  More recently, other endothelial cell connexins (Cx37 and Cx40) were 
also investigated in this in vitro flow system. (190)  Patterns of protein expression and 
roles of different connexin isotypes in endothelial gap junction communication were 
investigated using dye transfer techniques in conjuction with peptide channel blockers.  
In addition to studies focusing on vascular connexin response to mechanical forces, 
differential expression by shear stress has been reported in numerous microarray studies. 
(48, 81, 83) 
Although this dissertation focuses on gap junctions in the blood vessel wall, it is 
also interesting to note recent evidence of mechanical regulation in heart valves.  A 
microarray study evaluating gene expression of normal porcine valve leaflets identified a 
downregulation of Cx43 in endothelial cells from the aortic side of the leaflet compared 
to the ventricular side. (191)  Additionally, a separate immunohistological study 
evaluated the presence of connexin proteins on the upstream and downstream surfaces of 
rat heart valves.  Assessment of valve endothelial cells concluded equal expression of 
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Cx37 on both sides of the valve, no detectable expression of Cx40 protein and a 
differential expression of Cx43 with higher expression on the upstream surface compared 




CHAPTER THREE: Experimental Methods 
 
Experimental Procedures 
Human Cell Culture 
 Human aortic endothelial cells (HAEC) (Cambrex) were cultured to passage 6 in 
MCDB 131 supplemented with 5% FBS, 1% penicillin-streptomycin, 1% l-glutamine, 
10ng/ml EGF, 2ng/ml FGF-basic, 1ng/ml VEGF, 2ng/ml IGF-1, 50µg/ml ascorbic acid 
and 1µg/ml hydrocortisone.  Human aortic smooth muscle cells (HASMC) (Cambrex) 
were cultured to passage 8 in MCDB 131 supplemented with 5% FBS, 1% penicillin-
streptomycin, 1% l-glutamine, 0.5ng/ml EGF, 2ng/ml FGF-basic, 5µg/ml insulin.  All 
experiments were conducted in a co-culture media of MCDB 131 supplemented with 5% 
FBS, 1% penicillin-streptomycin, 1% l-glutamine, 0.5ng/ml EGF and 2ng/ml FGF-basic 
which were common to both cell culture mediums. 
 
Substrate Fabrication 
Adsorbed Collagen Slide 
The Adsorbed Collagen Slide substrate was created by coating a glass slide with 
50 µg/ml collagen type I (BD Biosciences) and allowing protein to adsorb to the surface 
for one hour prior to removal of the solution.  Endothelial cells were seeded at a density 
of 40,000 cells/cm2 to produce a confluent monolayer and cultured for 48 hours prior to 
exposure to static or shear conditions. 
For RNA interference studies, a silicone gasket was adhered to the perimeter of 
the glass slide.  The gasket then provided a means to contain higher fluid volumes needed 
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for transfection but could be removed prior to static or shear stress experiments.  
Following adhesion of the gasket, slides were autoclaved and coated with 50 µg/ml 
collagen type I for one hour.  Endothelial cells were then seeded at 35,000 cells/cm2 and 
cultured for 24 hours prior to transfection. 
 
Tissue Engineered Blood Vessel Wall Model (TEWM) 
The Tissue Engineered Wall Model substrate was created by suspending 1 million 
HASMC per ml in 5x concentrated MCDB-131, 10% FBS and 2 mg/ml rat tail type I 
collagen (BD Biosciences).  Sodium hydroxide was added to neutralize the acidic 
collagen solution and promote polymerization.  Tubular HASMC-collagen gels were 
created using a central mandrel during gelation and were cultured for six days to allow 
for cell-mediated compaction of the collagen fibers.  The tubular gels were then cut 
longitudinally and embedded in agar to expose a flat lumen for seeding of HAEC and 
fluid shear experiments. (43)  Figure 3.1 shows a tubular HASMC-collagen gel following 
static culture in panel A and then embedded in agar supported by a polycarbonate mold in 
panel B.  Endothelial cells were seeded at a density of 40,000 cells/cm2 to produce a 




































Figure 3.1 Tissue Engineered Blood Vessel Wall Model 
Panel A shows a tubular HASMC-collagen gel following six days of static culture.  Panel B shows the 







Exposure to Shear Stress 
The parallel plate flow chamber used to expose endothelial cells to laminar shear 
stress has been previously established in our laboratory. (42, 49)  In this closed loop, a 
peristaltic pump moves medium from a container into a pulse dampener and then through 
parallel plates where endothelial cells are exposed to a steady laminar shear stress.  Shear 
stress is controlled by fluid flow rate and dimensions of the chamber according to the 
equation: τ = 6Qµ/bh2.  Exposure of endothelial cells on the tissue engineered wall model 
was accomplished by placing the entire mold/agar apparatus into the flow chamber as 
depicted in Figure 3.2.  To expose endothelial cells on the slide to shear stress, the 
identical system was used except instead of the mold immobilized TEWM in the flow 
chamber, the collagen coated slide was inserted.  Endothelial cells on all substrates were 
exposed to a shear stress of 15 dynes/cm2 for 24 hours. 
 
Endothelial Isolation from TEWM 
To evaluate endothelial cell gene and protein expression following culture on the 
TEWM, pure endothelial cells must be removed without contamination of neighboring 
smooth muscle cells.  To achieve a pure population of endothelial cells with adequate 
quantity for further analysis, a positive selection technique was developed.  Following 
cell exposure to static or shear stress conditions, the TEWM lumen was briefly treated 
with 600U/ml collagenase and scraped gently to release cells near the surface.  The cell 
mixture was incubated with a primary PE-conjugated antibody to PECAM-1 (Santa Cruz) 








































Figure 3.2 Parallel Plate Flow Circuit Exposes Endothelial Cells to Shear Stress 
Endothelial cells can be exposed to shear stress in the flow chamber on a TEWM substrate (as depicted) or 
















Smooth Muscle Cells 




Following a brief wash, the cell mixture was then incubated with a magnetic 
bead-conjugated secondary antibody to PE which binds the primary antibody.  The cell 
mixture with labeled endothelial cells was passed through a separation column placed in 
a magnetic field.  Due to the magnetic bead secondary antibody, endothelial cells were 
trapped in the column and smooth muscle cells passed through into the negative effluent.  
Following multiple washes, the separation column is removed from the magnetic field 
and trapped endothelial cells are flushed out into the positive effluent.  With the entire 
process lasting 45 minutes and conducted almost entirely on ice or at 4°C, endothelial 
cells can be fixed or lysed for mRNA or protein analysis. 
Effectiveness of the magnetic separation procedure was validated using pre-
labeled endothelial cells mixed with smooth muscle cells and flow cytometry analysis 
post-separation.  Endothelial cells in culture were incubated with 5µM cell tracker orange 
(Molecular Probes) in DMSO and serum-free media for 45 minutes to label the 
cytoplasm which would allow them to be distinguished from unlabeled smooth muscle 
cells in downstream analysis.  Orange endothelial cells were then seeded onto the TEWM 
which contained unlabeled smooth muscle cells.  Following the magnetic separation 
technique, samples of cell mixture (column feed), negative effluent and positive effluent 
were analyszed using flow cytometry.   
Figure 3.3 details composition of the cell mixture before and after magnetic 
separation.  Panel A shows the column feed which contains both endothelial cells 
(fluorescent orange) and smooth muscle cells (autofluorescence only).  Panel B shows the 
composition of the positive effluent which contains cells which were trapped in the 













































Figure 3.3 Validation of Endothelial Cell – Smooth Muscle Cell Separation 
Panel A shows the mixture of endothelial and smooth muscle cells removed from the TEWM which is fed 
into the magnetic separation column.  Panel B shows the positive effluent which is retrieved from the 
column following separation containing pure endothelial cells.  Panel C shows the negative effluent which 








Pure endothelial cells are selected by the column as shown by the presence of the 
fluorescent orange peak and absence of the smooth muscle cell peak.  Panel C shows the 
composition of the negative effluent which contains cells which passed through the 
separation column and magnetic field.  This cell mixture contains mostly smooth muscle 
cells with some endothelial cells which were not trapped in the column.  Thus by positive 
selection using PECAM-1 based magnetic separation, a pure population of endothelial 
cells can be obtained in a rapid and reliable manner. 
To explore any effects of the magnetic cell separation on endothelial cell gene 
expression, microarrays were used to compare transcriptional profiles.  Endothelial cells 
were either i) lysed and RNA collected immediately or ii) followed the entire labeling 
and magnetic separation procedure prior to lysis and RNA isolation.  Microarray 
comparisons (n=2) detected changes in 34 genes (fold change > 1.5 and p-value < 0.01) 
out of a total possible 12,814 genes.  With changes in only 0.2% of genes and fold 
changes not exceeding 3-fold, the procedure does not significantly alter endothelial cell 
gene expression and can thus be used for subsequent analysis. 
 
RNA Interference 
RNA interference was conducted using short interfering RNA (siRNA) designed by and 
purchased commercially from Ambion.  Multiple sequences were tested for ability to 
knockdown target connexin mRNA at least 70% without other adverse effects (eg. cell 
death).  In addition to sequences targeting connexins, a negative control siRNA labeled 
with Cy3 (Negative Control #1 – Ambion 4621) which does not target any known human 
sequence was used to develop transfection protocols and to evaluate the effect of the 
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transfection procedure on endpoints.  The following siRNA sequences designed for the 
human sequence were successfully used to knockdown connexin mRNA. 
Cx37: Ambion siRNA ID#7185, annealed, standard purity 
Cx37 Sense (5’ to 3’): GGACUUGAUCACAAAAAAAtt 
Cx37 Antisense (5’ to 3’): UUUUUUUGUGAUCAAGUCCtg 
Cx40: Ambion siRNA ID#145161, annealed, standard purity 
Cx40 Sense (5’ to 3’): GGUAAACGAUGCUUGGAAUtt 
Cx40 Antisense (5’ to 3’): AUUCCAAGCAUCGUUUACCtt 
Cx43: Ambion siRNA ID# 144485, annealed, standard purity 
Cx43 Sense (5’ to 3’): GCCUUAUUCAUGAGGCUUAtt 
Cx43 Antisense (5’ to 3’): UAAGCCUCAUGAAUAAGGCtg 
 Endothelial cells were transfected under serum-free conditions using OptiMEM 
medium (Invitrogen) with the chemical transfection reagent Oligofectamine (Invitrogen).  
Development of transfection protocols using Cy3-labeled negative control siRNA 
allowed for confirmation of siRNA entry into endothelial cells and residence over time.  
Dosage studies showed knockdown of each connexin mRNA by >80% with siRNA 
concentrations ranging from 10nM to 80nM.  Figure 3.4 shows a dosage study of the 
siRNA sequence identified which successfully knocks down Cx37.  Comparison to the 
OptiMEM control shows a significant reduction in Cx37 mRNA with treatment doses 
ranging from 10nM to 80nM.  Figure 3.5 shows a dosage study of the siRNA sequence 
identified which successfully knocks down Cx40.  Comparison to the OptiMEM control 
shows a significant reduction in Cx40 mRNA with treatment doses ranging from 10nM to 


































Figure 3.4 Dosage Study of Cx37 siRNA Knockdown of Cx37 mRNA 
Endothelial cells treated with Cx37 siRNA at multiple treatment dosages show reduced expression of Cx37 
mRNA compared to a control sample. 



















































Figure 3.5 Dosage Study of Cx40 siRNA Knockdown of Cx40 mRNA 
Endothelial cells treated with Cx40 siRNA at multiple treatment dosages show reduced expression of Cx40 
mRNA compared to a control sample. 
 



















































Figure 3.6 Dosage Study of Cx43 siRNA Knockdown of Cx43 mRNA 
Endothelial cells treated with Cx43 siRNA at multiple treatment dosages show reduced expression of Cx43 
mRNA compared to a control sample. 
 
 






























Figure 3.6 shows a dosage study of the siRNA sequence identified which successfully 
knocks down Cx43.  Comparison to the OptiMEM control shows a significant reduction 
in Cx43 mRNA with treatment doses ranging from 5nM to 80nM.  A broader range of 
siRNA dose using in this study shows a reduced capability to knock down Cx43 mRNA 
at the 1nM level. 
 A time course study using 10nM siRNA demonstrated knockdown of target 
mRNA for 96 hours following transfection.  Cells were transfected starting at time zero 
for six hours, at which point serum was added to promote cell survival.  At 48 hours, 
transfection reagents were removed and cells were exposed to experimental medium.  
This time course of RNAi steps was identical to the timeline of later experiments.  Figure 
3.7 shows time course data for knockdown of connexin mRNA in siRNA treated samples 
compared to controls.  Panel A shows knockdown of Cx37 mRNA by Cx37 siRNA and 
panel B shows knockdown of Cx43 mRNA by Cx43 siRNA.  Connexin levels are higher 
in OptiMEM controls compared to siRNA treated cells at 24 hours and 48 hours while 
cells are still exposed to transfection reagents.  Removal of transfection reagents and 
addition of experimental medium results in an increase of connexin mRNA in control 
samples but the knockdown remains in effect in siRNA treated samples.  Time course 
data shows a knockdown in connexin mRNA using RNA interference as early as 24 












































Figure 3.7 Time Course of Connexin mRNA Knockdown by siRNA 
Endothelial cells treated with a low dose (10nM) of siRNA show reduced expression of target mRNA up to 
96 hours following transfection.  Panel A shows time course of Cx37 mRNA following Cx37 siRNA 
transfection compared to control.  Panel B shows time course of Cx43 mRNA following Cx43 siRNA 
transfection compared to control. 
















OptiMEM control Cx37 siRNA 10nM


































To avoid any potential side effects of abundant siRNA in the cells but ensure a cushion of 
adequate knockdown, a concentration of 40nM was chosen for all studies.  Thus the 
siRNA transfection and experimental timeline is as follows. 
 Endothelial cells were seeded onto collagen coated glass slides and cultured for 
24 hours prior to transfection at which point they are 90% confluent.  Stock siRNA in 
sterile, RNase-free water is diluted in OptiMEM medium and oligofectamine transfection 
reagent is also diluted in OptiMEM medium.  The two mixtures are combined to create a 
transfection cocktail which sits at room temperature for 20 minutes to allow complexing 
of siRNA by oligofectamine.  Endothelial monolayers are rinsed twice in OptiMEM to 
remove any remaining culture medium and thus all serum and antibiotics.  OptiMEM is 
added to endothelial slides and the transfection cocktail is added dropwise to each 
sample.  Cells are transferred to the incubator at 37°C and transfection proceeds for 6 
hours.  During the transfection process, the final concentration of siRNA is 40nM and the 
final concentration of oligofectamine is 0.4% (10µL in 2.5mL).  After six hours, a 
volume of experimental media with 22% FBS is added to the 
OptiMEM/oligofectamine/siRNA mixture to restore the total FBS concentration to 5%.  
Slides are incubated for an additional 42 hours (total of 48 hours since transfection) prior 
to removal of the mixture of OptiMEM/oligofectamine/siRNA/FBS/experimental media 
and beginning of the 24 hour experimental period where cells are exposed to static or 
laminar shear stress.  All manipulations of siRNA are conducted under sterile, RNase-






Total RNA was extracted from endothelial cells using an RNeasy kit (Qiagen) 
with an added DNase digestion step.  To evaluate quality of RNA prior to microarray or 
RT-PCR analysis, samples were assessed using the RNA 6000 Nano LabChip (Agilent) 
on an Agilent Bioanalyzer 2100.  Profiles of ribosomal peaks were evaluated for 
degradation as a measure of overall RNA degradation and preliminary measurements of 
RNA quantity were determined.  Bioanalyzer analysis can evaluate integrity of RNA 
samples using very low quantities due to its quantitative range of 25-500ng/µl.  Of total 
RNA samples, approximately 90% is ribosomal RNA while only 1-3% is mRNA.  
Ribosomes have two subunits of differing size which allows for gel separation and 
evaluation.  By examining the degradation of ribosomal RNA subunits, the degree of 
possible mRNA degradation can be determined since degradation is not specific to type 
of RNA.  Figure 3.8 depicts electopherogram analysis of two RNA samples.  Panel A 
shows an intact endothelial RNA sample with two clearly defined ribosomal peaks.  
Panel B shows a partially degraded endothelial RNA sample which is apparent from the 
double peak and bumpy baseline.  Following screening by Bioanalyzer, quantity of high 
quality RNA was assessed by absorbance at 260nm prior to use in microarray or reverse 








































Figure 3.8 Bioanalyzer Analysis of Endothelial RNA Integrity 
Bioanalyzer analysis evaluates quality of RNA samples prior to use in RT-PCR or microarray analysis. 
Panel A shows intact RNA with two clearly defined ribosomal subunit peaks.  Panel B shows degraded 
















































Following quality analysis by Bioanalyzer 2100 and quantity assessment by UV 
absorbance, 500ng of total RNA from experimental samples and from Reference RNA 
were prepared for competitive microarray hybridization.  Samples were amplified using 
the Agilent Low RNA Input Fluorescent Linear Amplification Kit and labeled with Cy-3 
and Cy-5 CTP (Perkin-Elmer).  Hybridization was performed using the Agilent In Situ 
Hybridization Plus kit to 44,000 60-mer Human Whole Genome Oligo Microarrays 
(Agilent).  Arrays were scanned using the Agilent dual laser DNA microarray scanner 
with SureScan technology and image extraction was conducted using Agilent Feature 
Extraction software 7.5.1.   
 
Microarray Data Analysis 
GeneSpring® software was used to normalize data, interpret triplicates, filter 
spots and generate experiment files for gene expression analysis.  It was also used to 
calculate significance and fold change values for all genes.  Ingenuity Pathways 
Analysis® was used to interpret genes identified as significant in the context of known 
biological functions and disease states. 
Following hybridization, scanning and image extraction, raw data was analyzed 
using GeneSpring® software.  First, the entire data set was examined to determine the 
number of spots on the array from which a signal could be read.  Each spot on each array 
was given an evaluation and the total number of spots with flags present or marginal was 
determined.  The second criteria was that flags for each spot be present or marginal in all 
twelve arrays analyzed.  Following identification of spots which can be analyzed, an 
 52
ANOVA was run on the entire data set using the multiple testing correction (MTC) 
method: Benjamini and Hochberg False Discovery Rate.  Each gene was assigned a p-
value based on this ANOVA with MTC and the cutoff criteria was p-value < 1.  A 
multiple testing correction is necessary to adjust p-values in analysis of large sets of 
microarray data since the number of false positives is proportional to the number of tests 
performed.  For further analysis, the data set was split into pairwise comparisons and a 
student’s t-test was conducted on each pair of samples to determine significance for the 
comparison in question.  With the cutoff criteria of t-test p-value < 1, the number of 
genes was further reduced and the number of candidate genes for each comparison was 
identified.  Following the number of candidate genes being identified for each 
comparison, the next step was to identify the genes which were significantly different.  
To limit false positives, the most stringent set of criteria was used to identify significantly 
regulated genes: ANOVA with MTC p-value < 0.05 and t-test p-value < 0.05 and fold 
change > 1.5. 
 Data were analyzed through the use of Ingenuity Pathways Analysis (Ingenuity® 
Systems, www.ingenuity.com).  The purpose of Ingenuity Pathways Analysis (IPA) was 
to evaluate gene microarray data in a systematic fashion to gain insight regarding affected 
biological pathways and disease mechanisms.  For this software analysis, the user inputs 
genes designated as significant based upon user-defined criteria.  Genes which are 
entered into the program are overlaid into the Ingenuity Pathways Knowledge Base 
(IPKB) which is a constantly evolving database of molecular interactions developed 
based on published, peer-reviewed literature.  Genes that are deemed significant by the 
user and are found to interact with at least one other gene in the IPKB are designated 
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“focus genes”.  IPA then uses computational algorithms to identify networks of 
molecular interactions which are enriched for the focus genes.  Networks are ranked 
based on number of focus genes and overall size and are also assigned biological 
functions based on known diseases and cellular events.  IPA also conducts a Functional 
Analysis to identify the biological functions and/or diseases that are most significant in 
each data set.  Fischer’s exact test is used to calculate a p-value determining the 
probability that each biological function and/or disease assigned to that data set is due to 




Quantitative RT-PCR was used to assess mRNA expression in endothelial cells 
exposed to multiple experimental treatments.  One microgram of high quality endothelial 
RNA was reverse transcribed using the First Strand cDNA Synthesis Kit (Invitrogen) for 
each experimental sample.  Additionally, a –RT control sample was generated for each 
experimental sample following the cDNA synthesis procedure except for exclusion of the 
reverse transcription enzyme.  By conducting PCR on the –RT control as well as cDNA 
for each sample, any contamination of genomic DNA could be detected.   
Primers were designed using Primer Express (Applied Biosystems) and oligos 
were created by Integrated DNA Systems.   
Primer sequences are listed below for the four genes used in microarray data validation. 
Ang2 Forward: TCCTCCTGCCAGAGATGGAC 
Ang2 Reverse: TGCACAGCATTGGACACGTA 
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CYP1B1 Forward: TTTCGGCTGCCGCTACAG 
CYP1B1 Reverse: ACTCTTCGTTGTGGCTGAGCA 
E-selectin Forward: TTGGTAGCTGGACTTTCTGCTG 
E-selectin Reverse: CATTTCCGAAGCCAGAGGAG 
Pentaxin 3 Forward: TGGACAACGAAATAGACAATGGA 
Pentaxin 3 Reverse: CTGACCGCAGTCGCACG 
Primer sequences are listed below for the three connexins expressed in endothelial cells. 
Cx37 Forward: CATGGAGCCCGTGTTTGTG 
Cx37 Reverse: GAGACAAAGCAGTCCACGAGG 
Cx40 Forward: GGGCACTCTGCTCAACACCT 
Cx40 Reverse: TGAAGCCCACCTCCATGGT 
Cx43 Forward: TTAAGGGAAAGAGCGACCCTT 
Cx43 Reverse: GACCCACAGTCTTTGGCAGG 
Standards for each gene of interest were generated using PCR amplification and 
agarose gel separation.  Amplicons were extracted from agarose gel (Omega Bio-Tek) 
and pure cDNA was eluted.  Following quantification using UV absorbance, standards of 
known concentration were generated for each gene of interest.  Quantitative RT-PCR was 
conducted using cDNA from samples (in triplicate) and standards (in triplicate) with 
SYBR® Green PCR Master Mix (Applied Biosystems) on an ABI 7700 (Applied 
Biosystems) real time PCR machine.  Data was quantified using the absolute standard 
method where serial dilutions of the standard were plotted against CT values to generate a 




Single cell suspensions of endothelial cells were fixed in 4% formaldehyde for 5 
minutes, permeabilized in 0.1% Triton X-100 for 5 minutes and then incubated for 1 hour 
in 4% donkey serum to block non-specific binding of antibodies.  Cells were labeled with 
one of the following primary antibodies at 1:100 dilution: Rabbit Anti-Mouse Cx37 
(Alpha Diagnostic), Goat Anti-Human Cx40 (Santa Cruz Biotechnology), Goat Anti-
Human Cx43 (Santa Cruz Biotechnology) for 1 hour at 37°C.  Following two washes in 
T-TBS solution, cells were incubated with one of the following secondary antibodies: 
FITC-conjugated Donkey Anti-Rabbit (Jackson ImmunoResearch) or FITC-conjugated 
Donkey Anti-Goat (Jackson ImmunoResearch).  Control samples were fixed, 
permeabilized and blocked with experimental samples, then labeled with secondary 
antibody alone to account for autoflourescence and non-specific binding of secondary 
antibody.  Cell suspensions were analyzed using a BD LSR digital flow cytometer to 
determine mean fluorescence intensity of control and experimental samples.  During each 
sample run, standard beads (Bangs Labs) were analyzed to create a standard curve for 
conversion of fluorescence intensity measurements to units of MESF (molecules of 
equivalent soluble fluorescence). 
 
Western Blotting 
Endothelial cells were lysed in RIPA buffer (Sigma) with added protease inhibitor 
cocktail (Sigma) and centrifuged at 10,000rpm for 10 minutes to pellet DNA.  
Supernatant was collected and protein content was quantified using the BCA protein 
assay (Pierce) in comparison to albumin standards.  Samples were mixed with Laemmeli 
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buffer and heated at 95°C for 5 minutes prior to loading onto 12% Tris-Glycine gels 
(Invitrogen).  Following electrophoresis using Tris/Glycine/SDS running buffer (BioRad) 
of samples alongside a See Blue Plus 2 (Invitrogen) lane marker and a Magic Mark XP 
(Invitrogen) western protein standard of known molecular weights, proteins were 
transferred using Tris/Glycine transfer buffer (BioRad) to a PVDF membrane (BioRad).  
Blots were incubated overnight at 4°C in 5% milk in T-TBS to block non-specific 
binding before incubation with the primary antibody for 1 hour at room temperature.  
Blots were labeled with one of the following antibodies: Rabbit Anti-Mouse Cx37 (Alpha 
Diagnostic) at 1:500, Rabbit Anti-Mouse Cx40 (Alpha Diagnostic) at 1:500, Rabbit Anti-
Mouse Cx43 (Chemicon) at 1:1000 in 5% milk in T-TBS.  Following three washes in T-
TBS, blots were labeled the following secondary antibody: Horseradish Peroxidase 
Donkey Anti-Rabbit (Jackson ImmunoResearch) at 1:5000.  To measure signal, blots 
were covered with ECL Plus (Amersham Biosciences) for 5 minutes and then exposed to 
film.  Following staining of blots for the connexin protein of interest, membranes were 
stripped and reprobed for actin to ensure equal loading.  Antibodies used for this step 




To visualize connexin proteins, immunocytochemistry was conducted on 
endothelial cells following exposure to static or shear conditions.  Samples were fixed 
using 4% formaldehyde for 5 minutes for Slide samples and 1 hour for TEWM samples, 
permeabilized in 0.1% Triton X-100 for 5 minutes and then incubated for 1 hour in 4% 
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donkey serum to block non-specific binding of antibodies.  Cells were labeled with one 
of the following primary antibodies at 1:100 dilution: Rabbit Anti-Mouse Cx37 (Alpha 
Diagnostic), Goat Anti-Human Cx40 (Santa Cruz Biotechnology), Goat Anti-Human 
Cx43 (Santa Cruz Biotechnology) for 1 hour at 37°C.  Following two washes with PBS, 
cells were incubated with one of the following secondary antibodies: FITC-conjugated 
Donkey Anti-Rabbit (Jackson ImmunoResearch) or FITC-conjugated Donkey Anti-Goat 
(Jackson ImmunoResearch).  Samples were imaged using a laser-scanning confocal 
microscope with a 40x oil objective.   
 
Dye Transfer Assay 
Following exposure of endothelial monolayers to static or shear stress conditions, 
assessment of dye transfer between cells was conducted as a measure of gap junction 
communication.  In this assay of gap junction function, cells are loaded with two 
membrane-impermeant dyes: i) a small dye which can pass through gap junctions and ii) 
a large dye which cannot pass through gap junctions and is used to mark cells originally 
loaded with dye.  Following a defined period of time, cells are fixed and imaged to 
evaluate the extent of dye transferred from cells originally loaded with dye to 
neighboring cells as a measure of cell coupling by gap junctions.  In this study the dye 
used to pass through gap junctions is Biocytin (ε-biotinoyl-L-lysine) with a molecular 
weight of 372Da and neutral charge (Molecular Probes) and the dye used to mark cells 
originally loaded with dye is Tetramethylrhodamine Dextran (flouro-ruby) with a 
molecular weight of 10,000Da (Molecular Probes). 
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 Immediately upon removal from the static dish or flow chamber, monolayers are 
rinsed in Dulbecco’s PBS and excess fluid is blotted off.  A mixture of 4mg/ml Biocytin 
and 5mg/ml Rhodamine-Dextran in PBS is dripped onto the monolayer surface which is 
then scratched with a diamond-tipped pen (tip diameter 0.25mm).  Samples are 
immediately placed in the incubator at 37°C for 2 minutes to allow passage of dye.  
Excess dye is quickly removed, samples are rinsed in PBS and fixed in 4% formaldehyde 
for 20 minutes.  While the dextran is fluorescent, biocytin requires a secondary antibody 
for detection.  Monolayers are permeabilized with 0.1% Triton X-100 for 5 minutes and 
incubated with 4% donkey serum for 30 minutes to block non-specific binding prior to 
labeling with a secondary antibody Oregon Green 488 NeutrAvidin (Molecular Probes).  
Samples were imaged using a Nikon E600 fluorescent microscope using filters to 
separately detect red and green signals. 
 
Proliferation Analysis 
Endothelial cell proliferation was assessed using BrdU which is incorporated into 
DNA being synthesized during S-phase of the cell cycle.  BrdU is then detected using 
primary and secondary antibodies thus proliferating nuclei can be compared to non-
proliferating nuclei.  BrdU (5-bromo-2’-deoxyuridine) (MP Biomedicals) is added to 
experimental medium of slides being exposed to static or shear stress at a final 
concentration of 20µg/mL for the final 6 hours of the 24 hour experimental time period.  
At the end of the 6 hour exposure to BrdU, slides are fixed in 4% formaldehyde for 20 
minutes.  Cells are permeabilized by exposure to ice cold acetone for 10 minutes and then 
DNA is denatured by exposure to 2N HCL for 15 minutes at 37°C.  Following 
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neutralization and restoration of pH, slides are incubated with 5% donkey serum for 1 
hour at room temperature to block non-specific binding.  Slides are then incubated for 2 
hours at 37°C with 1:50 dilution of Mouse anti-BrdU (Sigma), rinsed with PBS and 
incubated with 1:200 Cy3-conjugated Donkey Anti-Mouse (Jackson ImmunoResearch) 
and 20µg/mL Hoechst 33258 (Molecular Probes) to detect both proliferating and non-
proliferation nuclei.  Slides are imaged using a laser scanning confocal microscope and 
images are analyzed using ImagePro software. 
 
Morphological Analysis 
To evaluate cell morphology, endothelial monolayers are stained for actin 
filaments and measured for elongation and angle of orientation.  Endothelial cell slides 
are fixed in 4% formaldehyde for 5 minutes, permeabilized in 0.1% Triton X-100 for 5 
minutes and incubated in 4% donkey serum for 30 minutes at room temperature.  
Monolayers are stained using Rhodamine-conjugated phalloidin (Invitrogen) which is a 
mushroom toxin that binds tightly to actin filaments.  Staining is conducted using 1:200 
phalloidin and Hoechst 33258 to identify nuclei.  Samples are imaged using a Nikon 
E600 fluorescent microscope using a triple filter to detect both red and blue signals.  
Images are analyzed using LSM 5 Image Browser (Zeiss) and an overlay writing tool is 
used to manually determine perimeter, area and angle of orientation.  Angle of orientation 
is measured from horizontal which is the axis of fluid shear stress.  Using perimeter and 
area data, a shape index of each cell is calculated according to the formula: SI = 
(4*Π*Area)/(Perimeter2).  The shape index ranges from 0 (indicating a straight line) to 1 
(indicated a circle) and quantifies elongation of endothelial cells. 
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CHAPTER FOUR: Transcriptional Profiling of Endothelial Cells Using 
a Tissue Engineered Blood Vessel Model 
 
Introduction 
Over the past several decades, there has been an explosion in research targeting 
the endothelium; the single-cell thick inner lining of blood vessels.  Endothelial cells are 
involved in numerous pathologic conditions which currently threaten global health in 
addition to playing a critical role in growth and development of the vasculature.  All of 
these studies investigating the role of endothelial cells in atherosclerosis or in 
angiogenesis or research evaluating their potential use as a therapy for myocardial 
infarction must choose a setting in which to ask questions: in vitro or in vivo. 
In vitro systems are simplified and controlled which allows reproducible probing 
of fundamental cellular mechanisms.  In vitro studies are particularly useful in isolating 
cellular pathways and in investigating response to an individual stimulus such as a 
growth factor or mechanical force.  In vivo systems more accurately represent the 
complexity in which the pathologic condition or developmental state resides.  In this 
physiologic environment, stimuli such as blood vessel structure and systemic circulation 
are included resulting in more variable, yet potentially more applicable data.  In vivo 
studies are extremely valuable when evaluating multifaceted processes such as 
atherosclerotic plaque development, growth of new blood vessels and control of 
hemostasis.  While the information gained through the use of in vitro and in vivo studies 
has been exceptionally valuable in building our understanding of the endothelium, there 
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is often a disconnect in relating in vitro and in vivo observations.  So we must ask if there 
is a way to bridge the gap between these two classical experimental settings. 
The primary focus of tissue engineering has been to develop living tissue 
substitutes which have a therapeutic value by repairing, replacing or enhancing function 
of native tissue.  However, there is an intermediate goal of tissue engineering whereby 
the living substitutes being generated can be used as more physiologic in vitro models.  
Tissue engineered constructs provide the link between traditional in vitro and in vivo 
systems as they are more complex than a single cell type on tissue culture plastic and yet 
are more controlled than an in vivo setting which includes all the physiologic variables.  
Tissue engineering provides the opportunity to evaluate cellular response to multiple 
stimuli as would be found in vivo, and yet these stimuli are controlled in a fashion which 
is the hallmark of in vitro studies.  A unique advantage of tissue engineering is the 
potential to develop human tissue models from human cells.  The opportunity to 
investigate human biological mechanisms and disease processes or test potential therapies 
without risk of endangering patients will promote tissue engineering to the forefront of 
research strategies. 
Endothelial cell behavior in response to shear stress has been extensively studied 
since the observation that regions of the arterial tree where flow is unidirectional and 
axially aligned have no intimal thickening whereas regions of low shear stress and flow 
separation exhibit intimal thickening and correspond with the presence of atherosclerosis. 
(44)  Early in vivo studies noted altered endothelial cell morphology and proliferation 
rates in these regions and subsequent in vitro studies on influence of shear stress 
confirmed these observations. (45, 46, 54-56)  Ensuing studies investigating endothelial 
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cell response to different types of shear stress found broad influence on cell behavior 
including altered LDL uptake, adhesion molecule expression and oxidation-reduction 
state. (60, 63, 68)  With extensive influence of shear stress on endothelial function being 
demonstrated, numerous mechanisms of control were investigated including the 
discovery of a shear stress response element (SSRE) in the promoter region of several 
genes confirming control over transcription. (75, 76)  More recent investigations using 
transcriptional profiling techniques have demonstrated the extent of shear stress influence 
on gene expression both in vivo and in vitro. (48, 80, 81, 83) 
Motivated by the fields of developmental and cancer biology, studies into 
extracellular matrix influence on endothelial cell function have shown distinct roles in 
angiogenesis, vascular migration and vascular patterning.  Various basement membrane 
proteins have been shown to appear in a spatially and temporally regulated manner 
during angiogenesis in vivo and these same molecules have been shown to control cell 
proliferation in vitro. (86)  Furthermore, endothelial cells are sensitive to the state of the 
extracellular matrix including whether it is assembled or in soluble form and which 
degradation sites may be exposed. (87)  The complexity of extracellular matrix influence 
on endothelial cells is further expanded to include binding and display of growth factors 
which then serve as chemo-repellent or chemo-attractive signals in vessel patterning. (89)  
Interest in endothelial cells and extracellular matrix also extends into studies of 
extracellular matrix degradation especially in the context of atherosclerosis and 
understanding plaque integrity. (193) 
In addition to shear stress and extracellular matrix, the in vivo endothelial cell 
environment also includes interactions with a number of other cell types in the blood and 
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vascular wall.  Pericytes wrapping the microvasculature and smooth muscle cells 
underlying the endothelium in large conduits have an interactive relationship with 
endothelial cells in which each cell type contributes to the phenotype of the other. (100)  
To better understand atherosclerosis, hypertension and restenosis, several studies have 
investigated the relationship between endothelial cells and smooth muscle cells using co-
culture systems.  Through both soluble and contact-mediated mechanisms, studies have 
shown reciprocal influence on cell proliferation, migration and growth factor production. 
(103, 107)  Smooth muscle cells have also been shown to influence endothelial cytokine 
secretion, response to external growth factors and tube formation. (106, 108) 
While research examining endothelial response to an individual stimulus has 
greatly expanded our understanding of their function, in vitro investigations including 
two stimuli have confirmed the complexity of cell behavior and the importance of the 
whole of the cellular microenvironment. Influence of extracellular matrix and shear stress 
on endothelial function converged with the study of integrin signaling.  Endothelial 
adhesion to extracellular matrix proteins by specific members of the integrin family alters 
the cellular response via specific signal transduction pathways. (96)  However, it is these 
same integrin signaling pathways which are critical in transmitting signals induced by 
shear stress. (98)  The simultaneous presence of smooth muscle cells and shear stress has 
been examined through the development of in vitro co-culture models which allow 
heterocellular contact yet expose only the endothelial surface to fluid flow. (109, 111)  
Studies using these systems have shown altered endothelial nitric oxide synthase (eNOS) 
and cyclooxygenase (cox) expression as well as altered adhesion molecule expression. 
(110, 111) 
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Development of tissue engineered blood vessels has been motivated by the 
clinical need for small diameter vascular grafts which will remain patent over time and 
reduce the need to harvest vessels from other areas of the body.  Numerous approaches 
using synthetic or naturally-derived materials and animal or human cells have been 
developed in a quest to produce a strong and biologically-active graft. (37, 38)  One 
particular biological approach involves dispersing smooth muscle cells within a tubular 
collagen type I gel to mimic the media and then seeding the lumen with endothelial cells 
to mimic the intima. (36)  This strategy is advantageous as it reconstructs the basic 
structure of a native vessel and by including multiple components of the endothelial 
microenvironment, is more complex than a traditional in vitro model.  However, it is 
much simplified compared to a native artery thus allowing reproducibility and control.  
Use of this tissue engineered wall model (TEWM) generated from human cells in 
previous studies conducted in our lab has shown a distinct influence on endothelial cell 
morphology, proliferation and migration. (42, 43)  To further understand the scope of 
microenvironment influence on endothelial cell behavior, the goal of this study is to 
examine the effect of substrate and shear stress on endothelial cell gene expression. 
 
Experimental Design and Methods 
Experimental Design 
 The approach taken to investigate influence of substrate and shear stress on 
endothelial cell gene expression is to examine transcriptional profiles of cells on 
traditional and tissue engineered substrates under different mechanical environments.  
Transcriptional profiling using microarray technology provides the opportunity to 
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examine cellular gene expression without pre-selecting genes which are hypothesized to 
be affected.  Furthermore, to gain insight most applicable to human development and 
disease, this study takes advantage of the tissue engineering approach by using human 
cells to create a human blood vessel model.  To examine the effect of shear stress, 
endothelial cells are exposed to either static or laminar shear stress (15 dynes/cm2) 
conditions.  To examine the effect of substrate, endothelial cells are exposed to two 
environments.  As a point of reference, a traditional in vitro model of monomer type I 
collagen adsorbed to glass is used.  As a more physiologic in vitro model, a biologically-
based blood vessel substitute is used.  This tissue engineered model is a three-
dimensional type I collagen gel containing dispersed human aortic smooth muscle cells to 
mimic the components and structure of the medial layer.  Confluent endothelial 
monolayers are cultured on each substrate for 48 hours prior to exposure to static or shear 
conditions for 24 hours.  Endothelial cell RNA is then isolated to conduct microarray 
analysis for transcriptional profiling and to conduct RT-PCR analysis for confirmation of 
microarray gene expression findings.  Similarities and differences in endothelial gene 
expression from the four experimental conditions provides insight into the influence of 




 Human aortic endothelial cells (HAEC) (Cambrex) were cultured to passage 6 in 
MCDB 131 supplemented with 5% FBS, antibiotics and growth factors while human 
aortic smooth muscle cells (HASMC) (Cambrex) were cultured to passage 8 in MCDB 
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131 supplemented with 5% FBS, antibiotics and growth factors.  All experiments were 
conducted in a co-culture media of MCDB 131 supplemented with 5% FBS, antibiotics 
and growth factors common to both cell culture mediums. 
 
Substrate Fabrication 
 Two types of substrate were used in this study: Adsorbed Collagen Slide and 
Tissue Engineered Wall Model (TEWM).  The Adsorbed Collagen Slide was created by 
coating glass slides with 50 µg/ml collagen type I (BD Biosciences) and allowing protein 
to adsorb to the surface for one hour prior to removal of the solution.    The Tissue 
Engineered Wall Model was created by suspending 1 million HASMC per ml in 5x 
concentrated MCDB-131, 10% FBS and 2 mg/ml rat tail type I collagen (BD 
Biosciences).  Sodium hydroxide was added to neutralize the acidic collagen solution and 
promote polymerization.  Tubular HASMC-collagen gels were created using a central 
mandrel during gelation and were cultured for six days to allow for cell-mediated 
compaction of the collagen fibers.  The tubular gels were then cut longitudinally and 
embedded in agar to expose a flat lumen for seeding of HAEC and fluid shear 
experiments. (43)  Endothelial cells were seeded on both models at a density of 40,000 
cells/cm2 to produce a confluent monolayer and cultured for 48 hours prior to exposure to 
static or shear conditions. 
 
Exposure to Shear Stress 
The parallel plate flow chamber used to expose endothelial cells to laminar shear 
stress has been previously established in our laboratory. (42, 49)  In this closed loop, a 
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peristaltic pump moves medium from a container into a pulse dampener and then through 
parallel plates where endothelial cells are exposed to a steady laminar shear stress.  Shear 
stress is controlled by fluid flow rate and dimensions of the chamber according to the 
equation: τ = 6Qµ/bh2.  Exposure of endothelial cells on the tissue engineered wall model 
was accomplished by embedding the depth of the collagen gel in agar supported by a 
polycarbonate mold.  The entire mold/agar apparatus was then placed into the flow 
chamber as depicted in Figure 4.1.  Endothelial cells on the Slide or TEWM were 
exposed to a shear stress of 15 dynes/cm2 for 24 hours. 
 
Endothelial Isolation from Tissue Engineered Wall Model 
 To evaluate endothelial cell gene expression following culture on the TEWM, 
pure endothelial cells must be removed without contamination of neighboring smooth 
muscle cells.  Following cell exposure to static or shear stress conditions, the TEWM 
lumen was briefly exposed to collagenase to release cells near the surface.  Endothelial 
cells were isolated from the cell mixture using a magnetic separation technique whereby 
a primary PE-conjugated antibody to PECAM-1 (Santa Cruz) followed by a magnetic 
bead-conjugated secondary antibody to PE positively selects for endothelial cells.  
Following passage through a separation column placed in a magnetic field, endothelial 
cells were collected and lysed for further analysis.  Effectiveness of the magnetic sorting 
procedure was validated using pre-labeled endothelial cells mixed with smooth muscle 





































Smooth Muscle Cells 




RNA Isolation and Analysis 
 Total RNA was extracted from endothelial cells using an RNeasy kit (Qiagen) 
with an added DNAse digestion step.  To evaluate quality of RNA prior to microarray or 
RT-PCR analysis, samples were assessed using the RNA 6000 Nano LabChip (Agilent) 
on an Agilent Bioanalyzer 2100.  Profiles of ribosomal peaks were evaluated for 
degradation as a measure of overall RNA degradation and preliminary measurements of 
RNA quantity were determined.  Quantity of high quality RNA was assessed by 




 One microgram of high quality endothelial RNA was reverse transcribed using 
the First Strand cDNA Synthesis Kit (Invitrogen) for each experimental sample.  Primers 
were designed using Primer Express (Applied Biosystems) and oligos were created by 
Integrated DNA Systems.  Primer sequences are listed below for four genes used in 
microarray data validation. 
Ang2 Forward: TCCTCCTGCCAGAGATGGAC 
Ang2 Reverse: TGCACAGCATTGGACACGTA 
CYP1B1 Forward: TTTCGGCTGCCGCTACAG 
CYP1B1 Reverse: ACTCTTCGTTGTGGCTGAGCA 
E-selectin Forward: TTGGTAGCTGGACTTTCTGCTG 
E-selectin Reverse: CATTTCCGAAGCCAGAGGAG 
Pentaxin 3 Forward: TGGACAACGAAATAGACAATGGA 
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Pentaxin 3 Reverse: CTGACCGCAGTCGCACG 
 Standards of known concentration were generated using PCR amplification and 
agarose gel extraction for each gene of interest.  Quantitative RT-PCR was conducted 
using cDNA from samples (in triplicate) and standards (in triplicate) with SYBR® Green 
PCR Master Mix (Applied Biosystems) on an ABI 7700 (Applied Biosystems) real time 
PCR machine.  Data was quantified using the absolute standard method where serial 
dilutions of the standard were plotted against CT values to generate a correlation used to 
convert sample CT values into concentrations. 
 
Microarray Experimental Design 
Experimental Samples 
 Endothelial cell RNA samples from four experimental conditions were used: Slide 
Static, Slide Shear, TEWM Static, TEWM Shear.  For each experimental condition, there 
were three independent samples resulting in a total number of twelve microarrays.  Each 
experimental sample was competitively hybridized against Universal Human Reference 
RNA (Stratagene) to allow for multiple comparisons within the data set and comparison 
to public data depositories.  The microarray experimental design is detailed below. 
A. Slide Static vs. Reference RNA (n=3) 
B. Slide Shear vs. Reference RNA (n=3) 
C. TEWM Static vs. Reference RNA (n=3) 
D. TEWM Shear vs. Reference RNA (n=3) 
To examine the influence of shear stress on endothelial cell gene expression, arrays A 
and B can be compared using a Slide substrate and arrays C and D can be compared 
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using a TEWM substrate.  To examine the influence of substrate on endothelial cell gene 
expression, arrays A and C can be compared under Static conditions and arrays B and D 
can be compared under Shear conditions. 
 
Microarray Analysis 
 Following quality analysis by Bioanalyzer 2100 and quantity assessment by UV 
absorbance, 500ng of total RNA from experimental samples and from Reference RNA 
were prepared for competitive microarray hybridization.  Samples were amplified using 
the Agilent Low RNA Input Fluorescent Linear Amplification Kit and labeled with Cy-3 
and Cy-5 CTP (Perkin-Elmer).  Hybridization was performed using the Agilent In Situ 
Hybridization Plus kit to 44,000 60-mer Human Whole Genome Oligo Microarrays 
(Agilent).  Arrays were scanned using the Agilent dual laser DNA microarray scanner 
with SureScan technology and image extraction was conducted using Agilent Feature 
Extraction software 7.5.1.  GeneSpring® software was used to normalize data, interpret 
triplicates, filter spots and generate experiment files for gene expression analysis.  It was 
also used to calculate significance and fold change values for all genes.  Ingenuity 
Pathways Analysis® was used to interpret genes identified as significant in the context of 
known biological functions and disease states. 
 
Results 
Microarray Data Analysis Criteria 
 Microarray analysis was conducted on twelve samples of endothelial cell mRNA 
to evaluate transcription under four different experimental conditions.  The four 
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conditions were the following: Slide Shear, Slide Static, TEWM Shear, TEWM Static 
and each condition had experimental samples in triplicate.  Following hybridization, 
scanning and image extraction, raw data was analyzed using GeneSpring® software.  
Figure 4.2 shows the steps taken in processing the raw data into a defined number of 
candidate genes.  First, the entire data set was examined to determine the number of spots 
on the array from which a signal could be read.  Each spot on each array was given an 
evaluation and the total number of spots with flags present or marginal was 40987.  The 
second criteria was that flags for each spot be present or marginal in all twelve arrays 
analyzed which reduced the number of genes to 40821.  Following identification of spots 
which can be analyzed, an ANOVA was run on the entire data set using the multiple 
testing correction (MTC) method: Benjamini and Hochberg False Discovery Rate.  Each 
gene was assigned a p-value based on this ANOVA with MTC and the cutoff criteria of 
p-value < 1 reduced the number of genes to 40754.  A multiple testing correction is 
necessary to adjust p-values in analysis of large sets of microarray data since the number 
of false positives is proportional to the number of tests performed.  For further analysis, 
the data set was split into the following four pairwise comparisons: 
1) Slide Shear vs. Slide Static 
2) TEWM Shear vs. TEWM Static 
3) Slide Static vs. TEWM Static 
4) Slide Shear vs. TEWM Shear 
While the ANOVA with MTC p-value remained affiliated with each gene, a student’s t-
test was conducted on each pair of samples to determine significance for the comparison 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































reduced and the number of candidate genes for each comparison was identified (see 
Figure 4.2 for values). 
 Following the number of candidate genes being identified for each comparison, 
the next step was to identify the genes which were significantly different.  The candidate 
genes already meet the following criteria: 
1) Flags are Present or Marginal in all 12 arrays 
2) ANOVA with MTC p-value < 1 
3) t-test p-value < 1 
To evaluate the most appropriate method for selecting significantly different genes, the 
following five significance criteria were applied to the candidate gene list one at a time. 
1) t-test p-value < 0.05 
2) ANOVA with MTC p-value < 0.05 
3) t-test p-value < 0.05 AND fold change > 1.5 
4) ANOVA with MTC p-value < 0.05 AND fold change > 1.5 
5) ANOVA with MTC p-value < 0.05 AND t-test p-value < 0.05 AND fold change 
> 1.5 
Table 4.1 shows the number of genes meeting analysis cutoffs following application of 
the different significance criteria.  To limit false positives, the most stringent set of 
criteria was used to identify significantly regulated genes: ANOVA with MTC p-value < 
0.05 AND t-test p-value < 0.05 AND fold change > 1.5.  Arguments can be made for 
more stringent or more relaxed criteria; however the author felt this combination 
provided the best balance to identify mathematically and biologically significant genes 





















































































































































































































































































Validation of Microarray Data 
 To validate significance of genes identified using microarray analysis, a separate 
technique examining levels of mRNA expression was used.  Quantitative RT-PCR was 
conducted on four genes identified as significantly expressed in microarray analysis: 
angiopoeitin 2, cytochrome p450 1B1, E-selectin, and pentaxin 3.  Samples were created, 
mRNA isolated and cDNA generated from three experiments for TEWM samples (Static 
and Shear) and four experiments for Slide samples (Static and Shear).  Using significance 
criteria of t-test p-value < 0.05 and fold change > 1.5 for RT-PCR data, a comparison of 
gene expression is listed in Table 4.2.  Of fourteen incidences of significant regulation 
identified by microarray analysis, twelve were confirmed significant by RT-PCR.  The 
two not determined significant by RT-PCR which were identified by microarray analysis 
met fold change criteria but did not meet t-test p-value criteria.  Of these validation 
genes, there were no cases of genes identified as significant by RT-PCR which were not 
identified as significant by microarray analysis.  From this comparison we conclude that 
although the microarray data may contain false positives or false negatives, the data set as 
a whole can be considered valid. 
 
Comparison of Microarray Data Sets 
 The microarray analysis consisted of four types of samples which represented two 
substrates and two mechanical environments (Slide Static, Slide Shear, TEWM Static, 



































































































































































































































































































































































































































































































































































































































samples were split into the following pairwise comparisons with a corresponding number 
of significantly regulated genes as described previously. 
1) Slide: Shear vs. Static – 1668 significant genes 
2) TEWM: Shear vs. Static – 1685 significant genes 
3) Static: Slide vs. TEWM – 1900 significant genes 
4) Shear: Slide vs. TEWM – 1278 significant genes 
 The comparison Slide: Shear vs. Static examines the influence of mechanical 
environment while the cells are on a Slide substrate.  The comparison TEWM: Shear vs. 
Static examines the influence of mechanical environment while the cells are on a TEWM 
substrate.  The comparison Static: Slide vs. TEWM examines the influence of substrate 
while the cells are under static conditions.  The comparison Shear: Slide vs. TEWM 
examines the influence of substrate while the cells are under shear stress conditions.  
These four comparisons individually provide great insight into the influence of substrate 
and shear stress; however, further insight can be gained by cross-comparing these four 
data sets.   
 Figure 4.3 shows the number of genes which are common or unique in the Shear 
vs. Static comparisons on either the Slide or TEWM substrate.  In other words, there are 
681 genes expressed differently under shear stress compared to static on both substrates.  
However there are 987 genes expressed differently under shear which appear uniquely on 
the Slide substrate while there are 1004 genes expressed differently under shear which 
appear uniquely on the TEWM substrate.  Figure 4.4 shows the number of genes which 
are common or unique in the Slide vs. TEWM comparisons under either Static or Shear 




































two substrates under both mechanical environments.  However there are 1239 genes 
expressed differently on the two substrates which appear only under static conditions and 
617 genes expressed differently on the two substrates which appear only under shear 
stress conditions.  A final comparison is overlapping all four of the pairwise comparisons 
to identify genes which are significantly regulated by substrate and shear stress at each 
combination.  Such an analysis results in 122 genes identified.  Results of these cross-
comparisons confirm that some genes are regulated by a particular stimulus regardless of 
other stimuli applied, however most often the effect of one stimulus is dependent on the 
presence or absence of another stimulus.  Thus we conclude that the whole of the cellular 
microenvironment is important in determining the overall cell phenotype. 
 
Ingenuity Pathways Analysis 
 Data were analyzed through the use of Ingenuity Pathways Analysis (Ingenuity® 
Systems, www.ingenuity.com).  The purpose of Ingenuity Pathways Analysis (IPA) was 
to evaluate gene microarray data in a systematic fashion to gain insight regarding affected 
biological pathways and disease mechanisms.  For this software analysis, the user inputs 
genes designated as significant based upon user-defined criteria.  Genes which are 
entered into the program are overlaid into the Ingenuity Pathways Knowledge Base 
(IPKB) which is a constantly evolving database of molecular interactions developed 
based on published, peer-reviewed literature.  Genes that are deemed significant by the 
user and are found to interact with at least one other gene in the IPKB are designated 
“focus genes”.  IPA then uses computational algorithms to identify networks of 
molecular interactions which are enriched for the focus genes.  Networks are ranked 
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based on number of focus genes and overall size and are also assigned biological 
functions based on known diseases and cellular events.  IPA also conducts a Functional 
Analysis to identify the biological functions and/or diseases that are most significant in 
each data set.  Fischer’s exact test is used to calculate a p-value determining the 
probability that each biological function and/or disease assigned to that data set is due to 
chance alone. 
 For IPA application to the Slide_TEWM_Static_Shear data set, genes previously 
designated as significant (ANOVA with MTC p-value < 0.05 AND t-test p-value < 0.05 
AND fold change > 1.5) were used.  For each pairwise comparison, the input data set 
included the Genbank ID, fold change, and ANOVA with MTC p-value.  Table 4.3 
shows the number of genes entered and the number of focus genes identified following 
comparison of input data with the IPKB.  Based on these focus genes, networks were 
generated for each pairwise comparison and biological functions were assigned.  
Functional Analysis was conducted on each data set and significant biological functions 
and diseases were identified.  For further insight into gene regulation by substrate and 
shear stress, charts were generated which compared functions identified for the Shear vs. 
Static data and also for the Slide vs. TEWM data.  Figure 4.5 shows a Functional 
Analysis chart for the TEWM: Shear vs. Static and Slide: Shear vs. Static data sets which 
compare the probability that genes in the stated categories are significantly affected by 
the experimental conditions.  In a similar fashion, Figure 4.6 shows a Functional Analysis 
chart for the Static: Slide vs. TEWM and Shear: Slide vs. TEWM data sets which 
compare the probability that genes in the stated categories are significantly affected by 











Table 4.3 Number of Focus Genes in Ingenuity Pathways Analysis 
 
Slide: TEWM: Static: Shear:
Shear vs. Static Shear vs. Static Slide vs. TEWM Slide vs. TEWM
Number of 
Significant Genes 1668 1685 1900 1278
Number of Focus 






























functions and/or diseases significantly regulated in each of the four data sets.  The 
following five functional categories are shown in the figures and will be discussed in 
further detail: 
1) Cell Cycle 
2) Cardiovascular System Development and Function 
3) Cardiovascular Disease 
4) Hematological System Development and Function 
5) Hematological Disease  
 
Discussion 
 As the motivation of this study was to evaluate endothelial cell gene expression in 
the context of developing more physiologic in vitro models to study vascular biology, we 
will focus on genes identified by IPA Functional Analysis as involved in Cardiovascular 
System Development & Function, Cardiovascular Disease, Hematological System 
Development & Function and Hematological Disease.  Genes identified are known to be 
involved in the cardiovascular and hematological systems and many have been studied 
for their particular roles in development or disease progression.  Many have uniquely 
cardiovascular functions and have been identified previously as shear or substrate 
responsive while others are newly identified as such in this study.  As an example of cell 
function not limited to the cardiovascular and hematological systems, we will first 




Biological Function: Cell Cycle 
 Control of cell cycle is a complex series of feedback loops and checkpoints which 
are critical in biological development and many disease states.  For endothelial cells, 
there is reduced cell proliferation in mature, healthy arteries while regions susceptible to 
atherosclerotic plaque have increased cell proliferation.  Additionally, levels of 
endothelial cell proliferation seen in vitro are often much higher than those seen in vivo 
which makes the cell cycle an ideal candidate for investigation of substrate and shear 
stress influence using a more physiologic in vitro model.  IPA analysis showed 
significant changes in genes involved in the cell cycle for all four pairwise comparisons 
suggesting a dramatic influence of shear stress and substrate on this important biological 
function.  Table 4.4 shows fold change (calculated as Shear/Static) and t-test p-value data 
for genes identified by IPA Functional Analysis in the Slide: Shear vs. Static and TEWM: 
Shear vs. Static microarray comparisons which are involved in cell cycle. 
 Initial impressions of the data set note the large number of cell cycle genes which 
change expression and the extreme changes in magnitude for many of the genes.  In first 
examining the Slide: Shear vs. Static data set, there are 42 genes which are changing 
expression and 38 of these are downregulated under shear compared to static conditions 
whereas four are upregulated under shear.  Of the families of genes involved in cell cycle 
progression, there is a reduction in five of the cyclin genes (cyclin A2, cyclin B1, cyclin 
B2, cyclin D2 and cyclin H), in six of the cell division cycle (cdc) and cdc-associated 
genes (cdc6, cdc7, cdc20, cdc45L, cdca5, cdca7) and changes in the cyclin-dependent 
kinase (cdk) 4 and cdk-inhibitors.  Changes in gene expression were also detected for 
other machinery involved in cell cycle progression including centromere proteins,  
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Table 4.4 Cell Cycle Genes in Shear vs. Static Comparisons 
Red text denotes gene downregulation and blue text denotes gene upregulation 
‘x’ denotes failure to meet significance criteria (t-test p<0.05 and ANOVA p<0.05 and fold change>1.5) 
 
fold change t-test p-value fold change t-test p-value
CCNA2 cyclin A2 NM_001237 0.3000 0.0006 x x
CCNB1 cyclin B1 NM_031966 0.1600 0.0014 0.3830 0.0052
CCNB1IP1 cyclin B1 interacting protein 1 NM_021178 x x 0.6110 0.0020
CCNB2 cyclin B2 NM_004701 0.1310 0.0000 0.4130 0.0137
CCND1 cyclin D1 BC014078 x x 0.6120 0.0283
CCND2 cyclin D2 M90813 0.5460 0.0019 0.6210 0.0115
CCNDBP1 cyclin D-type binding-protein 1 NM_012142 x x 1.6040 0.0048
CCNH cyclin H NM_001239 0.4090 0.0091 0.6540 0.0139
CDC6 CDC6 cell division cycle 6 NM_001254 0.1620 0.0000 0.5230 0.0007
CDC7 CDC7 cell division cycle 7 NM_003503 0.5410 0.0052 x x
CDC20 CDC20 cell division cycle 20 NM_001255 0.4300 0.0003 x x
CDC25B cell division cycle 25B NM_021874 x x 1.5910 0.0001
CDC45L CDC45 cell division cycle 45-like NM_003504 0.2790 0.0005 0.6490 0.0033
CDCA5 cell division cycle associated 5 NM_080668 0.1140 0.0001 0.3930 0.0071
CDCA7 cell division cycle associated 7 NM_031942 0.1630 0.0002 0.4290 0.0001
CDK4 cyclin-dependent kinase 4 NM_000075 0.4880 0.0006 x x
CDKN1A cyclin-dependent kinase inhibitor 1A NM_000389 x x 1.5600 0.0156
CDKN1B cyclin-dependent kinase inhibitor 1B NM_004064 1.7440 0.0238 1.8630 0.0017
CDKN1C cyclin-dependent kinase inhibitor 1C NM_000076 x x 0.4580 0.0039
CDKN3 cyclin-dependent kinase inhibitor 3 NM_005192 0.2290 0.0005 0.5740 0.0140
CDT1 DNA replication factor NM_030928 0.6270 0.0008 x x
CENPA centromere protein A NM_001809 0.0733 0.0000 0.4120 0.0141
CENPE centromere protein E NM_001813 0.4160 0.0003 x x
CENPF centromere protein F NM_016343 0.0980 0.0000 0.4160 0.0125
CHAF1A chromatin assembly factor 1, subunit A NM_005483 0.3640 0.0008 x x
CHAF1B chromatin assembly factor 1, subunit B NM_005441 0.4620 0.0035 x x
CHEK1 CHK1 checkpoint NM_001274 0.4780 0.0100 0.6640 0.0055
CHEK2 CHK2 checkpoint NM_007194 0.5550 0.0009 x x
FOXM1 forkhead box M1 NM_021953 0.5620 0.0024 x x
GTSE1 G-2 and S-phase expressed 1 NM_016426 0.3670 0.0012 0.6590 0.0360
H2AFX H2A histone family, member X NM_002105 0.4350 0.0027 x x
H3F3B H3 histone, family 3B BC020466 x x 2.0300 0.0022
HCAP-G chromosome condensation protein G NM_022346 0.0721 0.0001 0.1960 0.0027
HDAC1 histone deacetylase 1 NM_004964 x x 1.5280 0.0016
HIST1H1B histone 1, H1b NM_005322 0.2750 0.0061 x x
HIST1H2AC histone 1, H2ac U90551 x x 2.3950 0.0001
HIST1H4C histone 1, H4c NM_003542 0.3130 0.0002 x x
HIST2H2AA histone 2, H2aa AY131971 2.0930 0.0004 3.1850 0.0009
KNTC1 kinetochore associated 1 NM_014708 0.5150 0.0199 x x
KNTC2 kinetochore associated 2 NM_006101 0.0713 0.0000 0.2320 0.0044
MCM2 minichromosome maintenance deficient 2 NM_004526 0.5280 0.0020 x x
MCM3 minichromosome maintenance deficient 3 NM_002388 0.3790 0.0008 x x
MCM4 minichromosome maintenance deficient 4 NM_005914 0.3330 0.0025 x x
MCM5 minichromosome maintenance deficient 5 NM_006739 0.4640 0.0001 x x
MCM6 minichromosome maintenance deficient 6 NM_005915 0.2770 0.0017 0.6330 0.0023
MCM7 minichromosome maintenance deficient 7 NM_005916 0.3960 0.0004 x x
MCM8 minichromosome maintenance deficient 8 NM_032485 0.4390 0.0014 x x
MCM10 minichromosome maintenance deficient 10 AB042719 0.6440 0.0306 x x
PCNA proliferating cell nuclear antigen NM_002592 0.3990 0.0014 x x
PLCD1 phospholipase C, delta 1 NM_006225 1.5320 0.0004 x x
RHOA ras homolog gene family, member A NM_001664 1.6190 0.0054 2.3220 0.0001
Gene ID Gene Name Genbank ID
Slide: Shear vs. Static TEWM: Shear vs. Static
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chromatin assembly factors, histone and histone family members, kinetochore associated 
proteins and minichromosome maintenance (MCM) genes.  As a measure of overall level 
of proliferation, the gene for proliferating cell nuclear antigen (PCNA) is downregulated 
under shear stress compared to static conditions. 
 In examining the TEWM: Shear vs. Static data set, there are 28 genes changing 
expression and 19 of these are downregulated under shear compared to static whereas 
nine are upregulated under shear compared to static.  Of the families of genes involved in 
cell cycle progression, there is a reduction in four of the cyclin genes (cyclin B1, cyclin 
B2, cyclin D2 and cyclin H), in six of the cdc and cdc-associated genes (cdc6, cdc45L, 
cdca5 and cdca7) and changes in the cyclin-dependent kinase inhibitors.  There are also 
changes in gene expression for other cell cycle machinery however these changes are not 
as numerous as seen on the Slide substrate. 
 The Shear vs. Static data sets provide information on genes which change 
expression under shear stress compared to static conditions and by comparing the two 
data sets, one can gain insight into how a change in substrate affects the response to the 
mechanical environment.  Of the 51 genes identified between these two data sets to be 
involved in cell cycle, 19 of them are responsive to mechanical environment on both 
substrates.  However, a comparison of the magnitude of fold changes for these genes 
shows an interesting trend.  For 16 of the 19 genes, there is a greater change in gene 
expression between shear and static on the Slide than on the TEWM.  Additionally, the 
three genes which do not have a greater change in expression on the Slide are the only 
three which have an upregulation in expression under shear compared to static. 
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 From the Shear vs. Static microarray comparisons, we can conclude that cell cycle 
gene expression decreases dramatically in endothelial cells on the Slide when exposed to 
shear compared to static.  Cell cycle gene expression also decreases in endothelial cells 
on the TEWM when exposed to shear compared to static, however this decrease is not as 
large as that seen on the Slide.  The greater drop in cell cycle on the Slide is reflected in 
the total number of genes changing in response to shear as well as in the fold change 
magnitude of genes which decrease on both substrates.  One potential explanation for this 
observation is that the Slide Static proliferates more than the TEWM Static and therefore 
shear induces a greater drop in activity to reduce Slide proliferation levels.  An additional 
potential explanation is that endothelial cells on the TEWM are less responsive to shear 
stress than cells on the Slide.  In the case of either explanation, the data demonstrates that 
the presence of a substrate affects endothelial cell response to shear stress.  However, to 
evaluate the possible explanations, data from the Slide vs. TEWM can be used to 
examine the effect of substrate on cell cycle. 
 Table 4.5 shows fold change (calculated as Slide/TEWM) and t-test p-value data 
for genes identified by IPA Functional Analysis in the Static: Slide vs. TEWM and Shear: 
Slide vs. TEWM microarray comparisons to be involved in cell cycle.  Initial impressions 
of the data set include extensive cell cycle gene expression differences between the two 
substrates under static conditions and very few differences between the two substrates 
under shear conditions. 
 Looking at the Static: Slide vs. TEWM data, there are 26 genes differentially 
expressed between the two substrates under static conditions and 23 of those are 








Table 4.5 Cell Cycle Genes in Slide vs. TEWM Comparisons 
Red text denotes gene downregulation and blue text denotes gene upregulation 
‘x’ denotes failure to meet significance criteria (t-test p<0.05 and ANOVA p<0.05 and fold change>1.5) 
 
fold change t-test p-value fold change t-test p-value
BRCA1 breast cancer 1, early onset NM_007294 2.4970 0.0008 x x
CCNA2 cyclin A2 NM_001237 2.5760 0.0026 x x
CCNB1 cyclin B1 NM_031966 4.0190 0.0006 x x
CCNB2 cyclin B2 NM_004701 4.3180 0.0022 x x
CCNH cyclin H BF368083 1.8280 0.0001 x x
CDC6 CDC6 cell division cycle 6 homolog NM_001254 3.6760 0.0000 x x
CDC20 CDC20 cell division cycle 20 homolog NM_001255 2.1450 0.0000 x x
CDC25C cell division cycle 25C NM_001790 1.6180 0.0036 x x
CDC45L CDC45 cell division cycle 45-like NM_003504 3.0040 0.0002 x x
CDCA7 cell division cycle associated 7 NM_031942 3.0410 0.0001 x x
CDGAP Cdc42 GTPase-activating protein AB033030 0.5380 0.0030 0.6230 0.0094
CDKN1C cyclin-dependent kinase inhibitor 1C NM_000076 0.4500 0.0003 x x
CDKN3 cyclin-dependent kinase inhibitor 3 NM_005192 3.1260 0.0003 x x
CDT1 DNA replication factor NM_030928 1.5010 0.0004 x x
CENPA centromere protein A NM_001809 5.4280 0.0012 x x
CENPE centromere protein E NM_001813 2.2030 0.0005 x x
CENPF centromere protein F NM_016343 4.2700 0.0009 x x
CENPH centromere protein H NM_022909 1.5400 0.0017 x x
CHEK1 CHK1 checkpoint NM_001274 2.1420 0.0000 x x
FOXM1 forkhead box M1 NM_021953 1.8240 0.0030 x x
H1F0 H1 histone family, member 0 NM_005318 0.5270 0.0008 0.5410 0.0026
H2AFX H2A histone family, member X NM_002105 1.7750 0.0005 x x
H2AFZ H2A histone family, member Z NM_002106 1.5520 0.0159 x x
H3F3B H3 histone, family 3B BC020466 x x 0.5360 0.0076
HIST1H1B histone 1, H1b NM_005322 2.3580 0.0095 x x
HIST1H3D histone 1, H3d NM_003530 1.5390 0.0406 x x
HIST2H2AA histone 2, H2aa AY131971 x x 0.4980 0.0080
PCNA proliferating cell nuclear antigen NM_002592 2.0280 0.0002 x x
Gene ID Gene Name Genbank ID
Static: Slide vs. TEWM Shear: Slide vs. TEWM
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various genes involved in cell cycle progression, endothelial cells on the Slide express 
higher levels of cyclins, cdc and cdc-associated genes, centromere proteins and histone 
family members.  As a measure of overall cell proliferation, PCNA gene expression on 
the Slide is twice as high as expression on the TEWM.  From this data, we conclude that 
baseline cell cycle activity under static conditions is higher on the Slide than on the 
TEWM.  The pattern of gene expression seen in the Shear: Slide vs. TEWM data is 
drastically different from the data set under static conditions.  When comparing cell cycle 
gene expression in endothelial cells on the Slide and TEWM under shear stress, there are 
only four genes which are differentially regulated and all four have reduced expression 
on the Slide compared to the TEWM.  Two of which are also downregulated on the Slide 
under static conditions and the other two were not differentially regulated by the substrate 
under static but only appear in the context of shear stress.  Furthermore, we see no 
significant difference in levels of PCNA in the Slide Shear compared to the TEWM 
Shear.  Thus we conclude that cell cycle activity is relatively comparable on the two 
substrates under shear stress conditions. 
 Compiling these data sets to paint a picture of cell cycle activity in response to 
substrate and shear stress, we conclude that the presence of shear stress greatly reduces 
differences in cell cycle gene expression between the Slide and TEWM.  The extreme 
reduction in cell cycle on the Slide and lesser reduction on the TEWM in response to 
shear stress are explained by higher cell cycle activity on the Static Slide.  From the 
Shear vs. Static comparisons, we conclude that shear stress reduces cell cycle activity on 
each substrate; however the nature of the substrate alters the extent of the shear effect.  
Shear stress and substrate both affect cell cycle gene expression and the presence or 
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absence of one stimulus alters the conclusions drawn regarding the effect of the other 
stimulus.  The cell cycle gene expression data exemplifies the need for more physiologic 
in vitro models as it is very apparent how components of the endothelial 
microenvironment combine to affect the overall cell phenotype. 
 
Biological Function: Cardiovascular and Hematological Systems 
 Table 4.6 shows genes identified by IPA Functional Analysis in the Slide: Shear 
vs. Static and TEWM: Shear vs. Static microarray comparisons which are involved in the 
cardiovascular and hematological systems.  This table gives fold change (calculated as 
Shear/Static) and t-test p-value data as well as categories of cell function for each gene 
identified.  Data from these comparisons can identify genes which are differentially 
expressed under shear or static mechanical environments.  Moreover, genes which are 
regulated by shear on both substrates or on only one substrate can be further evaluated.  
The total number of cardiovascular and hematological system genes identified using 
Ingenuity Pathways Analysis in the Shear vs. Static data set is 40.  Of these, 26 are 
differentially expressed on the Slide substrate with 17 upregulated under shear and 9 
downregulated under shear.  On the TEWM substrate, 33 are differentially expressed 
under shear with 25 upregulated and eight downregulated. 
 Table 4.7 shows genes identified by IPA Functional Analysis in the Static: Slide 
vs. TEWM and Shear: Slide vs. TEWM microarray comparisons which are involved in 
the cardiovascular and hematological systems.  This table gives fold change (calculated 
as Shear/Static) and t-test p-value data as well as categories of cell function for each gene 







Table 4.6 Cardiovascular and Hematological System Genes in Shear vs. Static 
Comparisons 
Red text denotes gene downregulation and blue text denotes gene upregulation 
‘x’ denotes failure to meet significance criteria (t-test p<0.05 and ANOVA p<0.05 and fold change>1.5) 
 
fold change t-test p-value fold change t-test p-value
cell adhesion SELE selectin E (endothelial adhesion molecule 1) NM_000450 x x 5.3100 0.0433
cell adhesion VCAM1 vascular cell adhesion molecule 1 NM_001078 0.6650 0.0230 x x
cell adhesion ITGA1 integrin, alpha 1 X68742 x x 1.8420 0.0084
cell adhesion ITGA6 integrin, alpha 6 NM_000210 1.7470 0.0055 x x
cell adhesion ITGAV integrin, alpha V NM_002210 x x 3.1790 0.0223
cell adhesion ITGB3 integrin, beta 3 M35999 0.3300 0.0015 0.3870 0.0006
cell adhesion ITGB4 integrin, beta 4 NM_000213 1.8090 0.0097 1.5410 0.0031
cell surface receptor NRP1 neuropilin 1 AF086016 x x 0.6660 0.0053
cell surface receptor NRP2 neuropilin 2 AK024680 2.7720 0.0001 x x
cell surface receptor PDGFRA platelet-derived growth factor receptor, alpha NM_006206 x x 2.4150 0.0004
coagulation F2RL3 factor II (thrombin) receptor-like 3 (PAR-4) AF080214 1.9550 0.0254 1.9460 0.0269
coagulation PLAT plasminogen activator, tissue NM_000930 0.4320 0.0057 x x
coagulation PLAU plasminogen activator, urokinase NM_002658 0.6650 0.0059 x x
coagulation THBD thrombomodulin NM_000361 2.2420 0.0001 x x
enzyme ANG angiogenin, ribonuclease, RNase A family, 5 NM_001145 x x 1.6480 0.0022
enzyme LIPG lipase, endothelial NM_006033 2.7630 0.0000 1.8740 0.0239
growth factor ANGPT2 angiopoietin 2 NM_001147 0.1850 0.0012 0.2250 0.0055
growth factor ANGPTL2 angiopoietin-like 2 BC012368 x x 0.5980 0.0033
growth factor BMP4 bone morphogenetic protein 4 NM_001202 0.4270 0.0003 0.5350 0.0191
growth factor PDGFB platelet-derived growth factor, beta NM_002608 x x 0.6160 0.0171
growth factor PDGFC platelet derived growth factor C NM_016205 0.4730 0.0007 x x
growth factor VEGF vascular endothelial growth factor AK098750 x x 1.6550 0.0009
growth factor VEGFC vascular endothelial growth factor C NM_005429 0.4430 0.0001 1.6290 0.0074
matrix molecule COL12A1 collagen, type XII, alpha 1 NM_004370 x x 0.4490 0.0014
matrix molecule COL17A1 collagen, type XVII, alpha 1 NM_130778 2.7070 0.0205 3.9960 0.0079
matrix molecule COL5A1 collagen, type V, alpha 1 NM_000093 x x 1.5950 0.0118
matrix molecule COL9A3 collagen, type IX, alpha 3 NM_001853 1.6130 0.0008 1.5160 0.0012
matrix molecule FN1 fibronectin 1 NM_002026 x x 2.3800 0.0073
matrix turnover MMP1 matrix metalloproteinase 1 NM_002421 7.4440 0.0000 3.7450 0.0214
matrix turnover MMP10 matrix metalloproteinase 10 NM_002425 4.1380 0.0000 2.8170 0.0218
peptidase CTSC cathepsin C NM_148170 0.5670 0.0031 0.5170 0.0038
redox balance CYP1A1 cytochrome P450, 1A1 NM_000499 3.8770 0.0006 3.8210 0.0003
redox balance CYP1B1 cytochrome P450, 1B1 NM_000104 23.5500 0.0000 73.4700 0.0000
redox balance HMOX1 heme oxygenase (decycling) 1 NM_002133 5.3610 0.0002 6.4300 0.0001
redox balance PTGS2 prostaglandin-endoperoxide synthase 2 (cox-2) BC013734 3.9300 0.0000 5.7060 0.0024
redox balance SOD1 superoxide dismutase 1, soluble NM_000454 x x 2.2480 0.0003
transcription factor EPAS1 endothelial PAS domain protein 1 BC015869 2.0010 0.0010 2.6070 0.0002
transcription factor KLF2 Kruppel-like factor 2 (lung) NM_016270 3.1770 0.0001 7.2140 0.0006
transport GJA5 gap junction protein, alpha 5 (connexin 40) NM_005266 x x 2.3070 0.0019
transport LDLR low density lipoprotein receptor NM_000527 1.8470 0.0087 3.2550 0.0004
Category Gene ID Gene Name Genbank ID







Table 4.7 Cardiovascular and Hematological System Genes in Slide vs. TEWM 
Comparisons 
Red text denotes gene downregulation and blue text denotes gene upregulation 
‘x’ denotes failure to meet significance criteria (t-test p<0.05 and ANOVA p<0.05 and fold change>1.5) 
 
fold change t-test p-value fold change t-test p-value
cell adhesion ICAM1 intercellular adhesion molecule 1 NM_000201 0.4280 0.0028 0.6600 0.0282
cell adhesion ICAM2 intercellular adhesion molecule 2 NM_000873 x x 1.5890 0.0257
cell adhesion SELE selectin E (endothelial adhesion molecule 1) NM_000450 0.1960 0.0023 0.0274 0.0030
cell adhesion ITGA1 integrin, alpha 1 X68742 0.4450 0.0015 0.1940 0.0003
cell adhesion ITGA3 integrin, alpha 3 NM_005501 1.6260 0.0200 1.9380 0.0169
cell adhesion ITGB4BP integrin beta 4 binding protein NM_181468 1.5160 0.0003 x x
cell surface receptor KDR kinase insert domain receptor NM_002253 0.5060 0.0003 x x
cell surface receptor LDLR low density lipoprotein receptor BC014514 2.9200 0.0083 1.9340 0.0055
cell surface receptor ROBO1 roundabout 1 NM_133631 0.5840 0.0018 0.1810 0.0048
coagulation A2M alpha-2-macroglobulin M36501 0.0662 0.0002 0.1470 0.0052
coagulation FGL2 fibrinogen-like 2 NM_006682 0.3150 0.0001 x x
coagulation PLAU plasminogen activator, urokinase NM_002658 1.7780 0.0091 x x
coagulation PROCR protein C receptor, endothelial (EPCR) NM_006404 1.9310 0.0011 1.5240 0.0168
coagulation TFPI2 tissue factor pathway inhibitor 2 NM_006528 0.0869 0.0001 0.1090 0.0034
coagulation THBD thrombomodulin NM_000361 0.4500 0.0027 x x
coagulation VWF von Willebrand factor NM_000552 0.6600 0.0001 x x
enzyme LOX lysyl oxidase NM_002317 2.9920 0.0001 1.9970 0.0110
growth factor ANGPT2 angiopoietin 2 AJ289780 0.1880 0.0003 x x
growth factor ESM1 endothelial cell-specific molecule 1 NM_007036 x x 0.5650 0.0030
growth factor VEGF vascular endothelial growth factor AK098750 x x 0.6590 0.0158
matrix molecule COL12A1 collagen, type XII, alpha 1 NM_004370 0.2130 0.0001 0.3680 0.0005
matrix molecule COL17A1 collagen, type XVII, alpha 1 NM_130778 3.8100 0.0120 2.5810 0.0193
matrix molecule COL4A1 collagen, type IV, alpha 1 NM_001845 0.2730 0.0000 0.4440 0.0019
matrix molecule COL4A2 collagen, type IV, alpha 2 NM_001846 0.3200 0.0000 0.4060 0.0013
matrix molecule COL6A1 collagen, type VI, alpha 1 NM_001848 x x 0.5500 0.0156
matrix molecule COL8A1 collagen, type VIII, alpha 1 NM_001850 2.1020 0.0098 1.8410 0.0015
matrix molecule COL9A3 collagen, type IX, alpha 3 NM_001853 0.5230 0.0007 0.5570 0.0000
matrix molecule FN1 fibronectin 1 NM_002026 1.6660 0.0441 x x
matrix molecule LAMA5 laminin, alpha 5 NM_005560 1.5710 0.0057 x x
matrix molecule LAMB3 laminin, beta 3 NM_000228 3.0610 0.0000 x x
matrix turnover MMP1 matrix metalloproteinase 1 NM_002421 0.3620 0.0014 x x
matrix turnover MMP11 matrix metalloproteinase 11 NM_005940 0.3910 0.0000 0.5550 0.0057
matrix turnover MMP14 matrix metalloproteinase 14 NM_004995 0.5270 0.0014 x x
membrane protein CAV1 caveolin 1 BC006432 1.9890 0.0086 2.9670 0.0008
membrane protein EFNA1 ephrin-A1 NM_004428 0.2420 0.0001 0.1850 0.0006
membrane protein EFNB2 ephrin-B2 NM_004093 0.4370 0.0000 0.2540 0.0009
peptidase ADAM10 a disintegrin and metalloproteinase domain 10 NM_001110 x x 0.6510 0.0319
peptidase ADAM19 a disintegrin and metalloproteinase domain 19 NM_033274 0.5810 0.0007 x x
peptidase ADAMTS4 adam with thrombospondin type 1 motif, 4 NM_005099 0.5290 0.0000 0.5250 0.0010
peptidase CTSF cathepsin F NM_003793 0.5870 0.0004 x x
peptidase ECEL1 endothelin converting enzyme-like 1 NM_004826 x x 1.5790 0.0001
redox balance CYP1B1 cytochrome P450, 1B1 NM_000104 x x 0.4370 0.0005
redox balance GPX1 glutathione peroxidase 1 NM_000581 0.6020 0.0009 0.5050 0.0080
redox balance PTGS1 prostaglandin-endoperoxide synthase 1 (cox-1) M59979 2.8670 0.0001 x x
transcription factor EPAS1 endothelial PAS domain protein 1 BC015869 0.6180 0.0005 0.4740 0.0016
Category Gene ID Gene Name Genbank ID
Static: Slide vs. TEWM Shear: Slide vs. TEWM
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expressed by the experimental substrates: Slide or TEWM.  Moreover, we can evaluate 
how the mechanical environment to which these cells are exposed influences the 
substrate effect.  The total number of cardiovascular and hematological system genes 
identified using Ingenuity Pathways Analysis in the Slide vs. TEWM data set is 45.  Of 
these, 38 are differentially expressed under Static conditions with 13 upregulated on the 
Slide and 25 downregulated on the Slide.  Under Shear conditions, there are 30 genes 
differentially expressed by the two substrates with nine genes upregulated on the Slide 
and 21 downregulated on the Slide.   
 To further investigate the effect of substrate and shear stress on the identified 
genes of the cardiovascular and hematological systems, we will discuss them in the 
context of the following areas of endothelial cell function: 
a) Cell adhesion through integrins 
b) Coagulation balance 
c) Extracellular matrix deposition 
d) Extracellular matrix turnover 
e) Reduction-oxidation balance 
f) Vascular patterning and angiogenesis 
Gene expression data has been taken from Table 4.6 and Table 4.7 and re-stated in a table 
for each area to simplify analysis and discussion. 
 
Cell Adhesion through Integrins 
 Endothelial cell adhesion through integrin family members is an active area of 
research due to their established involvement in angiogenesis and well as response to 
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shear stress.  Migration of endothelial cells and sensing of extracellular matrix molecules 
using outside-in signal transduction pathways are an important part of vessel growth. 
(194)  Integrins are also well established in the endothelial cell response to fluid shear 
stress as the cells must be attached to the matrix in order to sense and transduce 
mechanical signals. (72)  In addition, integrins have been shown to play an intermediary 
role in major signaling cascades involving Shc and JNKs as well as Rho activation. (195)  
With their prominent roles in extracellular matrix recognition and mechanical signal 
transduction, differential regulation by substrate and shear stress seen here is not 
unexpected.   
 Table 4.8 shows data for integrin genes significantly expressed in all four 
pairwise microarray comparisons.  In first evaluating response in Shear vs. Static data 
sets, there is a mixed expression pattern.  On the Slide substrate, shear upregulates α6 and 
β4 expression while downregulating β3 expression.  On the TEWM substrate, shear 
upregulates α1, αV, and β4 expression while downregulating β3 expression.  Furthermore, 
downregulation of β3 and upregulation of β4 are present on both substrates while 
regulation of α1, α6, and αV are specific to the substrate provided. Thus we conclude that 
expression of integrin family members are influenced by mechanical environment, 
however the identity of integrins changing can depend on the substrate and the direction 
of change in response to shear stress is specific to the identity of the integrin family 
member.  In then evaluating the Slide vs. TEWM data sets, there is also a mixed 
expression pattern.  Integrin α1 is downregulated on the Slide compared to the TEWM 
whereas α3 and integrin β4 binding protein are upregulated on the Slide.  Integrin α1 is the 












































































































































































































































































































































































































































































































































































































































































































































































however other integrin genes show shifts in fold change magnitude depending on the 
combination of substrate and shear stress which is present. 
 
Coagulation Balance 
 Providing a non-thrombogenic surface for blood flow and participation in the 
coagulation cascade when necessary are critical functions of the endothelium.  Shear 
stress regulation of proteins involved in the coagulation cascade has been established for 
many of the important regulatory molecules. (65-67)  Both pro-coagulant and anti-
coagulant molecules are differentially regulated by shear stress and substrate as shown in 
Table 4.9.  In examining the Shear vs. Static data sets, we see upregulation of the pro-
coagulant molecule PAR-4 on both the Slide and TEWM substrates.  There is also 
change in anti-coagulant molecules with a downregulation of tissue plasminogen 
activator and urokinase plasminogen activator and upregulation of thrombomodulin 
under Shear compared to Static on the Slide but no significant difference on the TEWM.  
In examining the Slide vs. TEWM data sets, we see regulation by substrate of several 
genes which are also regulated by shear stress: urokinase plasminogen activator and 
thrombomodulin.  Under Static conditions, there is upregulation on the Slide of the 
procoagulant molecules vWF and FGL-2 and the anti-coagulant molecules 
thrombomodulin and tissue factor pathway inhibitor 2.  In the presence of shear stress, 
the differences in coagulation gene expression between the two substrates are reduced so 
that only the upregulation of endothelial protein C receptor (EPCR) and downregulation 
of alpha-2-macroglobulin and tissue factor pathway inhibitor 2 are similar to what is seen 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































cascade are influenced by substrate and shear stress, however based on the genes 
identified here, there is no clear trend in tipping the overall balance towards a pro-
coagulant or anti-coagulant phenotype.  As with previous gene examples, we see that 
regulation is dependent not only on substrate or shear stress but the combined presence or 
absence of multiple stimuli. 
 
Extracellular Matrix Deposition 
 Extracellular matrix proteins have wide-ranging effects on cell phenotype with 
established roles in adhesion, migration, proliferation and differentiation while also often 
contributing to the mechanical properties of the tissue of which they are a part.  Blood 
vessel extracellular matrix molecules have been extensively studied for their roles in 
numerous diseases such as atherosclerosis, hypertension and restenosis, thus it is 
interesting to evaluate endothelial production of extracellular matrix molecules in 
response to the microenvironment components: shear stress and substrate.  Table 4.10 
shows data for multiple matrix molecules which are significantly differentially regulated 
in at least one of the four microarray comparisons.  In examining the Shear vs. Static data 
sets, there is an overall trend where shear appears to increase gene expression of matrix 
molecules suggesting an active deposition of new extracellular matrix.  Shear stress 
increases expression of collagen XVII and collagen IX on both substrates, although the 
magnitude of fold change is dependent on the substrate.  Shear stress also regulates the 
expression of collagen XII, collagen V and fibronectin but only in endothelial cells on the 



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































response to shear stress but the breadth of this response and behavior of individual genes 
often depends on the substrate present. 
 To further evaluate the influence of substrate on extracellular matrix gene 
expression, Table 4.10 contains data on the Slide vs. TEWM comparisons.  There is a 
mixture of upregulation and downregulation of endothelial matrix genes in response to 
substrate.  Genes which are expressed at lower levels on the Slide than the TEWM 
include collagen XII, collagen IV (α1), collagen IV (α2), collagen VI and collagen IX.  
Genes which are expressed at higher levels on the Slide than the TEWM include collagen 
XVII, collagen VIII, fibronectin, laminin α5 and laminin β3.  For the majority of genes, 
the differences due to substrate are consistent regardless of mechanical environment, 
however the presence of shear stress does eliminate the difference due to substrate for 
fibronectin and both laminins.  Numerous basement membrane genes (collagen IV, 
fibronectin and laminin) are differentially regulated between the Slide and TEWM 
suggesting that the substrate provided to the endothelial cells alters their production of 
basement membrane.  With matrix molecules having extensive effects on cell function, 
altered production due to substrate and shear stress provides another mechanism through 
which cell phenotype can be modulated. 
 
Extracellular Matrix Turnover 
 Along with deposition of extracellular matrix is the equally important degradation 
and turnover of matrix molecules which has also been implicated in vascular 
development and disease.(196, 197)  Table 4.11 contains data from Shear vs. Static and 



















































































































































































































































































































































































































































































































































































































































which are a family of proteinases responsible for extracellular matrix protein degradation.  
In comparing mechanical environments by examining Shear vs. Static data sets, shear 
stress upregulates expression on both substrates of MMP-1 which is known to cleave 
collagen of types I, II, III, VII and X.  Also on both substrates, shear stress upregulates 
expression of MMP-10 which degrades fibronectin and gelatin of types I, III, IV and V as 
well as weakly degrades several types of collagen.  In evaluating the Slide vs. TEWM 
data sets, there is a general trend of reduced MMP expression on the Slide compared to 
the TEWM.  With this general observation, one could hypothesize that the presence of a 
more complex substrate stimulates endothelial cells to increase remodeling.  The 
interplay of stimuli is again apparent as MMP-1 and MMP-14 are not differentially 
regulated by substrate in the presence of shear stress. 
 
Reduction-Oxidation Balance 
 Oxidative stress is considered a leading cause of atherosclerosis progression and 
vascular dysfunction.  Production and catabolism of free radicals and activated oxygen 
species by endothelial cells has been heavily investigated in order to understand 
mechanisms by which atherosclerotic plaque develops. (198)  With the reduction-
oxidation balance an important mediator of vascular disease, response of genes involved 
in the balance to substrate and shear stress is of great interest.  Table 4.12 shows data 
from Shear vs. Static and Slide vs. TEWM microarray comparisons.  Looking first at the 
Shear vs. Static data, there is a clear trend of upregulation of identified redox genes under 
shear stress compared to static conditions on both substrates.  There is a significant 














































































































































































































































































































































































































































































































































































































































































































































































































































































Slide and TEWM substrates which confirm recent reports of their shear regulation. (199)  
There is also upregulation of heme oxygenase-1, superoxide dismutase-1 and cox-2 
which have all also been reported to respond to shear stress environments. (68, 69)  
Identity of the substrate does not seem to greatly affect the shear response of these genes; 
however there is detection of SOD-1 only on the TEWM substrate and greater fold 
change of cox-2 and CYP1B1 on the TEWM compared to the Slide. 
 In evaluating the Slide vs. TEWM data sets, there is little difference between the 
two substrates under static or shear conditions for the redox genes identified.  Gene 
expression of glutathione peroxidase-1 (GPX1), which is involved in catabolism of 
activated oxygen species and free radical detoxification, is downregulated on the Slide 
compared to the TEWM under Static and Shear conditions.  There is also a reduction in 
CYP1B1 expression on the Slide compared to the TEWM under Shear conditions which 
correlates to the fold changes seen in the Shear vs. Static data for this gene.  Finally, there 
is upregulation of cox-1 on the Slide compared to the TEWM but only when the cells are 
under static conditions.  Overall, we conclude that there is an upregulation of redox genes 
under shear stress compared to static conditions on both substrates.  The slightly greater 
response to shear stress by the redox genes in endothelial cells on the TEWM also 
suggests that substrate has an effect on oxidative stress.  This microarray data underlines 
the importance of shear stress in regulating the reduction-oxidation balance and provides 





Vascular Patterning and Angiogenesis 
 Development of new blood vessels, whether prompted by normal development or 
pathologic conditions, is a complex series of processes involving many players and 
carefully orchestrated cues.  While multiple genes are involved in the steps of vascular 
patterning and angiogenesis, there are several genes known to have specific functions in 
blood vessel development.  Table 4.13 contains data from the microarray comparisons for 
several genes involved in vascular patterning and angiogenesis which were significantly 
regulated in response to substrate and shear stress. 
 In examining the Shear vs. Static data sets, three genes are identified which were 
not previously recognized as being sensitive to mechanical environment.  Two related 
molecules, neuropilin 1 and neuropilin 2, are cell surface glycoproteins with established 
roles in axon guidance and more recently have been associated with angiogenesis. (200)  
Neuropilins bind semaphorins and specific isoforms of PGF and VEGF to mediate 
chemorepulsive and chemoattractive signals and they are among the many neural 
patterning genes which are now recognized to have similar functions in blood vessel 
patterning. (201)  Although the two neuropilins are identified here as responsive to shear 
stress, their shear response depends on the substrate present as NRP1 is downregulated 
under shear only on the TEWM and NRP2 is upregulated under shear only on the Slide.  
A third gene identified as differentially regulated under shear stress compared to static 
conditions is the ribonuclease angiogenin.  Angiogenin is a protein which moves into the 
nucleus where it is thought to control tRNAs as well as rRNA transcription and therefore 
may be a control point for multiple angiogenic factors. (202)  In this study, angiogenin is 






















































































































































































































































































































































































































































































































































































































































































has not previously been recognized as shear-responsive in endothelial cells; however it 
was recently reported to be upregulated in mouse embryonic stem cells which were 
exposed to laminar shear stress in efforts to promote a cardiovascular lineage. (203)  
Identification of these endothelial genes as shear-responsive, with the response being 
dependent on substrate, underlines the importance of cues from the cell 
microenvironment in vascular patterning and angiogenesis. 
 Examination of the Slide vs. TEWM data in Table 4.13 identifies three additional 
genes which are differentially regulated by substrate under static and shear stress 
conditions.  Gene expression of robo-1, ephrin A1 and ephrin B2 is downregulated in 
endothelial cells on the Slide compared to the TEWM under both Static and Shear 
conditions.  These three genes are membrane proteins and all have established roles in 
axon guidance and neural migration and are now recognized to play similar roles in 
vascular patterning. (201, 204)  Additionally, members of the ephrin family interact at the 
arterial-venous interface and ephrin B2, which is significantly regulated here, is present 
only on arterial endothelium.  While expression of these three genes is higher on the 
TEWM than the Slide under static conditions, the presence of shear stress only increases 
the disparity between the two substrates as reflected in the greater fold change 
magnitudes.  Identification of numerous genes important in vascular patterning and 
angiogenesis as differentially regulated by shear stress and substrate is important in 
understanding their many functions in development of the vasculature.  Furthermore, the 
more physiologic nature of the tissue engineered blood vessel provides an improved in 




 The expansive nature of microarray data is useful for mining of any number of 
particular genes but interpretation of the data as a whole can often be difficult.  Data 
presented here is a small fraction of the information generated from this study however 
the discussion of select areas of biological function serves to demonstrate the widespread 
influence of shear stress and substrate.  By examining expression of genes involved in the 
cell cycle, we can conclude that the type of mechanical environment and nature of the 
substrate have broad impact on endothelial behavior.  Specifically, shear stress reduces 
cell cycle activity on both substrates but the type of substrate present alters the extent of 
shear effect.  Comparisons of the two substrates show higher cell cycle activity on the 
Slide under static conditions but there is little difference in cell cycle gene expression 
between the substrates under shear conditions. 
 In focusing on multiple areas of biological function within the cardiovascular and 
hematological systems, we see extensive regulation of gene expression by substrate and 
shear stress but the exact influence of these stimuli depends on the function in question 
and the identity of each gene.  Integrin family gene expression shows significant 
regulation by both shear stress and substrate.  However the specific integrin determines 
whether the expression varies with mechanical environment or with substrate and the 
type of response, whether upregulation or downregulation.  Genes involved in the 
coagulation balance show a similar mixed pattern of influence with pro-coagulant and 
anti-coagulant molecules differentially upregulated or downregulated by both shear stress 
and substrate.  In the presence of shear stress, the differences in coagulation gene 
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expression between the two substrates is reduced, however there is no general trend in 
tipping the coagulation balance in one direction or the other. 
 Genes encoding for extracellular matrix tend to increase in response to shear 
stress but the breadth of the response and behavior of individual genes often depends on 
the substrate concurrently present.  However, for the majority of genes the substrate is a 
greater influence and differences due to substrate are consistent regardless of mechanical 
environment.  The counterparts to genes for matrix deposition are those for matrix 
turnover which also show responsiveness to shear stress and substrate.  Shear stress 
upregulates MMP expression on both substrates but there is a general trend of reduced 
expression on the Slide compared to the TEWM regardless of mechanical environment. 
 In examining genes involved in oxidation and reduction, there is a clear trend of 
upregulation under shear stress compared to static conditions on both substrates.  
Contrary to the general trend seen in extracellular matrix genes, substrate does not seem 
to greatly affect expression of redox genes with few significant differences identified and 
substrate effect seen only in fold change magnitudes in response to shear stress.  The 
pattern of expression for genes involved specifically in vascular patterning and 
angiogenesis is more mixed with significant influence of both shear stress and substrate.  
Genes of this biological function identified here were not previously recognized to be 
shear and substrate responsive which underlines the importance of cues from the cell 
microenvironment and the novel insight which can be gained from using more 
physiologic in vitro models. 
 Data in each of the areas of biological function which were discussed contain 
genes which are sensitive to shear stress, genes which are sensitive to substrate and genes 
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which are sensitive to both stimuli.  Overall some areas are more influenced by shear 
stress, such as genes in the redox balance, whereas other areas are more influenced by 
substrate, such as genes for extracellular matrix proteins.  Other cell functions, most 
notably the cell cycle, are dramatically influenced by both mechanical environment and 
substrate.  For all areas of biological function examined, the profile of gene expression is 
different for each combination of stimuli thus emphasizing the sensitivity of endothelial 
cells to cues from the microenvironment. 
 While this study provides new insight into endothelial cell behavior and explores 
the use of tissue engineered blood vessels in vascular biology, it has numerous limitations 
which are a basis for future work.  In particular, the stimuli being provided are still 
simplistic approximations of the physiologic environment.  The tissue engineered wall 
model (TEWM) is a more physiologic substrate than traditional in vitro models such as 
tissue culture plastic or the Slide substrate used in these studies, but it is a basic 
reconstruction of the vessel wall.  The TEWM is missing important matrix components 
present in vivo such as elastin and other types of collagen.  Furthermore, it does not 
achieve a native configuration with the current components such as collagen fiber 
structure and density of smooth muscle cells.  The steady laminar shear stress is a more 
physiologic mechanical force than static culture however it is a crude approximation of 
the complexity of fluid flow experienced by the endothelium.  A more physiologic 
system would use waveforms from different regions of the arterial tree and potentially 
compare these with steady flow or with each other.  Another next step would be the 
addition of environmental cues other than substrate and shear stress.  Other biological 
components such as plasma and blood cells as well as mechanical forces such as pressure 
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and cyclic strain have previously been shown to influence endothelial function.  
Additional of these physiologic cues to a system of multiple stimuli would increase the 
understanding of their effects by placing them in context with other components of the 
microenvironment. 
 As the more physiologic stimuli presented here are only a first step, the 
information provided by transcriptional profiling is only the beginning of insight into 
endothelial cell function.  Additional information regarding protein expression and how 
the mRNA profile translates into the protein profile is required for biological 
understanding.  Moreover, the way in which an array of proteins in a cell translates into a 
unified function in response to a challenge of the system must be investigated.  As 
systems biology and technology for profiling advance along with development of more 
sophisticated analysis tools, researchers will be able to compile expansive data sets from 
different levels of cell control to paint a picture of overall function. 
 In conclusion, this study is intended as a first step towards a better understanding 
of endothelial cell biology and the use of more physiologic in vitro models provided by 
tissue engineering.  Using the data presented in this study, pursuit of mechanisms of 
influence and identification of pathways sensitive to substrate and shear stress could 
provide novel insight into physiologic and pathologic conditions.  Furthermore, the 
improved understanding of biological response to environmental cues will aid in the 
development of improved physiologic in vitro models.  The iterative cycle of enhanced 
models and superior information will drive research to its ultimate goal of addressing 
physiologic and pathologic needs. 
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CHAPTER FIVE: Influence of Substrate and Shear Stress on 
Endothelial Gap Junctions 
 
Introduction 
 Gap junctions and their building blocks, connexins, have long been identified as 
critical to cell communication and tissue function.  They are found in almost every cell in 
the body and currently over 20 types of connexins, usually named by their molecular 
weight, have been identified in humans.  Within a cell, a single connexin protein 
assembles with five other connexins to form a hexameric array called a connexon or 
hemichannel.  Each hemichannel is trafficked to the cell membrane where it docks and 
covalently seals with a hemichannel from a neighboring cell to form a gap junction.  Gap 
junctions then cluster in the membrane at regions of cell-cell contact to form a gap 
junction plaque and regulate flow of chemical and electrical information through their 
pores.  While these fundamental processes of gap junctions have been established in 
model cell systems, little is understood about their synthesis, assembly, gating and 
function in native tissues. 
 Connexins in the cardiovascular system were first studied in the heart for their 
roles in conduction of electrical signals in the myocardium.  Changes in connexin 
expression level or changes in ratio of connexin isotypes have been linked to cardiac 
abnormalities. (205)  Recent interest in the role of connexins in the vascular wall has 
begun to build with evidence that they play critical and poorly understood roles in 
vascular development and disease.  Endothelial cells are known to expression Connexin 
37, Connexin 40 and Connexin 43 while smooth muscle cells express Connexin 40, 
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Connexin 43 and Connexin 45. (13, 119)  Distribution of these connexins varies amongst 
vascular beds and in different species as well as between in vivo and in vitro experimental 
settings. (120, 121)  It is thought that the heterogeneity in cellular and vascular bed 
distribution is linked to specialized functions of the connexin isotypes and needs for 
cellular communication which are not yet understood. (122)  Gap junctions coordinate 
cellular responses within the endothelium and also within the layers of smooth muscle 
cells in the vascular media.  However in addition to homocellular connections, 
heterocellular connections also exist.  Most notably, there are myoendothelial gap 
junctions (MEGJ) which link endothelial cells and smooth muscle cells together. (120, 
123)  While their existence was only recently confirmed, it is believed that signals passed 
through myoendothelial gap junctions function to control vascular tone. (124).   
With their primary function being to promote communication between cells, gap 
junctions are critical in development of many tissues.  There are four connexins 
expressed in the developing mouse heart: Cx37, Cx40, Cx43 and Cx45.  Cx37 is 
expressed in endothelial cells of blood vessels and in the endocardium, Cx40 is expressed 
in myocytes and appears to be regionally controlled while Cx43 often has either 
overlapping or complementary expression to Cx40 depending on the tissue region. (170)  
Knockout connexin models elucidate functions in development but attempts to study 
connexin influence on vascular wall biology have been hampered by the widespread 
expression of these molecules in other tissues and the drastic influence of knocking out 
the gene in all tissues.  Cx37-/- mice are viable but females are infertile because of 
abnormal development of both oocytes and ovarian follicles. (171)  Cx40-/- mice are 
viable but have prolonged atrioventricular conduction, right bundle branch block and a 
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predisposition for arrhythmias. Furthermore, Cx40-/- mice have diminished conduction 
of arteriolar dilatation in response to acetylcholine and bradykinin and are hypertensive 
but have no other obvious blood vessel abnormalities. (172)  Cx43-/- mice die perinatally 
due to abnormal development of the pulmonary outflow tract from atypical migration of 
cardiac neural crest cells. (173)  Single knockout connexin mice have characterized 
phenotypes which are largely non-blood vessel related because of the widespread 
expression of these molecules and their presumed functional overlap within the vessel 
wall. When in vivo expression of connexins is reduced further using a multiple knockout 
strategy, there are severe blood vessel abnormalities indicating an important interplay 
between the functions of connexins.  Cx37-/- Cx40-/- mice die perinatally with 
hemorrhages and severe blood vessel dilatation. (174)  Cx40-/- Cx43-/- have also been 
reported to die at E12.5 with malformed hearts including abnormally rotated 
ventricles.(175) 
While roles for connexins have been identified in both cardiac dysfunction and 
angiogenesis, we will focus on the recent evidence linking gap junctions to hypertension 
and atherosclerosis. (118, 161, 162)  In a recent study, the Cx43 gene was knocked out 
only in vascular endothelial cells therefore providing a model in which the role of 
connexins in the vascular wall can be studied without the confounding influence of 
perinatal death or impaired fertility of mice. Of particular interest is the finding that the 
VEC Cx43-/- mice exhibit hypotension and bradycardia compare to heterozygous 
littermates indicating a role for endothelial cell Cx43 in maintaining normal vascular 
function.(163)  Further demonstrating the link between connexins and hypertension are 
results from spontaneously hypertensive rats which show reduced connexin expression 
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compared to normal controls. (164)  Rats induced for hypertension also show reduced 
Cx37 and Cx43 expression but no change in Cx40 expression in endothelial cells 
compared to normotensive animals.  This reduction can be partially recovered by one 
drug treatment and completely restored by another drug treatment. (165) 
Connexins in the vascular wall have also been linked to the prevalence of 
atherosclerosis and have been shown to vary in expression with the progression of 
plaques.  Heterozygous Cx43+/- mice exhibit a 50% decrease in atherosclerotic plaques 
in vivo and in vitro experiments have shown that statins reduce the Cx43 expression in 
endothelial and smooth muscle cell cultures. (166)  Cx37 and Cx40 expression is reduced 
in endothelial cells of hyperlipidemic mice and only Cx37 levels recover with lipid-
lowering drug treatment. (167)  An altered pattern of connexin expression in endothelial 
and smooth muscle cells is seen in non-diseased arteries, early atheromas and advanced 
atheromas. (168)  Finally, naturally occurring Cx37 variants have also been implicated in 
the prevalence of atherosclerosis in human populations. (169)  
With links between gap junctions and atherosclerosis being established, there 
have been several studies investigating the response of vascular connexins to mechanical 
stimuli.  The first insight into the potential regulation of gap junctions by physical forces 
grew out of a study focused on mapping the regional distribution of Cx37, Cx40 and 
Cx43 in rat endothelium. (187)  While the distribution of Cx37 and Cx40 appeared in 
similar widespread patterns, it was noted that Cx43 expression was found mainly in 
regions near aortic branches where blood flow is disturbed.  Introduction of a flow 
disturbance into this model resulted in a strong upregulation of Cx43 in areas not 
previously showing high levels of expression.  An in vitro study of vascular cells and 
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mechanical forces found a sustained upregulation of Cx43 protein in rat aortic smooth 
muscle cells exposed to 20% stretch for 24 hours and a transient upregulation in Cx43 
mRNA in endothelial cells exposed to laminar shear stress. (188)  Further investigation of 
endothelial cell Cx43 regulation by shear stress was conducted using an in vitro parallel 
plate flow chamber system which exposed cells to four types of fluid shear from 
recirculating to fully developed laminar flow. (189)  It was found that Cx43 mRNA was 
transiently upregulated by all flow patterns however upregulation was only sustained 
after 30 hours in areas of disturbed, recirculating flow.  Furthermore, Cx43 protein 
appeared disorganized in regions of disturbed flow and cells showed little coupling as 
assessed by dye transfer indicating limited gap junction communication.  More recently, 
other endothelial cell connexins (Cx37 and Cx40) were also investigated in this in vitro 
flow system. (190)  Patterns of protein expression and roles of different connexin 
isotypes in endothelial gap junction communication were investigated using dye transfer 
techniques in conjuction with peptide channel blockers.  In addition to studies focusing 
on vascular connexin response to mechanical forces, differential expression by shear 
stress has been reported in numerous microarray studies. (48, 81, 83, 191) 
The link between endothelial cells and smooth muscle cells in the vascular wall is 
most intriguing when investigating the role gap junctions play in normal vascular 
function as well as disease.  It is widely believed that the direct communication between 
these two cell types, in addition to the connections which exist among each cell type, 
allow the vascular wall to act as a unit in response to a stimulus. (122)  Early studies of 
conductivity in arterioles first suggested that endothelial and smooth muscle cells are 
electrically coupled in both a homocellular and heterocellular manner. (152)  
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Subsequently, multiple dyes were used to trace the patterns of the potential endothelial-
smooth muscle cell coupling units. (153)  Anatomical evidence for myoendothelial gap 
junctions was then uncovered along with studies identifying movement of calcium and 
endothelial-derived hyperpolarizing factor directly between the two cell types. (154-156)  
The first in vitro study of myoendothelial gap junctions was recently reported where an 
endothelial-smooth muscle cell co-culture system was developed to better understand the 
role of specific connexin isotypes in their formation. (157) 
Due to their emerging importance in vascular development and disease, this study 
focuses on connexins and gap junctions in human endothelial cells.  As these structures 
serve to communicate information within the cellular microenvironment, we hypothesize 
that they are also regulated by stimuli present in the microenvironment.  Therefore the 
goal of this study is to investigate the influence of substrate and shear stress on 
endothelial cell connexin expression and gap junction communication. 
 
Experimental Design and Methods 
Experimental Design 
 The approach taken to investigate influence of substrate and shear stress on 
endothelial cell gap junctions is to examine connexin mRNA expression, protein 
expression and cell-cell communication in cells on traditional and tissue engineered 
substrates under different mechanical environments.  To profile the influence of substrate 
and shear stress, techniques will examine the three connexin isotypes present in 
endothelial cells (Cx37, Cx40 and Cx43) at the gene and protein levels while function 
will be evaluated by protein location and movement of dye through gap junctions.  
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Furthermore, to gain insight most applicable to human development and disease, this 
study takes advantage of the tissue engineering approach by using human cells to create a 
human blood vessel model.  To examine the effect of shear stress, endothelial cells are 
exposed to either static or laminar shear stress (15 dynes/cm2) conditions.  To examine 
the effect of substrate, endothelial cells are exposed to two environments.  As a point of 
reference, a traditional in vitro model of monomer type I collagen adsorbed to glass is 
used.  As a more physiologic in vitro model, a biologically-based blood vessel substitute 
is used.  This tissue engineered model is a three-dimensional type I collagen gel 
containing dispersed human aortic smooth muscle cells to mimic the components and 
structure of the medial layer.  Confluent endothelial monolayers are cultured on each 
substrate for 48 hours prior to exposure to static or shear conditions for 24 hours.  
Similarities and differences in endothelial cells from the four experimental conditions 
provide insight into the influence of substrate and shear stress on multiple aspects of 




 Human aortic endothelial cells (HAEC) (Cambrex) were cultured to passage 6 in 
MCDB 131 supplemented with 5% FBS, antibiotics and growth factors while human 
aortic smooth muscle cells (HASMC) (Cambrex) were cultured to passage 8 in MCDB 
131 supplemented with 5% FBS, antibiotics and growth factors.  All experiments were 
conducted in a co-culture media of MCDB 131 supplemented with 5% FBS, antibiotics 




 Two types of substrate were used in this study: Adsorbed Collagen Slide and 
Tissue Engineered Wall Model (TEWM).  The Adsorbed Collagen Slide was created by 
coating glass slides with 50 µg/ml collagen type I (BD Biosciences) and allowing protein 
to adsorb to the surface for one hour prior to removal of the solution.    The Tissue 
Engineered Wall Model was created by suspending 1 million HASMC per ml in 5x 
concentrated MCDB-131, 10% FBS and 2 mg/ml rat tail type I collagen (BD 
Biosciences).  Sodium hydroxide was added to neutralize the acidic collagen solution and 
promote polymerization.  Tubular HASMC-collagen gels were created using a central 
mandrel during gelation and were cultured for six days to allow for cell-mediated 
compaction of the collagen fibers.  The tubular gels were then cut longitudinally and 
embedded in agar to expose a flat lumen for seeding of HAEC and fluid shear 
experiments. (43)  Endothelial cells were seeded on both models at a density of 40,000 
cells/cm2 to produce a confluent monolayer and cultured for 48 hours prior to exposure to 
static or shear conditions. 
 
Exposure to Shear Stress 
The parallel plate flow chamber used to expose endothelial cells to laminar shear 
stress has been previously established in our laboratory. (42, 49)  In this closed loop, a 
peristaltic pump moves medium from a container into a pulse dampener and then through 
parallel plates where endothelial cells are exposed to a steady laminar shear stress.  Shear 
stress is controlled by fluid flow rate and dimensions of the chamber according to the 
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equation: τ = 6Qµ/bh2.  Exposure of endothelial cells on the tissue engineered wall model 
was accomplished by embedding the depth of the collagen gel in agar supported by a 
polycarbonate mold.  The entire mold/agar apparatus was then placed into the flow 
chamber.  Endothelial cells on the Slide or TEWM were exposed to a shear stress of 15 
dynes/cm2 for 24 hours. 
 
Endothelial Isolation from Tissue Engineered Wall Model 
 To evaluate endothelial cell gene and protein expression following culture on the 
TEWM, pure endothelial cells must be removed without contamination of neighboring 
smooth muscle cells.  Following cell exposure to static or shear stress conditions, the 
TEWM lumen was briefly exposed to collagenase to release cells near the surface.  
Endothelial cells were isolated from the cell mixture using a magnetic separation 
technique whereby a primary PE-conjugated antibody to PECAM-1 (Santa Cruz) 
followed by a magnetic bead-conjugated secondary antibody to PE positively selects for 
endothelial cells.  Following passage through a separation column placed in a magnetic 
field, endothelial cells were collected and lysed or fixed for further analysis.  
Effectiveness of the magnetic sorting procedure was validated using pre-labeled 
endothelial cells mixed with smooth muscle cells and flow cytometry analysis post-
separation. 
 
RNA Isolation and Analysis 
 Total RNA was extracted from endothelial cells using an RNeasy kit (Qiagen) 
with an added DNAse digestion step.  To evaluate quality of RNA prior to RT-PCR 
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analysis, samples were assessed using the RNA 6000 Nano LabChip (Agilent) on an 
Agilent Bioanalyzer 2100.  Profiles of ribosomal peaks were evaluated for degradation as 
a measure of overall RNA degradation and preliminary measurements of RNA quantity 
were determined.  Quantity of high quality RNA was assessed by absorbance at 260nm 
prior to reverse transcription to cDNA for RT-PCR. 
 
Quantitative RT-PCR 
 One microgram of high quality endothelial RNA was reverse transcribed using 
the First Strand cDNA Synthesis Kit (Invitrogen) for each experimental sample.  Primers 
were designed using Primer Express (Applied Biosystems) and oligos were created by 
Integrated DNA Systems.  Primer sequences are listed below for the three connexins 
expressed in endothelial cells. 
Cx37 Forward: CATGGAGCCCGTGTTTGTG 
Cx37 Reverse: GAGACAAAGCAGTCCACGAGG 
Cx40 Forward: GGGCACTCTGCTCAACACCT 
Cx40 Reverse: TGAAGCCCACCTCCATGGT 
Cx43 Forward: TTAAGGGAAAGAGCGACCCTT 
Cx43 Reverse: GACCCACAGTCTTTGGCAGG 
 Standards of known concentration were generated using PCR amplification and 
agarose gel extraction for each gene of interest.  Quantitative RT-PCR was conducted 
using cDNA from samples (in triplicate) and standards (in triplicate) with SYBR® Green 
PCR Master Mix (Applied Biosystems) on an ABI 7700 (Applied Biosystems) real time 
PCR machine.  Data was quantified using the absolute standard method where serial 
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dilutions of the standard were plotted against CT values to generate a correlation used to 
convert sample CT values into concentrations. 
 
Flow Cytometry 
 Single cell suspensions of endothelial cells were fixed in 4% formaldehyde for 5 
minutes, permeabilized in 0.1% Triton X-100 for 5 minutes and then incubated for 1 hour 
in 4% donkey serum to block non-specific binding of antibodies.  Cells were labeled with 
one of the following primary antibodies at 1:100 dilution: Rabbit Anti-Mouse Cx37 
(Alpha Diagnostic), Goat Anti-Human Cx40 (Santa Cruz Biotechnology), Goat Anti-
Human Cx43 (Santa Cruz Biotechnology) for 1 hour at 37°C.  Following two washes in 
T-TBS solution, cells were incubated with one of the following secondary antibodies: 
FITC-conjugated Donkey Anti-Rabbit (Jackson ImmunoResearch) or FITC-conjugated 
Donkey Anti-Goat (Jackson ImmunoResearch).  Control samples were fixed, 
permeabilized and blocked with experimental samples, then labeled with secondary 
antibody alone to account for autoflourescence and non-specific binding of secondary 
antibody.  Cell suspensions were analyzed using a BD LSR digital flow cytometer to 
determine mean fluorescence intensity of control and experimental samples.  During each 
sample run, standard beads were analyzed to create a standard curve for conversion of 







 Immunocytochemistry was conducted on endothelial cells on the Slide or TEWM 
substrate following exposure to static or shear conditions.  Samples were fixed using 4% 
formaldehyde for 5 minutes for Slide samples and 1 hour for TEWM samples.  Staining 
procedures were identical to flow cytometry analysis with steps for permeabilization, 
blocking, primary antibody incubation and secondary antibody incubation.  Samples were 
imaged using a laser-scanning confocal microscope with a 40x oil objective.   
 
Dye Transfer Assay 
 Following exposure of endothelial monolayers to static or shear stress conditions, 
assessment of dye transfer between cells was conducted as a measure of gap junction 
communication.  In this assay of gap junction function, cells are loaded with two 
membrane-impermeant dyes: i) a small dye which can pass through gap junctions and ii) 
a large dye which cannot pass through gap junctions and is used to mark cells originally 
loaded with dye.  Following a defined period of time, cells are fixed and imaged to 
evaluate the extent of dye transferred from cells originally loaded with dye to 
neighboring cells as a measure of cell coupling by gap junctions.  In this study the dye 
used to pass through gap junctions is Biocytin (ε-biotinoyl-L-lysine) with a molecular 
weight of 372Da and neutral charge (Molecular Probes) and the dye used to mark cells 
originally loaded with dye is Tetramethylrhodamine Dextran (flouro-ruby) with a 
molecular weight of 10,000Da (Molecular Probes). 
 Immediately upon removal from the static dish or flow chamber, monolayers are 
rinsed in Dulbecco’s PBS and excess fluid is blotted off.  A mixture of 4mg/ml Biocytin 
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and 5mg/ml Rhodamine-Dextran in PBS is dripped onto the monolayer surface which is 
then scratched with a diamond-tipped pen (tip diameter 0.25mm).  Samples are 
immediately placed in the incubator at 37°C for 2 minutes to allow passage of dye.  
Excess dye is quickly removed, samples are rinsed in PBS and fixed in 4% formaldehyde 
for 20 minutes.  While the dextran is fluorescent, biocytin requires a secondary antibody 
for detection.  Monolayers are permeabilized with 0.1% Triton X-100 for 5 minutes and 
incubated with 4% donkey serum for 30 minutes to block non-specific binding prior to 
labeling with a secondary antibody Oregon Green 488 NeutrAvidin (molecular probes).  
Samples were imaged using a Nikon E600 fluorescent microscope using filters to 
separately detect red and green signals. 
 
Results 
Connexin Gene Expression 
 The influence of substrate and shear stress on endothelial cell connexin gene 
expression was first identified using microarray analysis.  Comparison of endothelial 
cells on the Slide or TEWM substrate under Static or Shear conditions resulted in the 
differential expression of connexins as shown in Table 5.1.  ANOVA with multiple 
testing corrections showed significantly different regulation of Cx37 and Cx40 but not 
Cx43.  Pairwise comparisons of the two flow environments on both substrates and 
comparisons of the two substrates under both flow environments showed a significant 
upregulation of Cx37 and Cx40 gene expression under shear stress compared to static on 
the TEWM substrate.  Furthermore, there was also a significant downregulation of Cx37 
on the TEWM compared to the Slide under static conditions.  The significant regulation 
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of connexins by substrate and shear stress warranted further investigation, especially in 
light of the differential responses of the three endothelial connexin isotypes. 
 To further evaluate gene expression, RT-PCR was used to quantify levels of 
connexin mRNA in endothelial cells on the two experimental substrates under static and 
shear stress conditions.  The three connexin isotypes known to be expressed by 
endothelial cells: Cx37, Cx40 and Cx43, were detected under all experimental conditions.  
Figure 5.1 shows mRNA expression for the four experimental conditions as quantified 
using standards of known concentration.  Analysis by 2-way ANOVA identifies a 
significant effect of shear stress on Cx37 mRNA.  However, while there is not a 
significant effect of substrate, the substrate alters the influence of shear stress as indicated 
by the significant interaction p-value.  Figure 5.2 displays Cx40 mRNA expression in 
endothelial cells of the four experimental conditions and it is interesting to note that Cx40 
is expressed at higher levels that Cx37 or Cx43.  Shear stress significantly upregulates 
Cx40 mRNA to similar levels on both substrates while substrate does not have a 
significant effect nor does it significantly alter the influence of flow environment.  Figure 
5.3 displays levels of Cx43 mRNA in endothelial cells of the four experimental 
conditions which are similar to expression levels of Cx37 mRNA.  For Cx43, there is a 
significant influence of substrate on mRNA with reduced levels in endothelial cells on 
the TEWM compared to the Slide.  There is no significant effect of shear stress or 


































































































































































































































































































































































































































































































































































































































































































































Slide Static Slide Shear TEWM Static TEWM Shear
2-way ANOVA
Substrate: p = 0.069
Flow: p < 0.05
Interaction: p < 0.01
 
 
Figure 5.1 Endothelial Cx37 mRNA Expression Assessed by RT-PCR 






























Slide Static Slide Shear TEWM Static TEWM Shear
2-way ANOVA
Substrate: p = 0.112
Flow: p < 0.01
Interaction: p = 0.179
 
 
Figure 5.2 Endothelial Cx40 mRNA Expression Assessed by RT-PCR 





























Slide Static Slide Shear TEWM Static TEWM Shear
2-way ANOVA
Substrate: p < 0.001
Flow: p = 0.488
Interaction: p = 0.684
 
 
Figure 5.3 Endothelial Cx43 mRNA Expression Assessed by RT-PCR 




Connexin Protein Expression 
 Flow cytometry was used to examine the total levels of connexin protein 
expression in endothelial cells as influenced by substrate and shear stress.  Figure 5.4 
shows expression of Cx37 protein which was quantified using standards of known 
fluorescence intensity in MESF (molecules of equivalent soluble fluorescence).  Analysis 
by 2-way ANOVA shows no significant effect of shear stress but there is a significant 
effect of substrate on Cx37 protein levels.  Under both mechanical environments, there is 
an increased expression in endothelial cells on the TEWM compared to the Slide.  There 
is also no significant effect of flow on Cx40 protein levels, but Cx40 is significantly 
influenced by substrate as shown in Figure 5.5.  Cx40 protein is increased in endothelial 
cells on the TEWM compared to the Slide and no significant effect of flow is detected.  
Figure 5.6 displays levels of Cx43 protein in endothelial cells of the four experimental 
conditions.  Shear stress does not significantly affect Cx43 protein levels, however 
substrate significantly alters Cx43 with a dramatic increase in endothelial cells on the 
TEWM. 
 To further evaluate endothelial connexin protein expression and gain insight into 
the location of these proteins, immunocytochemistry was used to stain endothelial 
monolayers on both substrates under static and shear stress conditions.  Figure 5.7 shows 
staining of the three connexin isotypes following exposure of endothelial cells on the 
slide substrate to static or shear stress conditions.  Panels on the left (A, B and C) are of 
monolayers under static conditions and panels on the right (D, E and F) are of 
monolayers following exposure to laminar shear stress.  Cx37 protein is shown in panels 
A and D, Cx40 protein is shown in panels B and E, and Cx43 protein is shown in panels 
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C and F.  Connexins appear in punctate patterns at the cell membrane or in the cytoplasm.  
Bright white dots are clusters of connexins in gap junction plaques at the cell membrane 
or as annular gap junctions in the cytoplasm (denoted in Figure 5.7 with red arrowheads).  
More diffuse white dots are connexins or hemichannels which are more spread out and 
have not congregated with others (denoted in Figure 5.7 with green arrowheads).  Under 
static conditions, all three connexins are visible at the membrane and in the cytoplasm.  
Under shear stress, fewer connexins are present at the membrane but gap junction plaques 
still exist and connexins are still present in the cytoplasm. 
 Figure 5.8 shows staining of the three connexin isotypes following exposure of 
endothelial cells on the TEWM substrate to static or shear stress conditions.  Panels on 
the left (A, B and C) are of monolayers under static conditions and panels on the right (D, 
E and F) are of monolayers following exposure to laminar shear stress.  Cx37 protein is 
shown in panels A and D, Cx40 protein is shown in panels B and E, and Cx43 protein is 
shown in panels C and F.  As on the slide substrate, connexins appear in a punctate 
pattern either at the cell membrane or in the cytoplasm.  Imaging of endothelial cells on 
the TEWM substrate is more difficult than the Slide due to the subtle topography of the 
TEWM surface and auto-fluorescence of the collagen gel.  However, diffuse membrane 
staining of connexins is still visible in several images, most clearly in panel A.  More 
intense staining of Cx40 and Cx43 is visible in endothelial cells on the TEWM substrate; 


































Slide Static Slide Shear TEWM Static TEWM Shear
2-way ANOVA
Substrate: p < 0.01
Flow: p = 0.103
Interaction: p = 0.171
 
 
Figure 5.4 Endothelial Cx37 Protein Expression Assessed by Flow Cytometry 

































Slide Static Slide Shear TEWM Static TEWM Shear
2-way ANOVA
Substrate: p < 0.001
Flow: p = 0.529
Interaction: p = 0.968
 
 
Figure 5.5 Endothelial Cx40 Protein Expression Assessed by Flow Cytometry 


































Slide Static Slide Shear TEWM Static TEWM Shear
2-way ANOVA
Substrate: p < 0.001
Flow: p = 0.106
Interaction: p = 0.108
 
 
Figure 5.6 Endothelial Cx43 Protein Expression Assessed by Flow Cytometry 













































Figure 5.7 Endothelial Cell Connexin Protein Immunocytochemistry on a Slide 
Endothelial cell monolayers exposed to static conditions (Panels A, B and C) or laminar shear conditions 
(Panels D, E and F).  Staining shows expression of Cx37 (A and D), Cx40 (B and E) and Cx43 (C and F).  
Gap junction plaques visible by bright white punctate membrane staining (red arrowheads) and connexins 



















































Figure 5.8 Endothelial Cell Connexin Protein Immunocytochemistry on the TEWM 
Endothelial cell monolayers exposed to static conditions (Panels A, B and C) or laminar shear conditions 
(Panels D, E and F).  Staining shows expression of Cx37 (A and D), Cx40 (B and E) and Cx43 (C and F) 










Gap Junction Communication 
 Gap junctions serve to electrically and chemically couple neighboring cells to 
allow communication with a region of tissue.  To evaluate function and level of gap 
junction communication, a dye transfer assay is used.  Cells are loaded with two dyes: 
one of small molecular weight with favorable charge and steric properties which can pass 
through gap junctions and one of large molecular weight which cannot pass and is used to 
mark cells originally loaded with dye.  By evaluating the extent of dye transferred from 
cells loaded with dye to their neighbors, one can assess the gap junction communication 
within the population. 
 Figure 5.9 shows dye transfer in endothelial cells on the slide substrate following 
exposure to static or laminar shear stress conditions for 24 hours.  The left panels (A and 
B) show a region of endothelial cells on a Static Slide which have been scratched to load 
dye into cells adjacent to the scratch.  The field is shown using a red filter in panel A to 
identify cells originally loaded with dye which contain the large Rhodamine-Dextran 
(MW 10,000) dye.  The same field is shown using a green filter in panel B to identify 
cells containing the small dye Biocytin (MW 372) which include cells originally loaded 
with dye and those recipient cells that are linked to the donors by gap junctions.  The 
right panels (C and D) show a region of endothelial cells on a Shear Slide which have 
been scratched and imaged in the same manner as the Static Slide.  The images show a 
similar number of cells originally loaded with dye, however the endothelial cells exposed 
to static conditions pass the dye to more neighbors than cells exposed to laminar shear 
stress.  Images were quantified by counting the number of donor and recipient cells and 



































Figure 5.9 Dye Transfer in Endothelial Monolayers Exposed to Static or Shear 
Endothelial cell monolayer exposed to static conditions for 24 hours (Panels A and B) and endothelial cell 
monolayer exposed to laminar shear stress (15 dynes/cm2) for 24 hours (Panels C and D).  Upper panels (A 
and C) identify cells loaded with dye by scraping which contain Rhodamine-Dextran (red, MW 10000).  
Lower panels (B and D) identify cells loaded with dye by scraping (donor) and adjacent cells in gap 
junction communication (recipient) containing Biocytin (MW 372) detected using Oregon Green 488 







Quantification of dye transfer for endothelial cells on slides is displayed in Figure 5.10 
showing a significant reduction in cell coupling amongst endothelial cells exposed to 
laminar shear stress as assessed by biocytin dye transfer. 
 Due to the extensive restructuring endothelial cells undergo when initially 
exposed to shear stress in experimental conditions, additional studies were conducted 
where slide monolayers were exposed to static or shear conditions for 48 or 72 hours 
prior to dye transfer.  Quantification of endothelial cell dye transfer after 24, 48 or 72 
hours of static or laminar shear stress is displayed in Figure 5.11.  There is a significant 
effect of flow environment on dye transfer but no significant effect of time as assessed by 
2-way ANOVA.  Post hoc Tukey’s tests show a significant difference in each time 
matched static-shear pairing but no difference amongst static samples or shear samples of 
different time points. 
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Figure 5.10 Dye Transfer of Endothelial Cells on a Slide 

























Figure 5.11 Time Course of Endothelial Cell Dye Transfer 
Error bars represent SEM and statistical analysis by 2-way ANOVA is detailed. 
























24 hrs 48 hrs 72 hrs
2-way ANOVA
Flow: p < 0.001
Time: p = 0.093
Interaction: p = 0.149
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Discussion 
 Previous reports of endothelial expression of connexins 37, 40 and 43 and 
endothelial communication through gap junctions have been confirmed in experiments 
here.  Moreover, this study demonstrates that endothelial cell connexins and gap junction 
communication are influenced by substrate and shear stress. 
 
Connexin Gene Expression 
 Significant differences in gene expression of Cx37 and Cx40 due to substrate or 
shear stress as indicated by microarray are confirmed by RT-PCR analysis.  Additionally, 
significant regulation of Cx43 was identified by RT-PCR which was not previously 
identified by microarray.  RT-PCR analysis shows significant influence of flow on Cx37 
with an interaction effect of substrate, a significant effect of flow on Cx40 and a 
significant effect of substrate on Cx43.  Therefore mRNA levels of all three connexin 
isotypes expressed by endothelial cells are significantly influenced by shear stress or 
substrate.  Furthermore, the three connexins respond differently to stimuli leading to the 
hypothesis that they may be regulated independently and/or have unique functions which 
have not yet been elucidated. 
 Results of Cx43 gene expression in response to shear stress in this study confirm 
previous studies reporting Cx43 mRNA levels are comparable in endothelial cells 
exposed to laminar shear stress and static conditions. (188, 189)  To date there have been 
no other investigations of endothelial mRNA expression of Cx37 and Cx40 in response to 
shear stress which were determined to be significantly regulated by fluid flow in this 
study.  However several microarray studies have detected changes in Cx37 and Cx40 
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expression under various fluid flow profiles indicating there is additional support for the 
mechano-sensitive nature of these genes. (81, 83)  Additionally, sensitivity of endothelial 
cell connexin gene expression to substrate is identified here for the first time.   
 
Connexin Protein Expression 
 Analysis by flow cytometry showed no significant effect of flow environment on 
total protein expression of Cx37, Cx40 or Cx43.  However, there is a significant effect of 
substrate on all three connexins with expression being upregulated in endothelial cells on 
the TEWM substrate compared to the Slide substrate.  Immunocytochemistry shows 
presence of Cx37, Cx40 and Cx43 in endothelial cells on both substrates and under both 
mechanical environments.  Connexins are visible in gap junction plaques in the cell 
membrane and clustered in the cytoplasm as well as diffusely spread in the membrane 
and cytoplasm.  On the slide substrate, there is less abundant staining at the cell 
membrane under shear compared to static conditions but gap junction plaques are still 
visible.  Subtle alterations in connexin location seen in this study were also reported 
recently in endothelial cells exposed to shear stress in a different type fluid flow chamber. 
(190)  However due to the numerous mechanisms of connexin and gap junction 
regulation which have been identified or postulated, function cannot be determined based 
on location alone. 
 More intense staining of Cx40 and Cx43 in endothelial cells on the TEWM 
compared to the Slide confirms the increased levels of total expression detected by flow 
cytometry.  It is interesting to note that these connexins appear to be clustered within the 
cytoplasm when examining the two-dimensional images.  The significance of their 
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location is unknown: whether they may be internal storage of connexin proteins or gap 
junctions with underlying smooth muscle cells and thus are not cytoplasmic but in the 
endothelial basal membrane.  A confocal z-stack of endothelial cells on the TEWM 
surface was not able to pinpoint endothelial-smooth muscle connections but the TEWM 
structure does not lend itself to such an analysis due to the variations in smooth muscle 
cell distribution.   
Two previous studies have evaluated vascular connexins in co-culture systems 
and their results may provide some insight into data reported here.  Cell-cell contact is 
necessary for differentiation during blood vessel assembly and it was determined that 
Cx43 is involved in endothelial-mesenchymal gap junction communication which is 
required for endothelial-induced differentiation of mural cells. (206)  In a simplified co-
culture system of endothelial and smooth muscle cells, results reported indicate that Cx40 
and Cx43 in endothelial cells are the isotypes which form myoendothelial gap junctions 
with Cx43 in smooth muscle cells. (157)  With the demonstrated importance of Cx40 and 
Cx43 in endothelial heterocellular communication, we can hypothesize that increased 
Cx40 and Cx43 protein expression seen in endothelial cells on the TEWM may be 
involved in myoendothelial gap junctions and their upregulation may be due to the 
presence of smooth muscle cells. 
While there are no published reports of extracellular matrix influencing 
endothelial cell connexin expression, an effect has been demonstrated in other vascular 
cells.  Cardiac myocytes were recently reported to alter Cx43 expression in response to 
substrate and mechanical forces through signaling pathways involving integrin β1. (207)  
Thus results indicating altered connexin expression in endothelial cells on the TEWM 
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substrate may be due to either presence of smooth muscle cells, structure of extracellular 
matrix or a synergistic effect achieved only when including both stimuli. 
 
Gene and Protein Levels 
 In evaluating results of gene and protein expression for Cx37, Cx40 and Cx43 in 
endothelial cells, we note that changes detected in gene expression do not necessarily 
correlate to changes detected in protein expression.  Connexin 37 mRNA is significantly 
affected by flow with a substrate interaction effect while protein is significantly affected 
only by substrate.  Connexin 40 mRNA is significantly affected by flow with an 
upregulation by shear stress while protein is significantly affected by substrate with an 
upregulation by the TEWM.  Connexin 43 expression is significantly affected by 
substrate at the mRNA and protein levels; however mRNA levels are lower on the 
TEWM than the Slide while protein levels are higher on the TEWM than the Slide. 
A widespread trend of mismatched levels of mRNA and protein for connexins in 
the literature is noted in multiple recent reviews. (128-130)  Explanations for this 
phenomenon may lie in the complex processes used by cells to control connexin 
expression, gap junction formation and cell communication; however the mechanisms 
underlying these processes are largely unknown.  Initial investigations of gene structure 
and mRNA translation provide some insight into potential mechanisms however studies 
in these areas are ongoing. 
At the transcriptional level, mouse genes for Cx37, Cx40 and Cx43 have been 
analyzed to evaluate structure and potential regulatory mechanisms.  All three genes 
contain a TATA box and numerous putative transcription factor sites.  Cx37 is known to 
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also contain a GC box and a CCAAT box which may be involved in its regulation. (130)  
Cx40 and Cx43 both contain transcription factor binding sites for SP-1, AP-1 and AP-2 
as well as several other sites unique to each gene. (131, 132)  Human connexin sequences 
are similar to the mouse although some differences have been noted and future studies 
based on the sequencing of the human genome are sure to provide additional information. 
(133-135) 
At the post-transcriptional level, multiple mechanisms are thought to be involved 
in connexin regulation including mRNA stability, mRNA localization, rate of translation, 
efficiency of translation, and translation in the absence of normal machinery.  Specific 
mechanisms of control for connexins which are currently being investigated include 
sequences in the 5’UTR (untranslated region) and uORF (upstream open reading frame) 
as well as the presence of an IRES (internal ribosome entry sequence).   
Cx37 is the least investigated of the vascular connexins due to its relatively recent 
identification and restricted expression in the body.  Post-transcriptional control has not 
been specifically investigated for Cx37 although differing levels of mRNA and protein 
have been commonly seen. (130)  Additionally, all connexin genes have a 5’UTR longer 
than the normal length for cellular mRNAs (>50 nucleotides) which has been suggested 
to include a mechanism of regulation which requires a longer sequence. (136)  Mouse 
Cx40 was shown to contain a number of alternative promoters which result in multiple 
mRNA transcripts which contain identical coding regions but varied 5’UTR. (128)  It is 
currently unknown if this influences the translatability of the Cx40 message but similar 
structures in Cx32 and Cx43 have just such an effect.  Additionally, some Cx40 mRNA 
transcripts contain an extra noncoding exon whose function is currently unknown but has 
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been hypothesized to be involved in translataional control, mRNA localization or mRNA 
stability. 
Due to the early identification and widespread importance of Cx43, it is the most 
heavily investigated of the vascular connexins.  Analysis of Cx43 structure has identified 
mechanisms of post-transcriptional control involving an IRES and additional exons for 
alternative 5’UTRs. (129, 137)  An internal ribosome entry sequence (IRES) as detected 
in Cx43 is relatively uncommon in cellular mRNA because it allows the ribosome to 
translate the mRNA into protein from a point inside the sequence rather than at the 5’ cap 
which is normally required to start translation machinery.  The advantage of this system 
is that translation can occur under cellular conditions where the 5’ cap may be 
unavailable thus allowing the cell to maintain production of critical proteins. (136)  
Furthermore, it has been shown that IRES activity in cellular mRNAs can be modulated 
by mitotic stimuli, hypoxia and other stresses which adds an additional level of control. 
(138)  Finally, analysis of mouse Cx43 structure has shown the presence of four 
additional exons encoding for different 5’untranslated regions (UTR). (129)  Using 
different promoters and alternative splicing there are nine different mouse Cx43 mRNA 
transcripts which vary only in non-coding regions and have been demonstrated to exhibit 
a range of translational efficiencies.  It is unknown at this time if the human Cx43 
sequence also contains multiple additional 5’UTRs and if so, whether they play a role in 
mRNA stability and translation. 
Results presented here do not determine where the influence of substrate or shear 
stress occurs for Cx37, Cx40 and Cx43.  However based on the mounting evidence of 
mechanisms for transcriptional and post-transcriptional control of connexin expression, 
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explanations could include transcription factor upregulation, mRNA stability, rate of 
mRNA translation and protein stability.  While the mechanisms of control are still being 
elucidated and factors influencing expression, such as substrate and shear stress, are still 
being identified, connexins appear intricately regulated indicating expression must be 
critical to cell function. 
 
Gap Junction Communication 
 Levels of connexin mRNA and protein are only the beginning of the story in gap 
junction function.  Following translation, connexins are organized into hemichannels 
which are inserted in the plasma membrane where they move laterally until joining the 
edge of a gap junction plaque. (113, 125)  When docked in the cell membrane, the pore 
inside a gap junction can open allowing movement of chemical and electrical information 
from one cell to its neighbor.  One technique for measuring this communication is the dye 
transfer assay whereby cells are loaded with dye and the movement of the dye is 
indicative of cell coupling by gap junctions. 
 Following exposure to static or shear stress, confluent endothelial monolayers 
were scrape-loaded to introduce Rhodamine-Dextran (MW 10,000) and Biocytin (MW 
372, charge neutral) into cells adjacent to the scratch.  Quantification of dye transfer 
images showed a reduced level of gap junction communication in shear monolayers 
compared to static monolayers.  Reduction in dye transfer was maintained when 
endothelial cells were sheared for longer time points (48 or 72 hours) indicating it is not a 
transient phenomenon of cell adjustment to the onset of shear stress.  Dye transfer 
experiments were also conducted in endothelial cells on the TEWM substrate but the 
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assay is difficult to control due to the softness of the collagen gel.  When loading dye, it 
is possible to introduce dye into smooth muscle cells in addition to endothelial cells 
which could confound the results of endothelial-endothelial communication. 
 Altered endothelial dye transfer in response to shear stress has also been reported 
in two in vitro studies using microinjection of Lucifer Yellow dye.  In a study evaluating 
dye transfer immediately following endothelial exposure to static, disturbed or laminar 
shear stress, cell coupling was found in cells under static and laminar shear while little 
coupling was present in cells under disturbed shear. (189)  In a second study, samples 
were incubated up to 120 minutes following exposure to laminar shear or static 
conditions prior to dye transfer.  Results indicated an increase in movement of Lucifer 
Yellow in cells that had been exposed to shear stress compared to static cells. (126)  
However, duration of the post-flow incubation period could have altered the endothelial 
gap junction profile as the half life of connexins is very short (1.5 hours for Cx43).  
 While emphasizing the link between shear stress and gap junction communication 
in endothelial cells, comparison of results in the literature is complicated by the use of 
different loading methods and different dyes.  Lucifer yellow and biocytin dyes differ in 
molecular weight, charge characteristics and molecular structure. (153)  Due to the 
specificity of gap junction gating properties, most likely resulting from connexin make-
up, extent of transfer has been shown to depend on the dye used.  In endothelial cells, 
biocytin has been shown to pass more easily through gap junctions and demonstrates cell 
coupling where Lucifer Yellow can fail to transfer. (153, 176, 180) 
Additionally it is important to note that while this study has investigated the 
classical function of gap junctions, creation of a pore for communication between two 
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cells, there is mounting evidence for additional functions.  Individual connexins and 
hemichannels are now also thought to play specific roles in cell growth, differentiation, 
tumorigenicity, injury and apoptosis. (113, 116, 117)  These newly identified functions 
may give additional weight to observed presence of connexins and hemichannels not 
clustered in gap junction plaques but diffusely spread in the cell membrane or located in 
the nucleus or cytoplasm.  Furthermore, functions in addition to pore formation for cell-
cell communication may explain the need for multiple connexin isotypes, restricted 
distribution in cell types and potential specific roles in development and disease. 
 
Conclusions 
 Results presented here indicate that while endothelial cell connexin expression 
and gap junction communication is influenced by substrate and shear stress, the response 
to these stimuli is complex.  Connexin mRNA is influenced by substrate and shear stress 
but in an isotype dependent manner.  Endothelial cells express Cx37, Cx40 and Cx43 
protein in both the cell membrane and cytoplasm and quantification of total protein 
shows a significant regulation by substrate for all three connexins.  Gap junction 
communication measured by transfer of biocytin dye shows reduced cell coupling in 
endothelial cells following exposure to laminar shear stress compared to static controls.  
While we have demonstrated novel sensitivities of endothelial cell gap junctions, 
mechanisms of influence for substrate and shear stress as well as explanations for 
differential response of connexin isotypes remain unknown. 
 Endothelial connexin and gap junction responses to shear stress include mRNA 
regulation for specific isotypes and an overall reduction in cell coupling.  While these 
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results demonstrate mechanosensitivity, questions remain regarding the reasons for 
isotype-specific responses and mechanisms of influence.  An additional limitation of the 
shear stress experiments conducted here is the type of fluid flow imposed on the cells.  
Unidirectional laminar shear stress, while more physiologic than static conditions, is a 
much simplified stimulus compared to forces experienced in vivo.  To better understand 
connexin and gap junction mechanosensitivity and the potential link with atherosclerosis 
will require investigation using multiple waveforms representing forces felt in 
developmental, physiologic and pathologic conditions.  With an improved system 
mimicking shear forces, questions can then be posed regarding the mechanisms of 
influence on endothelial cell connexins and gap junctions.  Areas of investigation for 
future work should include control of transcription, translation, mRNA stability and 
degradation, protein stability and degradation as well as channel gating. 
 Connexin and gap junction response to substrate was demonstrated by comparing 
a traditional in vitro model of endothelial cells on monomer collagen adsorbed to glass to 
a more physiologic model using a tissue engineered blood vessel.  While bridging the gap 
between traditional in vitro and in vivo experimental settings as well as demonstrating a 
substrate influence, numerous questions remain.  By comparing two relatively different 
substrates, a limitation of this study is the identification of specific components of the 
substrate and their individual mechanisms of influence.  The substrate influence detected 
in this study could be due to the two-dimensional vs. three-dimensional nature of the 
extracellular matrix or the monomer vs. fibrillar structure of collagen or the absence vs. 
presence of smooth muscle cells.  While each substrate component most likely has an 
individual influence, studies into the complexity of cellular microenvironment lead us to 
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believe there is most likely a synergistic effect of multiple components which is 
important to grasp when considering multifaceted processes such as development or 
disease progression.  Although the tissue engineered blood vessel wall model used in this 
study is a more physiologic in vitro model, a major limitation of this study is the 
simplicity of this system in comparison to a human blood vessel.  Furthermore, its 
properties make assays such as immunocytochemistry and dye transfer more difficult to 
control and compare to other systems. 
 In evaluating results presented here, it also important to consider the advantages 
and limitations of techniques used to assess connexin expression and gap junction 
communication.  RT-PCR, flow cytometry, immunocytochemistry and dye transfer 
provide fundamental information regarding the major steps in connexin synthesis through 
gap junction function in response to a stimulus.  However, more advanced techniques are 
needed to evaluate the increasing complexity of connexin function and the increasing 
complexity of their regulation. 
 In conclusion, this study demonstrates novel influence of shear stress and 
substrate on endothelial cell connexins (37, 40, 43) and gap junction communication.  
Pursuit of mechanisms of influence for stimuli identified in this study has the potential to 
provide novel insight into characteristics of connexins and gap junctions.  Furthermore, 
an understanding of microenvironment influences on endothelial cell connexins and gap 




CHAPTER SIX: Knockdown of Connexins 37, 40 and 43 Identifies 
Distinct Roles in Endothelial Cell Function 
 
Introduction 
 Connexins and the gap junctions they form have long been identified as critical to 
cell communication and tissue function.  Over 20 human connexin isotypes currently 
exist and they can be found in almost every tissue of the body.  Within a cell, a single 
connexin protein assembles with five other connexins to form a hexameric array called a 
connexon or hemichannel.  Each hemichannel is trafficked to the cell membrane where it 
docks and covalently seals with a hemichannel from a neighboring cell to form a gap 
junction.  Gap junctions then cluster in the membrane at regions of cell-cell contact to 
form a gap junction plaque and regulate flow of chemical and electrical information 
through their pores.  While classically connexins and hemichannels were thought to only 
function when assembled into gap junctions, new evidence demonstrates otherwise. 
Hemichannels are routinely identified in the cell membrane but it has been 
assumed that their pores were closed and they were simply moving towards a gap 
junction plaque. (113)  Data now shows that hemichannels do open with functions 
including release of ATP and propagation of calcium waves.  Furthermore, their 
open/closed state is highly regulated by membrane voltage and pH. (114-116)  There is 
also new evidence supporting functions for connexins which are independent of 
hemichannels or gap junctions.  Connexins are often seen in the nucleus or cytoplasm and 
studies have shown they play roles in controlling cell growth and tumorigenicity as well 
as cell differentiation. (117)  While knowledge regarding connexin and hemichannel 
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functions is building, understanding of specific functions and regulatory mechanisms 
remain unknown. 
 While connexins in the cardiovascular system were first studied in the heart, 
recent interest in the role of connexins in the vascular wall has begun to build with 
evidence that they play critical and poorly understood roles in vascular development and 
disease.  Endothelial cells are known to express Connexin 37, Connexin 40 and Connexin 
43 while smooth muscle cells express Connexin 40, Connexin 43 and Connexin 45. (13, 
119)  Distribution of these connexins varies amongst vascular beds and in different 
species as well as between in vivo and in vitro experimental settings. (120, 121)  It is 
thought that the heterogeneity in cellular and vascular bed distribution is linked to 
specialized functions of the connexin isotypes and needs for cellular communication 
which are not yet understood. (122)  Gap junctions coordinate cellular responses within 
the endothelium, within smooth muscle cells, and between endothelial and smooth 
muscle cells through myoendothelial gap junctions which all contribute to controlling 
vascular tone. (120, 123) 
Contributing to the evidence supporting roles for connexins in vascular tone are 
studies implicating gap junctions in hypertension.  Data from spontaneously hypertensive 
rats shows reduced connexin expression compared to normal controls. (164)  Rats 
induced for hypertension also show reduced Cx37 and Cx43 expression but no change in 
Cx40 expression in endothelial cells compared to normotensive animals. (165) 
Connexins in the vascular wall have also been linked to the prevalence of 
atherosclerosis and have been shown to vary in expression with the progression of 
plaques.  Heterozygous Cx43+/- mice exhibit a 50% decrease in atherosclerotic plaques 
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in vivo and in vitro experiments have shown that statins reduce the Cx43 expression in 
endothelial and smooth muscle cell cultures. (166)  Cx37 and Cx40 expression is reduced 
in endothelial cells of hyperlipidemic mice and only Cx37 levels recover with lipid-
lowering drug treatment. (167)  An altered pattern of connexin expression in endothelial 
and smooth muscle cells is seen in non-diseased arteries, early atheromas and advanced 
atheromas. (168)  Finally, naturally occurring Cx37 variants have also been implicated in 
the prevalence of atherosclerosis in human populations. (169)  
With links between gap junctions and atherosclerosis developing, there have been 
several studies investigating the response of vascular connexins to mechanical stimuli.  In 
evaluating endothelial connexin expression, it was noted that while Cx37 and Cx40 
appeared in similar widespread patterns, Cx43 expression was found mainly in regions 
near aortic branches where blood flow is disturbed. (187)  Introduction of a flow 
disturbance into this model resulted in a strong upregulation of Cx43 in areas not 
previously showing high levels of expression.  An in vitro study of vascular cells and 
mechanical forces found a transient upregulation in Cx43 mRNA in endothelial cells 
exposed to laminar shear stress. (188)  Further investigation of endothelial cell Cx43 
regulation by shear stress was conducted by exposing cells to four types of fluid shear 
from recirculating to fully developed laminar flow. (189)  While Cx43 mRNA was 
transiently upregulated by all flow patterns, an increase was only sustained after 30 hours 
in areas of disturbed, recirculating flow.  Furthermore, Cx43 protein appeared 
disorganized in regions of disturbed flow and cells showed little coupling as assessed by 
dye transfer indicating limited gap junction communication.  More recently, other 
endothelial cell connexins (Cx37 and Cx40) were examined in this in vitro flow system. 
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(190)  Patterns of protein expression and roles of different connexin isotypes in 
endothelial gap junction communication were investigated using dye transfer techniques 
in conjuction with peptide channel blockers.   
In addition to studies demonstrating mechano-sensitivity of vascular gap 
junctions, numerous studies have investigated the response of specific connexins to 
chemical stimuli and pathologic conditions.  In endothelial cells, Cx43 is highly 
expressed in subconfluent cultures and levels decrease at confluence while Cx37 levels 
are minimal at subconfluence and rise when cells contact.  Furthering this polarity in 
behavior of connexin isotypes is response to TGF-β1 where Cx43 levels increase and 
Cx37 levels decrease. (181)  Nitric oxide has also been shown to differentially affect 
endothelial connexin isotypes by decreasing coupling of gap junctions which contain 
Cx37 and increasing new formation of gap junctions which contain Cx40. (182, 183)  In 
response to injury in vivo, rat endothelial connexin expression drops initially and then 
over time Cx40 expression returns to normal while Cx37 and Cx43 are expressed at 
higher levels than uninjured artery. (162)  In response to injury in vitro, wounding of an 
endothelial monolayer results in upregulation of Cx43 at the wounded edge, decrease in 
Cx37 at the injury site and no change in Cx40. (184)  Exposure of human endothelial 
cells to TNF-α resulted in a downregulation of Cx37 and Cx40 mRNA while Cx43 
mRNA was unaffected. (185)  Finally, sepsis induced in a rat model increased Cx40 
mRNA but did not alter expression of endothelial Cx37 or Cx43. (186) 
With their primary function being to promote communication between cells, gap 
junctions are critical in development of many tissues.  Knockout connexin models 
elucidate functions in development but attempts to study connexin influence on vascular 
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wall biology have been hampered by the widespread expression of these molecules in 
other tissues and the drastic influence of a genomic knockout.  Cx37-/- mice are viable 
but females are infertile because of abnormal development of both oocytes and ovarian 
follicles. (171)  Cx40-/- mice are viable but have prolonged atrioventricular conduction, 
right bundle branch block and a predisposition for arrhythmias. Furthermore, Cx40-/- 
mice have diminished conduction of arteriolar dilatation in response to acetylcholine and 
bradykinin and are hypertensive but have no other obvious blood vessel abnormalities. 
(172)  Cx43-/- mice die perinatally due to abnormal development of the pulmonary 
outflow tract from atypical migration of cardiac neural crest cells. (173)  Single knockout 
connexin mice have characterized phenotypes which are largely non-blood vessel related 
because of the widespread expression of these molecules and their presumed functional 
overlap within the vessel wall. When in vivo expression of connexins is reduced further 
using a multiple knockout strategy, there are severe blood vessel abnormalities indicating 
an important interplay between the functions of connexin isotypes.  Cx37-/- Cx40-/- mice 
die perinatally with hemorrhages and severe blood vessel dilatation. (174)  Cx40-/- Cx43-
/- have also been reported to die at E12.5 with malformed hearts including abnormally 
rotated ventricles.(175)  In a recent study, the Cx43 gene was knocked out only in 
vascular endothelial cells therefore providing a model in which the role of connexins in 
the vascular wall can be studied without the confounding influence of perinatal death or 
impaired fertility of mice.  The VEC Cx43-/- mice exhibit hypotension and bradycardia 
compared to heterozygous littermates indicating a role for endothelial cell Cx43 in 
maintaining normal vascular function.(163) 
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While knockout models provide valuable information regarding the missing gene, 
several reports have identified effects on non-ablated connexins.  Evaluation of Cx40-/- 
mice found expression of Cx37 protein upregulated three-fold and redistributed in a more 
homogeneous manner. (176)  In a separate study of Cx37-/- and Cx40-/- mice, data 
showed a drop in endothelial Cx40 protein in Cx37-/- animals and a drop in endothelial 
Cx37 protein in Cx40-/- animals however no changes in mRNA levels were detected. 
(177, 178)  An additional evaluation of Cx40-/- animals showed reduced staining of 
endothelial Cx43 at the cell membrane and reduced expression of smooth muscle cell 
Cx43. (179)  Evidence of reduced Cx43 expression in smooth muscle cells of animals 
where Cx43 was knocked out only in endothelial cells (VEC Cx43-/-) supports the 
hypothesis that effects on non-ablated connexins are not restricted to one cell type. (163)  
Following a complementary approach, a study which transfected endothelial cells with an 
adenovirus for Cx37 demonstrated no change in Cx43 mRNA but a substantial drop in 
Cx43 protein. (180)   
Gap junction channels composed of each connexin isotype appear to have unique 
properties of permeability, conductivity and gating.  While it was originally believed that 
hemichannels and gap junctions could only be created using a single type of connexin, 
data has proven otherwise.  Hemichannels of one connexin type are termed homomeric 
and those of multiple connexin types are termed heteromeric.  Gap junctions of two 
hemichannels containing one type of connexin are termed homotypic and gap junctions 
of two hemichannels containing multiple connexins are termed heterotypic.  While many 
types of connexins can mix and match, not all isotypes are compatible.  Of the vascular 
endothelial connexins, extensive compatibility and resulting channel types have been 
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shown.  Cx40 and Cx43 can form homotypic, heterotypic and heteromeric channels 
which result in unique gating and conductance properties. (149, 150)  In addition, the 
permeability properties of these channels can be predicted based on the ratio of 
components but the electrical properties appear to derive from protein interactions and 
are not an average of components. (151)  Connexins 37 and 43 can also form homotypic, 
heterotypic and heteromeric channels.  Again the characteristics of these heteromeric 
channels are not predicted based on single connexin channel properties indicating an 
interaction effect amongst the connexins. (142, 148)  The final combination possible in 
endothelial cells is with Cx37 and Cx40 which have been shown to form heterotypic gap 
junctions but have not been evaluated for potential heteromeric mixing capabilities. (147) 
With the common and unique functions displayed by endothelial connexins and 
effects seen using animal knockout strategies, a new approach of RNA interference 
promises insight into isotype function.  The technique of RNA interference allows for 
selective destruction of specific mRNA sequences in a transient manner.  By taking 
advantage of the native cellular system which destroys double stranded RNA, a short 
interfering RNA (siRNA) which is complementary in sequence to the target mRNA is 
introduced into a cell and allowed to bind the target which results in its destruction. (208, 
209)  While avoiding the complexity and often embryonic lethality of genome 
manipulation, studies can be conducted which temporarily silence a particular gene of 
interest.  RNA interference of connexins was recently used to knock down Cx43 in a 
breast cancer cell line resulting in a higher growth rate and more migratory behavior. 
(210)  Connexin gene silencing was also used to show mutual dependence of N-cadherin 
and Cx43 on each other for expression at the cell surface. (211)  To date the only use of 
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RNA interference in studies of vascular connexins was a knockdown in Cx43 which 
demonstrated its role in the formation of myoendothelial gap junctions. (157) 
With the growing evidence linking vascular connexins to pathological conditions 
and their complex responses to multiple stimuli, the goal of this study is to investigate the 
individual roles of Cx37, Cx40 and Cx43 in endothelial cell behavior. 
 
 
Experimental Design and Methods 
Experimental Design 
The approach taken to investigate endothelial cell connexin function is to 
selectively knockdown gene expression and examine resulting effects on non-ablated 
connexin expression and on cell behavior.  Connexin expression is evaluated at the 
mRNA level by RT-PCR and at the protein level using western blotting and 
immunocytochemistry.  As important characteristics of endothelial cell function, effects 
of connexin knockdown on gap junction communication, cell proliferation and cell 
morphology are examined.  Furthermore, to gain the most valuable insight into human 
physiology, experiments are conducted using human aortic endothelial cells under static 
and laminar shear stress conditions.  Endothelial monolayers are transfected with siRNA 
(short interfering RNA) targeting each connexin sequence individually thus knocking 
down expression of one isotype.  Cells are then exposed to static or shear stress and 
assessed for mRNA expression, protein expression, gap junction communication, cell 
proliferation and cell morphology.  Effects of ablated connexins on non-ablated 
connexins provides insight into potential co-regulation or interactions between isotypes 
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and effects on the selected cell behaviors provides insight into roles of different isotypes 




 Human aortic endothelial cells (HAEC) (Cambrex) were cultured to passage 6 in 
MCDB 131 supplemented with 5% FBS, antibiotics and growth factors.  Cells were 
seeded on glass slides with sterile silicone frames around the border which provided a 
boundary to contain fluid volume during transfection.  Experiments exposing monolayers 
to static or shear conditions were conducted in a co-culture media of MCDB 131 
supplemented with 5% FBS, antibiotics and low level of growth factors. 
 
RNA Interference 
 RNA interference was conducted using short interfering RNA (siRNA) designed 
by and purchased commercially from Ambion.  Multiple sequences were tested for ability 
to knockdown target connexin mRNA at least 70% without other adverse effects (eg. cell 
death).  The following siRNA sequences designed for the human sequence were 
successfully used to knockdown connexin mRNA. 
Cx37: Ambion siRNA ID#7185, annealed, standard purity 
Cx37 Sense (5’ to 3’): GGACUUGAUCACAAAAAAAtt 
Cx37 Antisense (5’ to 3’): UUUUUUUGUGAUCAAGUCCtg 
Cx40: Ambion siRNA ID#145161, annealed, standard purity 
Cx40 Sense (5’ to 3’): GGUAAACGAUGCUUGGAAUtt 
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Cx40 Antisense (5’ to 3’): AUUCCAAGCAUCGUUUACCtt 
Cx43: Ambion siRNA ID# 144485, annealed, standard purity 
Cx43 Sense (5’ to 3’): GCCUUAUUCAUGAGGCUUAtt 
Cx43 Antisense (5’ to 3’): UAAGCCUCAUGAAUAAGGCtg 
In addition to sequences targeting connexins, a negative control siRNA labeled with Cy3 
(Negative Control #1 – Ambion 4621) which does not target any known human sequence 
was used to develop transfection protocols and to evaluate the effect of the transfection 
procedure on endpoints. 
 Endothelial cells were transfected under serum-free conditions using OptiMEM 
medium (Invitrogen) with the chemical transfection reagent Oligofectamine (Invitrogen).  
A time course study using 10nM siRNA demonstrated knockdown of mRNA for 96 
hours following transfection (entire duration of the study).  A dosage study showed 
knockdown of each connexin mRNA by >80% with siRNA concentrations ranging from 
10nM to 80nM.  To avoid any potential side effects of abundant siRNA in the cells but 
ensure adequate knockdown, a concentration of 40nM was chosen for all studies.  Thus 
the siRNA transfection and experimental timeline is as follows. 
 Endothelial cells were seeded onto collagen coated glass slides and cultured for 
24 hours prior to transfection at which point they are 90% confluent.  Stock siRNA in 
sterile, RNase-free water is diluted in OptiMEM medium and oligofectamine transfection 
reagent is also diluted in OptiMEM medium.  The two mixtures are combined to create a 
transfection cocktail which sits at room temperature for 20 minutes to allow complexing 
of siRNA by oligofectamine.  Endothelial monolayers are rinsed twice in OptiMEM to 
remove any remaining culture medium and thus all serum and antibiotics.  OptiMEM is 
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added to endothelial slides and the transfection cocktail is added dropwise to each 
sample.  Cells are transferred to the incubator at 37°C and transfection proceeds for 6 
hours.  During the transfection process, the final concentration of siRNA is 40nM and the 
final concentration of oligofectamine is 0.4% (10µL in 2.5mL).  After six hours, a 
volume of experimental medium with 22% FBS is added to the 
OptiMEM/oligofectamine/siRNA mixture to restore the total FBS concentration to 5%.  
Slides are incubated for an additional 42 hours (total of 48 hours since transfection) prior 
to removal of the mixture of OptiMEM/oligofectamine/siRNA/FBS/experimental media 
and beginning of the 24 hour experimental period where cells are exposed to static or 
laminar shear stress.  All manipulations of siRNA are conducted under sterile, RNase-
free, DNase-free conditions to preserve integrity of sequences and samples. 
 
Exposure to Shear Stress 
The parallel plate flow chamber used to expose endothelial cells to laminar shear 
stress has been previously established in our laboratory. (42, 49)  In this closed loop, a 
peristaltic pump moves medium from a container into a pulse dampener and then through 
parallel plates where endothelial cells are exposed to a steady laminar shear stress.  Shear 
stress is controlled by fluid flow rate and dimensions of the chamber according to the 
equation: τ = 6Qµ/bh2.  Silicone gaskets were removed from transfected slides prior to 
shear stress exposure of 15 dynes/cm2 for 24 hours. 
  
RNA Isolation and Quantitative RT-PCR 
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Total RNA was extracted from endothelial cells using an RNeasy kit (Qiagen) 
with an added DNAse digestion step.  To evaluate quality of RNA prior to RT-PCR 
analysis, samples were assessed using the RNA 6000 Nano LabChip (Agilent) on an 
Agilent Bioanalyzer 2100.  Profiles of ribosomal peaks were evaluated for degradation as 
a measure of overall RNA degradation and preliminary measurements of RNA quantity 
were determined.  Quantity of high quality RNA was assessed by absorbance at 260nm 
prior to reverse transcription to cDNA for RT-PCR. 
One microgram of high quality endothelial RNA was reverse transcribed using 
the First Strand cDNA Synthesis Kit (Invitrogen) for each experimental sample.  Primers 
were designed using Primer Express (Applied Biosystems) and oligos were created by 
Integrated DNA Systems.  Primer sequences are listed below for the three connexins 
expressed in endothelial cells. 
Cx37 Forward: CATGGAGCCCGTGTTTGTG 
Cx37 Reverse: GAGACAAAGCAGTCCACGAGG 
Cx40 Forward: GGGCACTCTGCTCAACACCT 
Cx40 Reverse: TGAAGCCCACCTCCATGGT 
Cx43 Forward: TTAAGGGAAAGAGCGACCCTT 
Cx43 Reverse: GACCCACAGTCTTTGGCAGG 
 Standards of known concentration were generated using PCR amplification and 
agarose gel extraction for each gene of interest.  Quantitative RT-PCR was conducted 
using cDNA from samples (in triplicate) and standards (in triplicate) with SYBR® Green 
PCR Master Mix (Applied Biosystems) on an ABI 7700 (Applied Biosystems) real time 
PCR machine.  Data was quantified using the absolute standard method where serial 
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dilutions of the standard were plotted against CT values to generate a correlation used to 
convert sample CT values into concentrations. 
 
Western Blotting 
 Endothelial cells were lysed in RIPA buffer (Sigma) with added protease inhibitor 
cocktail (Sigma) and centrifuged at 10,000rpm for 10 minutes to pellet DNA.  
Supernatant was collected and protein content was quantified using the BCA protein 
assay (Pierce) in comparison to albumin standards.  Samples were mixed with Laemmeli 
buffer and heated at 95°C for 5 minutes prior to loading onto 12% Tris-Glycine gels 
(Invitrogen).  Following electrophoresis using Tris/Glycine/SDS running buffer (BioRad) 
of samples alongside a See Blue Plus 2 (Invitrogen) lane marker and a Magic Mark XP 
(Invitrogen) western protein standard of known molecular weights, proteins were 
transferred using Tris/Glycine transfer buffer (BioRad) to a PVDF membrane (BioRad).  
Blots were incubated overnight at 4°C in 5% milk in T-TBS to block non-specific 
binding before incubation with the primary antibody for 1 hour at room temperature.  
Blots were labeled with one of the following antibodies: Rabbit Anti-Mouse Cx37 (Alpha 
Diagnostic) at 1:500, Rabbit Anti-Mouse Cx40 (Alpha Diagnostic) at 1:500, Rabbit Anti-
Mouse Cx43 (Chemicon) at 1:1000 in 5% milk in T-TBS.  Following three washes in T-
TBS, blots were labeled with the following secondary antibody: Horseradish Peroxidase 
Donkey Anti-Rabbit (Jackson ImmunoResearch) at 1:5000.  To measure signal, blots 
were covered with ECL Plus (Amersham Biosciences) for 5 minutes and then exposed to 
film.  Following staining of blots for the connexin protein of interest, membranes were 
stripped and reprobed for actin to ensure equal loading.  Antibodies used for this step 
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 Immunocytochemistry was conducted to visualize endothelial cell connexins 
following exposure to static or shear conditions.  Endothelial cells on slides were fixed in 
4% formaldehyde for 5 minutes, permeabilized in 0.1% Triton X-100 for 5 minutes and 
then incubated for 1 hour in 4% donkey serum to block non-specific binding of 
antibodies.  Cells were labeled with one of the following primary antibodies at 1:100 
dilution: Rabbit Anti-Mouse Cx37 (Alpha Diagnostic), Goat Anti-Human Cx40 (Santa 
Cruz Biotechnology), Goat Anti-Human Cx43 (Santa Cruz Biotechnology) for 1 hour at 
37°C.  Following two washes in PBS, cells were incubated with one of the following 
secondary antibodies: FITC-conjugated Donkey Anti-Rabbit (Jackson ImmunoResearch) 
or FITC-conjugated Donkey Anti-Goat (Jackson ImmunoResearch).  Samples were 
imaged using a laser-scanning confocal microscope with a 40x oil objective.   
 
Dye Transfer Assay 
 Following exposure of endothelial monolayers to static or shear stress conditions, 
assessment of dye transfer between cells was conducted as a measure of gap junction 
communication.  In this assay of gap junction function, cells are loaded with two 
membrane-impermeant dyes: i) a small dye which can pass through gap junctions and ii) 
a large dye which cannot pass through gap junctions and is used to mark cells originally 
loaded with dye.  Following a defined period of time, cells are fixed and imaged to 
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evaluate the extent of dye transferred from cells originally loaded with dye to 
neighboring cells as a measure of cell coupling by gap junctions.  In this study the dye 
used to pass through gap junctions is Biocytin (ε-biotinoyl-L-lysine) with a molecular 
weight of 372Da and neutral charge (Molecular Probes) and the dye used to mark cells 
originally loaded with dye is Tetramethylrhodamine Dextran (flouro-ruby) with a 
molecular weight of 10,000Da (Molecular Probes). 
 Immediately upon removal from the static dish or flow chamber, monolayers are 
rinsed in Dulbecco’s PBS and excess fluid is blotted off.  A mixture of 4mg/ml Biocytin 
and 5mg/ml Rhodamine-Dextran in PBS is dripped onto the monolayer surface which is 
then scratched with a diamond-tipped pen (tip diameter 0.25mm).  Samples are 
immediately placed in the incubator at 37°C for 2 minutes to allow passage of dye.  
Excess dye is quickly removed, samples are rinsed in PBS and fixed in 4% formaldehyde 
for 20 minutes.  While the dextran is fluorescent, biocytin requires a secondary antibody 
for detection.  Monolayers are permeabilized with 0.1% Triton X-100 for 5 minutes and 
incubated with 4% donkey serum for 30 minutes to block non-specific binding prior to 
labeling with a secondary antibody Oregon Green 488 NeutrAvidin (molecular probes).  
Samples were imaged using a Nikon E600 fluorescent microscope using filters to 
separately detect red and green signals. 
 
Cell Proliferation Assay 
 Endothelial cell proliferation was assessed using BrdU which is incorporated into 
DNA being synthesized during S-phase of the cell cycle.  BrdU is then detected using 
primary and secondary antibodies thus proliferating nuclei can be compared to non-
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proliferating nuclei.  BrdU (5-bromo-2’-deoxyuridine) (MP Biomedicals) is added to 
experimental medium of slides being exposed to static or shear stress at a final 
concentration of 20µg/mL for the final 6 hours of the 24 hour experimental time period.  
At the end of the 6 hour exposure to BrdU, slides are fixed in 4% formaldehyde for 20 
minutes.  Cells are permeabilized by exposure to ice cold acetone for 10 minutes and then 
DNA is denatured by exposure to 2N HCL for 15 minutes at 37°C.  Following 
neutralization and restoration of pH, slides are incubated with 5% donkey serum for 1 
hour at room temperature to block non-specific binding.  Slides are then incubated for 2 
hours at 37°C with 1:50 dilution of Mouse anti-BrdU (Sigma), rinsed with PBS and 
incubated with 1:200 Cy3-conjugated Donkey Anti-Mouse (Jackson ImmunoResearch) 
and 20µg/mL Hoechst 33258 (Molecular Probes) to detect both proliferating and non-
proliferating nuclei.  Slides are imaged using a laser scanning confocal microscope and 
images are analyzed using ImagePro software. 
 
Cell Morphology Analysis 
 To evaluate cell morphology, endothelial monolayers are stained for actin 
filaments and measured for elongation and angle of orientation.  Endothelial cell slides 
are fixed in 4% formaldehyde for 5 minutes, permeabilized in 0.1% Triton X-100 for 5 
minutes and incubated in 4% donkey serum for 30 minutes at room temperature.  
Monolayers are stained using Rhodamine-conjugated phalloidin (Invitrogen) which is a 
mushroom toxin that binds tightly to actin filaments.  Staining is conducted using 1:200 
dilution of phalloidin and Hoechst 33258 to identify nuclei.  Samples are imaged using a 
Nikon E600 fluorescent microscope using a triple filter to detect both red and blue 
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signals.  Images are analyzed using LSM 5 Image Browser (Zeiss) and an overlay writing 
tool is used to manually determine perimeter, area and angle of orientation.  Angle of 
orientation is measured from horizontal which is the axis of fluid shear stress.  Using 
perimeter and area data, a shape index of each cell is calculated according to the formula: 
SI = (4*Π*Area)/(Perimeter2).  The shape index ranges from 0 (indicating a straight line) 
to 1 (indicating a circle) and quantifies elongation of endothelial cells. 
 
Results 
Target Connexin Knockdown 
 To investigate the individual roles of connexins 37, 40 and 43 in endothelial cell 
biology, each isotype was targeted by siRNA specific to its coding sequence to 
knockdown expression starting at the mRNA level.  Knockdown of target mRNA was 
assessed during development of the RNA interference protocol and identification of 
siRNA sequence to be used.  Since experimental conditions could change the 
effectiveness of the knockdown, target mRNA levels were again assessed in experimental 
samples.   
Figure 6.1 shows data for knockdown of Cx37 mRNA by Cx37 siRNA in slides 
which have been transfected and then exposed to static or shear conditions.  Comparison 
of samples treated with Cx37 siRNA 40nM to OptiMEM controls shows significant 
reduction in Cx37 mRNA by 88% in static slides and significant reduction in Cx37 
mRNA by 97% in shear slides.  Data confirms knockdown in experimental samples 
which was previously seen in RNAi protocol development. 
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Figure 6.2 shows data for knockdown of Cx40 mRNA by Cx40 siRNA in slides 
which have been transfected and then exposed to static or shear conditions.  Comparison 
of samples treated with Cx40 siRNA 40nM to OptiMEM controls shows significant 
reduction in Cx40 mRNA by 83% in static slides and significant reduction in Cx40 
mRNA by 87% in shear slides.  Data confirms knockdown in experimental samples 
which was previously seen in RNAi protocol development. 
Figure 6.3 shows data for knockdown of Cx43 mRNA by Cx43 siRNA in slides 
which have been transfected and then exposed to static or shear conditions.  Comparison 
of samples treated with Cx43 siRNA 40nM to OptiMEM controls shows significant 
reduction in Cx43 mRNA by 86% in static slides and significant reduction in Cx43 
mRNA by 87% in shear slides.  Data confirms knockdown in experimental samples 
which was previously seen in RNAi protocol development. 
Immunocytochemistry and western blotting were used to evaluate the knockdown 
of connexin protein expression.  Immunocytochemistry of static and shear slides showed 
no expression of Cx37 protein in samples treated with Cx37 siRNA 40nM, no expression 
of Cx40 protein in samples treated with Cx40 siRNA 40nM and no expression of Cx43 
protein in samples treated with Cx43 siRNA 40nM.  While immunocytochemistry is 
valuable in gaining information about expression and localization of proteins, connexins 
are difficult to detect and thus quantitative analysis of protein knockdown was conducted 
using western blotting.  Western blotting of Cx43 in endothelial cells shows presence of 
protein in OptiMEM control samples and absence of protein in Cx43 siRNA 40nM 
treated samples.  Western blots to detect Cx37 and Cx40 protein were also repeatedly 











































Figure 6.1 Cx37 mRNA Knockdown by Cx37 siRNA 
Cx37 mRNA is significantly reduced ( >88%) in endothelial cells under static or shear conditions following 
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Figure 6.2 Cx40 mRNA Knockdown by Cx40 siRNA 
Cx40 mRNA is significantly reduced ( >83%) in endothelial cells under static or shear conditions following 














































































Figure 6.3 Cx43 mRNA Knockdown by Cx43 siRNA 
Cx43 mRNA is significantly reduced ( >86%) in endothelial cells under static or shear conditions following 
treatment with Cx43 siRNA. 
% mRNA 
knockdown 86.8%






















































Changes in Non-Target Connexins 
 While knockdown of target connexins with siRNA was effective, studies in 
knockout animal models have demonstrated effects of connexin ablation on non-targeted 
connexins.  Whether a compensatory response, a result of co-regulation or a result of 
mixed channels, changes in non-targeted connexins impact the conclusions drawn from 
data on overall cell function following siRNA treatment.  For each siRNA treatment in 
this study, the effect on the target connexin and two other non-targeted connexins was 
evaluated in endothelial experimental samples under static and shear conditions. 
 Figure 6.4 shows the effects of Cx37 siRNA 40nM treatment on the mRNA 
expression of Cx37, Cx40 and Cx43 in comparison to OptiMEM controls.  While Cx37 
mRNA is significantly reduced as detailed in Figure 6.1, significant effects are also seen 
on Cx40 and Cx43.  Evaluation of Cx40 mRNA shows a significant increase in cells 
treated with Cx37 siRNA under static and shear conditions with an increase in expression 
of approximately 3-fold.  In addition, there is an increase in Cx40 mRNA expression by 
the presence of shear stress.  Evaluation of Cx43 mRNA shows a significant increase in 
cells treated with Cx37 siRNA under static and shear conditions with a 20% and 40% 
increase, respectively. 
 Figure 6.5 shows the effects of Cx40 siRNA 40nM treatment on the mRNA 
expression of Cx37, Cx40 and Cx43 in comparison to OptiMEM controls.  While Cx40 
mRNA is significantly reduced as detailed in Figure 6.2, significant effects are also seen 












































Figure 6.4 Effects of Cx37 siRNA on Connexin mRNA Expression 
Treatment with Cx37 siRNA significantly reduces Cx37 mRNA expression, but also significantly increases 
Cx40 mRNA and significantly increases Cx43 mRNA. 






















OptiMEM control Cx37 siRNA 40nM
Cx37 mRNA Cx40 mRNA Cx43 mRNA
siRNA p-value 0.001 0.001 0.017
flow p-value 0.231 0.004 0.002
interaction p-value 0.155 0.374 0.123
ANOVA of Cx37 siRNA on mRNA Expression











































































Figure 6.5 Effects of Cx40 siRNA on Connexin mRNA Expression 
Treatment with Cx40 siRNA significantly reduces Cx40 mRNA expression, but also significantly decreases 
Cx37 mRNA expression. 
 
 
Cx37 mRNA Cx40 mRNA Cx43 mRNA
siRNA p-value 0.002 0.000 0.143
flow p-value 0.370 0.002 0.001
interaction p-value 0.097 0.006 0.316
ANOVA of Cx40 siRNA on mRNA Expression




















OptiMEM control Cx40 siRNA 40nM









































































Figure 6.6 Effects of Cx43 siRNA on Connexin mRNA Expression 
Treatment with Cx43 siRNA significantly reduces Cx43 mRNA expression, but also significantly decreases 
Cx37 mRNA and significantly decreases Cx40 mRNA. 
 
 
Cx37 mRNA Cx40 mRNA Cx43 mRNA
siRNA p-value 0.015 0.000 0.000
flow p-value 0.455 0.006 0.075
interaction p-value 0.165 0.018 0.170
ANOVA of Cx43 siRNA on mRNA Expression





















OptiMEM control Cx43 siRNA 40nM
































Evaluation of Cx37 mRNA shows a significant decrease in cells treated with Cx40 
siRNA under static and shear conditions with a 2.6-fold and 12.7-fold reduction, 
respectively.  Evaluation of Cx43 mRNA shows no significant effects of treatment with 
Cx40 siRNA.  While there is no effect of shear stress on Cx37 mRNA expression, shear 
induces an upregulation in Cx40 mRNA and Cx43 mRNA. 
 Figure 6.6 shows the effects of Cx43 siRNA 40nM treatment on the mRNA 
expression of Cx37, Cx40 and Cx43 in comparison to OptiMEM controls.  While Cx43 
mRNA is significantly reduced as detailed in Figure 6.3, significant effects are also seen 
on Cx37 and Cx40.  Evaluation of Cx37 mRNA shows a significant decrease in cells 
treated with Cx43 siRNA under static and shear conditions with a 2-fold and 6-fold 
reduction, respectively.  Evaluation of Cx40 mRNA shows a significant decrease in cells 
treated with Cx43 siRNA under static and shear conditions with a 3.2-fold and 5.4-fold 
reduction, respectively.  While there is no effect of shear stress on Cx37 or Cx43 mRNA 
expression, shear induces an upregulation in Cx40 mRNA. 
 Immunocytochemistry analysis shows no obvious changes in protein expression 
of non-target connexins, however due to the non-quantitative nature of this technique, it 
is difficult to draw measurable conclusions.  Failure to detect Cx37 and Cx40 proteins in 
western blots has hampered the evaluation of non-target connexin protein expression 
following siRNA treatment. 
 
Gap Junction Communication 
 The most established function of connexins is the assembly into hemichannels 
and formation of gap junction channels which allow passage of small molecules between 
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neighboring cells.  To evaluate the role of specific connexin isotypes in endothelial gap 
junction communication, a dye transfer assay was conducted on experimental samples 
treated with siRNA and exposed to static or shear conditions.  In the dye transfer assay, 
endothelial monolayers are scratched to load cells adjacent to the scratch with a dye 
mixture of Rhodamine-Dextran (MW 10,000) and Biocytin (MW 372, neutral charge).  
The large dye marks cells originally loaded with dye (donor cells) and the small dye 
passes to neighboring cells which are connected by gap junctions (recipient cells).  
Quantification of images following transfer of dye for 2 minutes allows calculation of a 
cell coupling index which is the ratio of recipient cells to donor cells.  Figure 6.7 displays 
dye transfer data assessing gap junction communication in endothelial monolayers 
following RNA interference and static or shear stress conditions. 
 Statistical analysis identifies significant differences in gap junction 
communication due to siRNA treatment, shear stress and an interaction effect.  Tukey 
post-hoc testing breaks down the statistical analysis with pairwise comparisons.  Dye 
transfer is significantly reduced in endothelial cells exposed to shear stress compared to 
static for OptiMEM controls, NC (negative control) siRNA 40nM, Cx37 siRNA 40nM 
and Cx40 siRNA 40nM.  However, no shear effect is seen in monolayers treated with 
Cx43 siRNA 40nM as the level of dye transfer is reduced regardless of mechanical 
environment.  Static Cx43 siRNA monolayers have significantly less dye transfer than 
static OptiMEM and static NC siRNA monolayers and furthermore, shear Cx43 siRNA 
































Figure 6.7 Effects of Connexin Knockdown on Gap Junction Communication 
Treatment with Cx43 siRNA reduces endothelial cell gap junction communication and exposure to shear 
stress reduces endothelial cell gap junction communication.  Treatment with Cx37 siRNA or Cx40 siRNA 
does not significantly alter gap junction communication. 
ANOVA: siRNA p = 0.000, flow p = 0.000, interaction p = 0.012 Tukey post hoc tests denoted as follows: 
* p < 0.01 for static vs. shear pairwise comparisons 
‡ p < 0.001 Cx43 siRNA static vs. OptiMEM static, NC siRNA static 
† p < 0.05 Cx43 siRNA shear vs. OptiMEM shear 
§ p < 0.0001 Cx43 siRNA vs. OptiMEM, NC siRNA, Cx37 siRNA, Cx40 siRNA 

















































With respect to siRNA treatment, Cx43 siRNA treated endothelial monolayers have 
significantly less gap junction communication compared to OptiMEM, NC siRNA, Cx37 
siRNA and Cx40 siRNA treated monolayers. 
 
Cell Proliferation 
 Gap junctions and possibly individual connexins are thought to play a role in cell 
proliferation therefore the effect of endothelial connexin knockdown on cell proliferation 
under static and shear conditions was evaluated.  Proliferation was assessed by exposing 
cells to a thymidine analog, BrdU, for six hours and measuring its presence in cell nuclei 
indicating incorporation into DNA during S-phase of the cell cycle.  Percentage of 
proliferating nuclei as a portion of total nuclei was calculated for cells following 
treatment with siRNA and exposure to static or shear conditions.  Figure 6.8 shows data 
evaluating the effect of connexin knockdown on endothelial cell proliferation.  Statistical 
analysis shows no significant effect of siRNA treatment on proliferation; however shear 

































Figure 6.8 Effects of Connexin Knockdown on Cell Proliferation 
Treatment with connexin siRNA has no significant effect on cell proliferation while exposure to shear 
stress significantly reduces cell proliferation. 
ANOVA: siRNA p = 0.384, flow p = 0.000, interaction p = 0.280 
































 Cell morphology and changes in response to fluid shear stress are a hallmark of 
endothelial cell biology.  Two components of cell morphology are the angle of 
orientation and the elongation of the cell.  Cell morphology following siRNA treatment 
and exposure to static or shear stress was assessed by imaging actin fibers of the cell.  
Angle of orientation with respect to the horizontal axis (also direction of fluid flow) was 
determined by evaluating the orientation of actin stress fibers within the cell.  Elongation 
of the cell was evaluated by measuring the perimeter and area of a cell and calculating a 
shape index which assesses whether the shape more closely resembles a line or a circle. 
 Figure 6.9 shows the effect of siRNA treatment on endothelial angle of 
orientation following exposure to shear stress or static conditions.  There is no significant 
difference on endothelial cell angle of orientation due to siRNA treatment; however cells 
do align in direction of flow following exposure to shear stress. 
 Figure 6.10 shows the effect of siRNA treatment on endothelial cell elongation 
following exposure to shear stress or static conditions.  ANOVA statistical analysis 
indicates a significant effect of siRNA on cell elongation and a significant effect of flow 
with changes to a more elongated shape following exposure to shear stress.  Tukey post 
hoc testing indicates a significant difference in elongation of cells treated with Cx40 
siRNA compared to monolayers treated with OptiMEM, Cx37 siRNA and Cx43 siRNA.  
Endothelial cells are more elongated under static and shear stress conditions following 


































Figure 6.9 Effects of Connexin Knockdown on Cell Angle of Orientation 
Treatment with connexin siRNA has no significant effect on cell angle of orientation while exposure to 
shear stress significantly alters angle of orientation by aligning cells in direction of fluid flow. 
ANOVA: siRNA p = 0.185, flow p = 0.000, interaction p = 0.711 
 
 























































Figure 6.10 Effects of Connexin Knockdown on Cell Elongation 
Treatment with Cx40 siRNA significantly alters endothelial shape index to a more elongated morphology.  
Exposure to shear stress also significantly alters endothelial shape index to a more elongated morphology.  
Treatment with Cx37 siRNA or Cx43 siRNA does not significantly alter cell elongation. 
ANOVA: siRNA p = 0.000, flow p = 0.000, interaction p = 0.418 Tukey post hoc tests denoted as follows: 
§ p < 0.005 Cx40 siRNA vs. OptiMEM, Cx37 siRNA, Cx43 siRNA 
 
 





























Role of Connexin 37 
 Of the connexins expressed in vascular endothelium, Connexin 37 is the least 
investigated due to its recent identification and restricted tissue expression pattern.  
Within the vasculature, Cx37 is expressed only in endothelial cells and is not found in 
smooth muscle cells or myocytes.  A naturally occurring variant of Cx37 has been 
implicated in the prevalence of atherosclerosis in the human population. (169)  Altered 
endothelial cell Cx37 expression has been linked to hypertension along with its presumed 
role in atherosclerosis. (165, 167, 168)  Cx37-/- mice are viable but females are infertile 
due to abnormal reproductive development. (171)  No obvious vascular abnormalities are 
seen in Cx37-/- models, however this is presumed to be due to the presence of other 
vascular connexins since double knockouts exhibit severe vascular deformities. (174)  
 Knockdown of Cx37 expression using RNA interference was used in this study to 
evaluate its effects on endothelial cell function including gap junction communication, 
cell proliferation and cell morphology.  Furthermore, knockdown using RNAi as opposed 
to animal model genomic knockouts provided a new opportunity to evaluate the effects of 
Cx37 loss on expression of other endothelial connexins, Cx40 and Cx43.  A short 
interfering RNA (siRNA) sequence designed to target only Cx37 mRNA was successful 
in knocking down mRNA expression in endothelial cells exposed to static and shear 
stress conditions.  When Cx37 was reduced, endothelial cells significantly upregulated 
Cx40 mRNA expression approximately three-fold under static and shear conditions.  
Additionally, there was a statistically significant upregulation in Cx43 mRNA although 
the change was less dramatic.  While RNA interference of Cx37 resulted in changes of 
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Cx40 and Cx43 expression, targeting of other connexins also impacted Cx37 mRNA 
expression.  Knockdown of Cx40 mRNA resulted in a decrease in Cx37 mRNA and 
knockdown of Cx43 mRNA also resulted in a decrease in Cx37 mRNA. 
 While treatment of endothelial cells with Cx37 siRNA significantly altered Cx40 
and Cx43 mRNA expression, effects on cell function assessed in this study were less 
pronounced.  Results from the dye transfer assay, which measures extent of gap junction 
communication within a cell population, showed no significant difference between Cx37 
siRNA treated monolayers and control samples under static or shear stress.  A significant 
difference was seen between Cx37 siRNA static slides and Cx37 siRNA shear slides with 
a reduced level of dye transfer in endothelial cells following exposure to shear stress.  
This response to shear stress is also seen in control samples and thus Cx37 siRNA 
treatment does not alter endothelial cell adaptation of gap junction communication 
following shear exposure.  Dye transfer has been conducted in endothelial cells of mouse 
Cx37-/- aorta to investigate the role in Cx37 in communication during development.  
Evaluation found no significant differences compared to wild type in embryonic aortas, a 
reduction in dye transfer in young animals (3 weeks and 6-7 weeks) and no effect of 
Cx37-/- in dye transfer of adults. (177) 
 In evaluating endothelial cell proliferation by BrdU incorporation, Cx37 siRNA 
treatment has no significant effect on endothelial cell monolayers under static or shear 
stress conditions.  While proliferation levels of Cx37 siRNA treated static endothelial 
cells are slightly higher than control samples, there is no statistical significance.  A 
significant difference was seen between Cx37 siRNA static slides and Cx37 siRNA shear 
slides with a reduced level of proliferation following endothelial exposure to shear stress.  
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Thus the ability of endothelial cells to decrease proliferation in response to shear was not 
impacted by the treatment with Cx37 siRNA.  While there are no previous reports 
investigating Cx37 knockdown on endothelial cell proliferation, a complementary 
approach of Cx37 adenovirus transfection into endothelial cells resulted in cell apoptosis. 
(180) 
 Endothelial cell morphology including angle of orientation and cell elongation 
was assessed using staining of actin filaments.  Treatment with Cx37 siRNA did not 
significantly alter endothelial cell angle of orientation or elongation compared to controls 
under static or shear conditions.  As with endothelial cell response to shear stress altering 
gap junction communication and cell proliferation, morphology is also modified.  During 
exposure to steady laminar shear stress, endothelial cells align in direction of fluid flow 
and elongate in shape.  Treatment with Cx37 siRNA did not impact this response as cells 
elongated and aligned in a manner similar to control monolayers. 
 
Role of Connexin 40 
 Within the vascular system, Connexin 40 is expressed in endothelial cells, smooth 
muscle cells and myocardium.  It is potentially thought to be the constitutive endothelial 
connexin with stable, widespread expression while Cx37 and Cx43 expression varies. 
(121, 123, 187)  Connexin 40 has been implicated in vascular diseases including 
atherosclerosis and hypertension following both in vivo and in vitro studies. (167, 172)  
While Cx40-/- mice are viable, they exhibit multiple conduction abnormalities in the 
heart and blood vessels and are hypertensive. (172)  Due to the potential overlap in 
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function or compensatory responses of other vascular connexins, Cx40 double knockout 
models show more extensive blood vessel abnormalities. (174, 175) 
 Knockdown of Cx40 expression using RNA interference was used in this study to 
evaluate its effects on endothelial cell function including gap junction communication, 
cell proliferation and cell morphology under static and shear stress conditions.  Using 
RNAi to reduce Cx40 expression provided a novel opportunity to evaluate the effects of 
Cx40 loss on other endothelial cell connexins, Cx37 and Cx43, without the use of 
knockout animal models.  A short interfering RNA (siRNA) sequence designed to target 
only Cx40 was successful in knocking down endothelial cell Cx40 mRNA in static and 
shear monolayers.  Comparison of static and shear monolayers showed an upregulation of 
Cx40 mRNA in response to shear stress which was reported in previous studies from our 
laboratory using monolayers untreated with RNAi.  Even though levels of Cx40 mRNA 
increase in response to shear stress, the knockdown using siRNA remained in effect.  
When Cx40 was reduced by siRNA, endothelial cells also decreased levels of Cx37 
mRNA while there was no affect on levels of Cx43 mRNA.  Furthermore, RNA 
interference targeting Cx37 resulted in increased levels of Cx40 mRNA while RNAi 
targeting Cx43 resulted in decreased levels of Cx40 mRNA. 
 Cx40 siRNA treatment of endothelial monolayers resulted in changes in 
endothelial cell behavior under static and shear stress.  In evaluating gap junction 
communication by dye transfer, results from Cx40 siRNA treatment were not 
significantly different from controls under static or shear stress conditions.  Control 
samples demonstrate that in response to shear stress, endothelial cells reduce gap junction 
communication as assessed by dye transfer.  Treatment with Cx40 siRNA does not 
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impact this endothelial cell adjustment in communication due to fluid flow.  Dye transfer 
has been conducted in endothelial cells of mouse Cx40-/- aorta to evaluate the role of 
Cx40 in communication during development.  Investigation found significant reduction 
of dye transfer in knockout aortas during embryonic stages as well as during growth at 3 
weeks, 6-7 weeks and 8 weeks indicating a prominent role in communication during 
mouse development. (177) 
 Assessment of endothelial cell proliferation under static or shear conditions by 
BrdU incorporation found no significant differences between control samples and Cx40 
siRNA treated monolayers.  Endothelial cells exhibit reduced proliferation under laminar 
shear stress compared to static conditions and treatment with Cx40 siRNA had no 
significant effect on this response to mechanical environment.  Evaluation of endothelial 
cell morphology including angle of orientation and cell elongation was assessed by 
visualization of actin filaments.  Cx40 siRNA treatment does not affect endothelial cell 
angle of orientation under static or shear conditions.  Alignment of endothelial cells in 
direction of flow following exposure to shear stress is also not significantly affected by 
Cx40 siRNA treatment.  Endothelial cell shape is significantly altered by treatment with 
Cx40 siRNA resulting in cells which are more elongated than control samples and 
monolayers treated with Cx37 or Cx43 siRNA.  There are no previous reports of 
connexin knockdown affecting endothelial cell morphology and thus the mechanism 
behind this effect is unknown.  We can hypothesize that knockdown of Cx40 alters 
contacts at endothelial cell-cell junctions, focal adhesions or interactions with 
cytoskeletal components.  There is emerging evidence that connexins interact with other 
structural proteins including tight junction proteins, adherens junction proteins and 
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signaling molecules such as src. (212)  However, most investigations on connexin-
cytoskeletal interactions have focused on Cx43 due to its widespread expression and 
excellent model cell systems. 
 
Role of Connexin 43 
 Connexin 43 is the most extensively studied connexin due to its widespread 
expression in the vascular system and other tissues.  Furthermore, it contains several 
known phosphorylation sites and a complex pattern regulating expression is emerging. 
(113, 137)  Focusing on the role of Cx43 in the vasculature, multiple studies have 
implicated it in both atherosclerosis and hypertension. (163, 165, 166, 168)  While the 
genomic Cx43 knockout is embryonic lethal due to malformation of the heart, additional 
strategies have provided insight into its role in blood vessels. (173)  A Cx43 knockout 
restricted to vascular endothelial cells (VEC Cx43-/-) was developed and this model 
exhibited both hypotension and bradycardia. (163) 
 Knockdown of Cx43 expression using RNA interference was used in this study to 
evaluate its effects on endothelial cell function including gap junction communication, 
cell proliferation and cell morphology.  Use of RNAi to knockdown Cx43 expression 
provides a unique opportunity to study its function since mouse Cx43-/- are embryonic 
lethal.  In addition, Cx43 siRNA treatment of endothelial cells allows for evaluation of 
effects on non-targeted connexins, namely Cx37 and Cx40.  A short interfering RNA 
(siRNA) sequence designed to target only Cx43 was successful in knocking down 
endothelial cell Cx43 mRNA in static and shear monolayers.  While a slight increase in 
Cx43 mRNA in shear samples compared to static samples can sometimes be observed, 
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this difference is not statistically significant which confirms data previously reported 
from our laboratory.  When Cx43 mRNA is knocked down by siRNA, a decrease in Cx37 
mRNA and a decrease in Cx40 mRNA are also seen.  Moreover, Cx43 is also affected by 
siRNA targeting Cx37 but not in treatment targeting Cx40.  When endothelial cells are 
treated with Cx37 siRNA, there is a statistically significant increase in Cx43 mRNA 
levels however the degree of change is small. 
 RNA interference of Cx43 in endothelial cells resulted in changes in cell behavior 
under static and shear stress conditions.  Results from the dye transfer assay show 
significant impact of Cx43 siRNA on endothelial cell gap junction communication in 
monolayers exposed to static and shear stress conditions.  Treatment with Cx43 siRNA 
results in significantly reduced dye transfer compared to OptiMEM control, NC siRNA, 
Cx37 siRNA and Cx40 siRNA.  Under static conditions, Cx43 siRNA treated monolayers 
have reduced gap junction communication compared to medium and siRNA controls.  
Under shear conditions, dye transfer is further reduced and Cx43 siRNA treated 
monolayers are significantly lower than the medium control.  With the low level of dye 
transfer under static conditions, Cx43 siRNA is the only treatment group which does not 
significantly reduce gap junction communication under shear compared to static 
conditions.  Dye transfer of Cx43 genomic knockouts has not been conducted due to 
embryonic lethality and it was not reported in the study of Cx43 knockout restricted to 
endothelial cells. (163, 173) 
 Evaluation of endothelial cell proliferation by BrdU incorporation demonstrated 
no statistically significant effect of Cx43 siRNA treatment on levels of proliferation.  
However, there is a trend towards reduced proliferation in static monolayers of Cx43 
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siRNA treated cells compared to static controls.  It is unknown if this trend is due to the 
loss of gap junction communication as seen by dye transfer or potentially effects due to 
loss of connexins or hemichannels.  While only a trend, it is interesting that loss of gap 
junction communication corresponds to potentially lower proliferation rates since the 
trend often seen in cancer is a loss of gap junctions resulting in higher proliferation. (210)  
Endothelial cell angle of orientation and elongation were evaluated by actin filaments to 
provide measures of morphology.  Under static conditions, there is no significant 
difference in angle of orientation or elongation in Cx43 siRNA treated monolayers 
compared to controls.  Under shear conditions, endothelial cells elongate and align in 
direction of flow compared to static samples.  Knockdown of Cx43 does not impact this 
morphological response to shear stress with similar elongation and orientation to controls.  
It is interesting to note that endothelial cell monolayers treated with Cx43 siRNA 
exhibited what appear to be fragmented actin filaments near cell-cell junctions.  Figure 
6.11 displays two fields of endothelial cells treated with Cx43 siRNA displaying this 
unusual staining pattern.  While this was repeatedly observed, any mechanism remains 












































Figure 6.11 Endothelial Cell Actin Fragmentation in Cx43 siRNA Treated Samples 
Endothelial monolayer stained for actin filaments (orange) and nuclei (blue) shows fragmentation of actin 
at cell-cell junctions. 
100µm
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Non-Target Connexin Expression 
 Knockdown of individually targeted connexins by RNA interference in this study 
resulted in numerous changes in expression of non-targeted connexins.  Cx37 siRNA 
knocked down Cx37 expression, but also increased Cx40 expression and increased Cx43 
expression.  Cx40 siRNA knocked down Cx40 expression, but also decreased Cx37 
expression with no changes in Cx43 expression.  Cx43 siRNA knocked down Cx43 
expression, but also decreased Cx37 expression and decreased Cx40 expression. 
Multiple examples of effects on non-targeted connexins have been reported in 
studies of connexin knockouts in mouse models.  Knockout of Cx37-/- has been reported 
to result in a decrease of Cx40 expression. (177)  Multiple reports on Cx40-/- animals 
have arrived at conflicting conclusions with one group reporting an increase in Cx37 and 
another group reporting a decrease in Cx37. (176, 177)  Furthermore, an additional study 
found no change in Cx43 expression levels in Cx40-/- but a change in the pattern of 
protein location. (179)  While the Cx43-/- is embryonic lethal, the VEC Cx43-/- knockout 
study reported changes in Cx43 of smooth muscle cells but no other changes in 
endothelial connexin expression. (163)  While it is unclear from these studies what the 
pattern of cross-regulation amongst connexin isotypes may be, it is clear that changes in 
non-targeted connexins occur.  Further complicating the picture is the controversy over 
expression of Cx43 in mouse vasculature.  While many groups report no detection, the 
VEC Cx43-/- mouse exhibits significant differences from wild-type suggesting its 
presence is required in this model for normal function.  The only study altering the 
connexin balance in human cells used an adenovirus transfection approach to increase 
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connexin expression in HUVEC which showed that transfection with Cx37 resulted in 
decreased Cx43 expression. (180) 
 Thus questions remain regarding the ablation of one connexin affecting 
expression of other connexin isotypes.  One hypothesis is that of compensation where 
cells are attempting to retain gap junction communication capability despite loss of one 
connexin.  While this is certainly a possibility, one might expect that a knockdown of one 
connexin would always result in the upregulation of remaining isotypes which is not the 
effect seen in this study and previous investigations.  However, if the connexin isotypes 
have very different properties including electrical conductivity, permeability and gating, 
maintenance of communication might require upregulation or downregulation depending 
on the connexins involved.  A second rationale behind the effects on non-targeted 
connexins might be due to the profile of channels which are normally created in 
endothelial cells.  Connexins 37, 40 and 43 are known to mix and match in forming 
heteromeric hemichannels and heterotypic gap junctions. (147, 148, 150)  With 
characteristics of heteromeric and heterotypic combinations known to be distinct from 
homomeric and homotypic combinations, the loss of one connexin component could alter 
the levels of other connexins required to maintain cell function.  In addition to unique 
properties resulting from mixed hemichannels and gap junctions, another hypothesis is 
that loss of one connexin isotype alters the stability of channels which remain.  If the 
profile of stability in remaining channels is higher or lower than normal, an increase or 
decrease in levels of non-targeted connexin may be required to maintain cell function.  
While explanations for effects on non-targeted connexins remain unknown, this study 
confirms cross-regulation of connexins seen in mouse knockout systems.  Furthermore, 
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individual knockdowns establish a pattern of dependence between the connexin isotypes 
which provides additional insight into their functions. 
 
Connexins in Endothelial Function 
 Cx37, Cx40 and Cx43 are thought to have specific cellular functions, although 
their unique characteristics remain largely unknown.  Differences in electrical 
conductivity of channels have been established but individual permeability and gating 
properties continue to be evaluated. (12)  Previous studies have demonstrated individual 
responses of endothelial connexin isotypes to stimuli thus emphasizing their potential 
unique functions.  Endothelial connexins are differentially regulated by cell density, 
presence of TGF-β and nitric oxide. (181, 183)  In vitro and in vivo injury studies have 
shown differential regulation, location and expression patterns over time. (162, 184)  
Finally, danger signals such as TNF-α and sepsis have demonstrated changes in different 
endothelial cell connexin expression levels. (185, 186) 
 Individual knockdown of connexins in this study has added information regarding 
their unique functions in endothelial cells.  Knockdown of Cx37 resulted in no significant 
differences in gap junction communication, proliferation, angle of orientation or 
elongation and did not alter the normal cellular responses to shear stress which are 
associated with these functions.  Knockdown of Cx40 had no significant impact on gap 
junction communication, proliferation or angle of orientation, but unexpectedly altered 
cell morphology resulting in a more elongated shape.  A link between Cx40 and 
cytoskeletal structures remains unknown but results from this study suggest it should be 
pursued.  In addition, endothelial cell behavior in response to shear stress was not altered 
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by Cx40 siRNA treatment.  Knockdown of Cx43 did not significantly alter endothelial 
cell morphology, however it did dramatically decrease gap junction communication and 
while not significant, appeared to reduce cell proliferation.  The reduction in gap junction 
communication as assessed by dye transfer in Cx43 siRNA treated endothelial cells was 
so severe in static and shear samples that any effect due to shear was abolished.  Whether 
shear reduction of endothelial gap junction communication is due to effects of 
mechanical forces on Cx43 remains to be conclusively determined, but it was the only 
knockdown treatment lacking a differential shear response. 
 
Conclusions 
 While connexin knockouts in the mouse model have been generated, this study is 
the first to knockdown connexins in a transient manner in endothelial cells or human 
primary cells.  Although this study takes a novel approach to understanding all three 
connexin isotypes expressed in endothelial cells, it has numerous limitations which must 
be considered in drawing conclusions.  RNA interference, while an extremely powerful 
tool, does not result in a complete loss of mRNA transcript which could potentially 
complicate analysis.  Treatment by RNAi may also have unanticipated side effects on cell 
function or on molecules of interest.  A major shortfall of the data presented here is the 
lack of information on Cx37 and Cx40 protein expression due to the unsuccessful 
western blot analysis.  Effects on non-targeted connexins, while providing insight on 
interactions between isotypes, complicate interpretation of cell function data due to 
multiple rather than isolated changes.  As studies from this laboratory have previously 
demonstrated, while an in vitro two-dimensional substrate supporting a monolayer of 
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endothelial cells is not an accurate representation of the physiologic state, it is a 
controlled environment for the first step such as experiments presented here.  Especially 
in light of myoendothelial gap junctions which exist between endothelial and smooth 
muscle cells, knockdown of endothelial connexins should also be conducted in a system 
which contains this neighboring cell type.  In the spirit of recreating the physiologic 
environment in which endothelial cells reside, the mechanical forces used in this study 
are much simplified.  While laminar shear stress is a better approximation of the fluid 
flow environment than static conditions, if the mechanosensitive nature of endothelial 
connexins is to be fully investigated, multiple flow regimes should be recreated. 
 Although this study provides novel insight into endothelial connexin function, it is 
merely a launching point for future studies incorporating the powerful technique of RNA 
interference.  Future studies should include a multiple connexin knockdown strategy to 
more fully elucidate functions in a manner similar to double knockout animal models.  
Also of great interest is a more in depth analysis of known gap junction functions in 
endothelial cells under static and shear stress conditions.  Primarily studies should 
incorporate additional permeability tracers to elucidate potential size or charge specificity 
and electrical conductance measurements since previous reports have established that 
movement of chemical and electrical signals are not always similarly modulated.  Pursuit 
of mechanisms underlying results presented here provides numerous opportunities to add 
to understanding of connexin function.  Notably, the interaction of connexins in response 
to knockdowns and how shifts in expression are regulated should be examined.  
Additionally, the role of Cx43 in endothelial gap junction communication and response to 
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shear stress as well as the role of Cx40 in endothelial cell morphology remain to be fully 
understood. 
 While major endothelial cell functions were investigated here: gap junction 
communication, cell proliferation and morphology, exploration of connexins in other 
critical endothelial functions such as barrier formation and coagulation balance could 
provide valuable insight.  Expansion of the endothelial cell experimental setting to 
include components such as complex extracellular matrix, smooth muscle cells and fluid 
flow patterns would recreate a more physiologic microenvironment.  In addition, the 
continued use of human cell systems is important in accurately capturing physiologic 
functions, especially in light of known differences in connexin expression patterns 
amongst species. 
 In conclusion, this study demonstrates specific roles of connexin isotypes in 
endothelial cell behavior under static and shear stress conditions and confirms 
adaptations in non-targeted connexins.  The use of RNA interference to knockdown 
human endothelial connexins provides novel insight into individual isotypes and 
demonstrates the power of this technique for future studies.  Taken together, results 
presented here contribute to the understanding of vascular connexins and may add insight 
to their functions in development and disease. 
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CHAPTER SEVEN: Discussion and Conclusions 
 
 Widespread prevalence of cardiovascular disease and the associated mortality and 
morbidity are the driving force behind numerous investigations including this 
dissertation.  The staggering clinical statistics of atherosclerosis have motivated extensive 
study into endothelial cell biology in attempts to understand the clinical problem and 
have motivated the development of tissue engineered blood vessels in attempts to provide 
a new clinical therapy.  While substantial progress has been made in both the 
understanding and treatment of atherosclerosis, cardiovascular disease remains the 
greatest threat to American health.  Questions persist in endothelial cell biology and the 
disparity among results from in vitro experiments, in vivo animal studies and human 
patients perplexes the field.  Development of tissue engineered blood vessels for use as 
vascular grafts continues to proceed rapidly but these tissue substitutes are not ready for 
clinical use.  A new approach taken in this dissertation aims to combine the efforts to 
understand and treat the clinical problem by using a tissue engineered substitute a as 
more physiologic model for the study of human endothelial cell biology.  Results from 
this novel strategy provide insights into human physiology and pathology as well as aid 
in the development of improved tissue engineered vascular grafts. 
 While studies presented here are among the first to combine these two areas into 
one strategy for novel discovery, discussion of limitations of this approach as well as 
work presented in this dissertation is important in developing conclusions and 
considering directions for future work.  Use of engineered human tissues and inclusion of 
mechanical forces in the study of cell biology provides the opportunity to work with a 
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more physiologic, yet still controlled experimental setting.  Although an improvement 
over traditional in vitro experimental settings, the environmental cues provided by the 
tissue engineered blood vessel wall model and laminar shear stress system used here are 
still simplistic approximations of the native environment. 
 The tissue engineered wall model (TEWM) is a basic reconstruction of the medial 
layer of the blood vessel wall by including the major cell type, smooth muscle cells, and 
the major extracellular matrix protein, collagen type I.  While addition of these primary 
components adds significant complexity over traditional in vitro endothelial substrates, 
there is room for substantial improvement.  The collagen fibers and smooth muscle cells 
of the TEWM do not achieve a configuration matching the native vessel with respect to 
fiber structure and cell density.  Addition of other extracellular matrix components, such 
as elastin, proteoglycans and other types of collagen, would significantly improve the 
relevance of this model for use in investigating cell biology.  Future modifications of the 
engineered substrate to recreate the native vascular environment should also include an 
adventitial layer and a vasa vasorum.  Finally, while the TEWM used in these studies was 
an arterial model using aortic cells, an advantage of tissue engineering is the ability to 
customize the tissue for its downstream purpose.  Therefore models of the venous system 
or capillary beds could also be developed. 
 Mechanical forces are increasingly recognized for their important roles in 
numerous vascular physiologic and pathologic processes.  While shear stress effects on 
endothelial cells were first discovered many years ago, the complexity of forces which 
cells can interpret is only now being appreciated.  The fluid flow system used in this 
dissertation provides a steady laminar shear stress across a flat surface of endothelial 
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cells.  While inclusion of fluid flow is a significant component in recreating the native 
endothelial environment, the forces provided in this system are simplified approximations 
of blood flow in vivo.  Fluid flow and therefore the shear stress exerted on the vessel wall 
differs both spatially and temporally in the human body.  Profiles from athero-susceptible 
and athero-resistant areas of the vasculature vary in magnitude, reversal characteristics 
and frequency of oscillations which recent studies have shown can be detected by 
endothelial cells.  A more physiologic fluid flow experimental setting would include 
waveforms representing multiple regions of the vasculature as well as characteristics over 
the time period of interest such as during bedrest or exercise.  A more advanced fluid 
flow system could also be used to investigate differences in arterial versus venous flow 
environments and embryonic versus adult systems. 
 While each additional component increases the physiologic nature of the re-
created endothelial cell microenvironment, it also increases the complexity in 
determining mechanisms behind the influence.  For example, cellular differences detected 
between the TEWM and adsorbed collagen slide in this dissertation could be due to the 
presence versus absence of smooth muscle cells, the fibrillar versus monomer form of 
collagen, or the three-dimensional versus two-dimensional nature of the substrate.  
However with this trade-off in mind, the addition of other stimuli could provide new 
opportunities to understand endothelial function.  Thus besides improving the current 
tissue engineered wall model and shear stress system, inclusion of other biological 
components such as plasma and blood cells or inclusion of other mechanical forces such 
as pressure and cyclic strain should be considered for future work. 
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 A current drawback in using the tissue engineered wall model is the challenge it 
poses in applying traditional techniques for endpoint analysis.  Many in vitro protocols 
commonly employed today are designed for use with a single cell type or in systems 
where a high level of sample recovery is possible.  The challenge of the TEWM arises 
from its key advantage, which is the presence of multiple environmental components.  To 
evaluate responses at the cellular and molecular level in this dissertation, new techniques 
had to be conceived.  To analyze endothelial cells exposed to the TEWM substrate using 
non in situ techniques such as real time RT-PCR, flow cytometry and western blotting, an 
isolation procedure had to be developed.  Furthermore, RNA amplification techniques 
incorporated into the microarray labeling procedure were required to work with small 
amounts of RNA achieved from the low yield of endothelial cells recovered from the 
TEWM lumen.  Finally, due to the limited quantity of cells retrieved from this system, 
the number of experiments required to generate adequate sample for analysis is very high 
and thus less efficient than simplified systems. 
 While limitations are always present when branching into a new area, the use of a 
more physiologic in vitro environment also provides a fresh perspective to a heavily 
studied field.  The goal of this dissertation was to contribute to vascular biology by 
investigating impact of smooth muscle cells, extracellular matrix and fluid flow on 
endothelial cell behavior.  Using a tissue engineered human blood vessel as a model of 
the vascular wall and a mechanical environment of laminar shear stress, endothelial cell 
transcriptional profiles were compared to create a broad view of cellular function in 
response to these stimuli.  As a case study of endothelial cell behavior, studies focused on 
cell-cell communication through gap junctions.  Specifically, we investigated the 
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modulation of endothelial gap junctions by substrate and shear stress and examined the 
involvement individual connexin isotypes in endothelial cell function. 
 Chapter four details experiments conducted to address the first specific aim which 
was to compare transcriptional profiles of endothelial cells on a collagen coated slide to 
cells on a tissue engineered blood vessel under laminar shear stress and static conditions.  
Results from this study indicate that type of mechanical environment and nature of 
substrate have a broad impact on endothelial cell function which is exemplified in 
discussion of multiple areas of biological function.  Within the cardiovascular and 
hematological systems, areas of cell function including adhesion through integrins, 
coagulation balance, matrix deposition and turnover, redox state, and vascular patterning 
illustrated some of the critical cell behaviors sensitive to substrate and shear stress.  
However, the regulation of gene expression by these stimuli depends on the function in 
question and the identity of each gene.  Furthermore, for all areas of biological function 
examined, the profile of gene expression is different for each combination of stimuli 
which emphasizes the sensitivity of endothelial cells to cues from the microenvironment.  
Data presented here are a first step towards a better understanding of endothelial cell 
biology.  The pursuit of mechanisms of influence for areas identified as differentially 
regulated could provide additional insight.  How changes in transcriptional profile 
translate into changes in cell function was further investigated in chapters five and six 
with a focus on endothelial gap junctions and connexins 37, 40 and 43. 
 In addition to the limitations of the TEWM and flow environment previously 
discussed, this study of transcriptional profiling has additional drawbacks to be 
considered in formulating conclusions.  Microarray analysis is an increasingly powerful 
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tool for gathering an enormous amount of information regarding cellular response to 
stimuli.  While very useful for data mining and as a launching point for multiple in depth 
studies, interpretation of the data set as a whole can be difficult.  Transcriptional 
information is extremely valuable; however it only provides a partial picture of the 
endothelial cell response.  How changes in mRNA convert to changes in protein and how 
changes in protein mesh to alter cellular response are critical in understanding biological 
function.  Advances in systems biology and modeling cellular behavior will be useful in 
assembling the large amounts of information generated by transcriptional profiling as 
well as from protein analysis and cell function assays. 
 Chapter five details experiments conducted to address the second specific aim 
which was to compare endothelial cell connexin expression and gap junction 
communication on a collagen coated slide and tissue engineered blood vessel under 
laminar shear stress and static conditions.  Results indicate that while endothelial cell 
connexin expression and gap junction communication are influenced by substrate and 
shear stress, the response to these stimuli is complex.  Connexin mRNA is altered by 
substrate and shear stress in an isotype dependent manner.  Endothelial cells express 
Cx37, Cx40 and Cx43 proteins that are visible in the cell membrane and cytoplasm and 
quantification of expression shows significant increase in all three isotypes in cells on the 
TEWM substrate.  Gap junction communication measured by dye transfer shows 
decreased cell coupling in endothelial monolayers exposed to laminar shear stress 
compared to static conditions.  Data presented in this study are the first to demonstrate 
endothelial cell connexin sensitivity to substrate.  The source of influence, whether 
induced primarily by the presence of smooth muscle cells or a three-dimensional fibrillar 
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extracellular matrix, remains to be determined.  Mechanosensitivity of endothelial Cx43 
has been previously investigated yet response to shear stress of the two other isotypes, 
Cx37 and Cx40 is demonstrated in this study.  Furthermore, results presented here 
establish a reduction in endothelial cell gap junction communication following exposure 
to laminar shear stress compared to static culture. 
 While revealing novel sensitivity of endothelial connexins to substrate and shear 
stress, this study has limitations in both technique and approach.  The techniques used in 
this study: RT-PCR, flow cytometry, immunocytochemistry and dye transfer, provide 
fundamental information about the expression levels and function of endothelial gap 
junctions which are important in establishing response to new stimuli.  Nevertheless, an 
understanding of the underlying processes is lacking.  Use of more advanced techniques 
to investigate the difference in expression patterns of connexin mRNA and connexin 
protein would greatly contribute to identifying the point of influence for substrate and 
shear stress.  Use of additional dyes for permeability tracing and electrical conductivity 
measurements would provide further detail on the change in gap junction communication 
caused by exposure to laminar shear stress.  Additionally, the multiple differences 
between the TEWM and adsorbed collagen slide demonstrate sensitivity of connexins to 
substrate and the importance of using more physiologic models in studying cell biology, 
but identification of specific components responsible for changing cell behavior is not 
possible using only these two models. 
 Chapter six details experiments conducted to address the third specific aim which 
was to knockdown expression of individual connexins to determine their specific roles in 
endothelial gap junction communication, cell proliferation and cell morphology.  Results 
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demonstrate unique functions of connexin isotypes in endothelial cell behavior and also 
establish a pattern of adaptation in expression of non-ablated connexins.  RNA 
interference of Cx37 results in successful knockdown of Cx37 mRNA but also increases 
Cx40 and Cx43 mRNA.  RNA interference of Cx40 results in successful knockdown of 
Cx40 mRNA but also decreases Cx37 mRNA while not affecting Cx43 expression.  RNA 
interference of Cx43 results in successful knockdown of Cx43 mRNA but also decreases 
Cx37 and Cx40 mRNA.  While the mechanisms behind this pattern of off-target effects 
and the potential implication on cellular function remain unknown, one can speculate on 
potential explanations.  Cx37 and Cx40 are both located on chromosome one while Cx43 
is located on chromosome six and this spatial proximity could be involved in feedback 
mechanisms or sharing of regulatory molecules.  Additionally, the three endothelial 
connexins are known to have several transcription factors in common which could be 
involved in modulating rates of mRNA synthesis. 
Endothelial cells treated with Cx37 siRNA do not alter gap junction 
communication, cell proliferation or cell morphology under static or shear conditions and 
do not modify the normal response to shear stress seen in these functions.  Treatment 
with Cx40 siRNA does not affect endothelial gap junction communication, cell 
proliferation or cell angle of orientation, however it does significantly elongate the cell 
morphology under both static and shear conditions.  Cx40 RNAi also does not alter the 
normal response to shear stress for the examined cell functions.  Endothelial cells treated 
with Cx43 siRNA do not alter cell morphology under static or shear stress conditions, 
however there are significant changes in gap junction communication and a trend towards 
an effect on cell proliferation.  Cx43 RNAi significantly reduces gap junction 
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communication under static and laminar shear stress conditions and abolishes the change 
normally seen in response to shear stress.  While not statistically significant, treatment 
with Cx43 siRNA also appears to reduce the level of endothelial cell proliferation under 
static conditions.   
This study is the first to knockdown connexin expression using RNA interference 
in human primary cells or endothelial cells.  Application of this powerful technique to 
research on endothelial cell communication can now be used to more fully understand 
connexin isotype expression, regulation and function.  Data presented here establish a 
pattern of effects on non-ablated connexins which had previously only been seen in 
knockout animal models.  Furthermore, it demonstrates connexin isotype-specific 
functions in endothelial cells and lays the groundwork for further investigation into 
differences and similarities of the three endothelial connexin isotypes. 
 Although novel in its approach and conclusions, this study is limited in its 
techniques and depth of understanding as more work in this area is clearly required.  The 
technique of RNA interference, while extraordinarily powerful and revolutionizing 
studies of gene function, has several drawbacks.  Potential pitfalls include the presence of 
remaining mRNA since it is a knockdown and not a knockout of expression as well as 
possible side effects of transfection reagents and siRNA on cell function and molecules 
of interest.  A significant gap in data presented in this chapter is the lack of protein 
quantification of Cx37 and Cx40 by western blotting.  Numerous adjustments in the 
protocol were made to find Cx37 and Cx40 expression, however a reliable series of steps 
was not determined.  A drawback to the study of connexins is the lack of significant 
expression levels in native cells as well as the poor antibody availability for many 
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isotypes.  Unfortunately, experiments in this study encountered these challenges resulting 
in incomplete information regarding protein expression with siRNA treatment.  Results of 
this study did identify new areas of focus for research including determining mechanisms 
behind effects on non-ablated connexins, role of Cx43 in endothelial gap junction 
communication and role of Cx40 in endothelial cell morphology. 
 Collectively, results in this dissertation demonstrate that endothelial cell behavior 
is significantly altered by substrate and mechanical environment.  Moreover, the response 
to these stimuli is dependent on the area of cell function and on the identity of genes in 
question.  This specificity of response is demonstrated in both the transcriptional profiles 
of multiple areas of cell behavior and in the analysis of endothelial gap junctions.  
Families of genes involved in particular areas of cell function are regulated differently by 
these stimuli and individual components of any given family may also be regulated 
differently.  Taken together, these results emphasize the complexity of cellular function 
and the sensitivity of endothelial cells to the whole of their microenvironment.  Results 
also underline the need to use more physiologic in vitro models which recreate this 
microenvironment so we can gain a better understanding of the cellular complexity in 
physiologic and pathologic processes. 
 This case study of endothelial responsiveness to substrate and shear stress focused 
on gap junctions and their building blocks: connexins.  Results from these experiments 
demonstrate that endothelial cell connexins are influenced by substrate and shear stress 
and gap junction communication is affected by the mechanical environment.  Connexin 
isotypes are differentially regulated by substrate and shear stress and have unique 
contributions to fundamental endothelial cell behaviors.  While endothelial connexins 
 211
have independent roles, their expression levels are linked together suggesting a need for 
co-expression in normal cell function. 
 As this dissertation is motivated by the clinical significance of atherosclerosis and 
the in vitro use of engineered human tissues leading to improved understanding of basic 
biology as well as development of superior tissue substitutes, the conclusions and impact 
of this work are focused in these areas. 
 While it is readily appreciated that endothelial cells alter their phenotype in 
response to shear stress, data presented here show an equally dramatic shift due to 
substrate.  Just as many studies now focus on the influence of shear stress or include the 
presence of shear stress in investigating other endothelial cell functions, results presented 
here should motivate the field to investigate the influence of smooth muscle cells and 
extracellular matrix or include a more physiologic substrate in studying other areas of 
endothelial cell biology.  Modulation of endothelial connexins and gap junctions in 
response to substrate and mechanical environment opens a new area of research in cell 
communication.  Understanding the purpose behind response to these cues will bring 
insight into how this adaptation may occur in physiologic and pathologic conditions.  
Identification of differences in endothelial cell connexin isotypes also generates new 
questions.  Ascertainment of their unique characteristics including permeability, electrical 
conductivity, gating and roles in other endothelial cell functions would greatly contribute 
to the current gaps in knowledge.  Furthermore, an understanding of how the connexin 
isotypes may work together or work independently could clarify much of the confusion 
which currently surrounds their functions.  Establishment of a co-expression pattern for 
individual isotypes is the first step in determining how connexins are linked together in 
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their regulation.  Questions abound regarding whether this is a mechanism designed to 
protect cell communication, and if there are changes in expression, how the adjustments 
in multiple isotypes affect overall cell function.  With clear differences in mRNA 
expression levels and protein expression levels established, determination of mechanisms 
underlying their regulation would also enhance understanding of their transcription, 
translation and stability. 
 Towards improving our understanding of atherosclerosis, results presented here 
can identify changes in response to substrate and mechanical environment which may 
lead to development of disease or may occur as a result of plaque progression.  By 
understanding the combined influence of substrate and mechanical cues, therapies can be 
developed to control these interactions and prevent development or halt progression of 
disease.  In the case of connexins and gap junctions, evidence exists linking changes in 
specific isotypes to atherosclerosis and hypertension.  A better understanding of the 
individual roles of each isotype will aid in determining why mutations in some connexins 
lead to development of or protection from disease and also why different disease states 
alter endothelial connexin expression.  Potential therapies targeting connexins or gap 
junctions could be used to control cell-cell communication to prevent disease 
development or slow its progression.  Furthermore, a thorough understanding of 
endothelial cell gap junction regulation and function could lead to modulation of the cell 
communication system to increase spread of athero-resistant signals or prevent spread of 
athero-susceptible signals. 
 With the clinical goal of developing living tissue substitutes for therapeutic 
applications, a thorough understanding of cell interactions with extracellular matrix, 
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neighboring cell types and mechanical environments will provide the tools needed to 
modulate cell phenotype in developing these engineered tissues.  For example, 
controlling cell proliferation, matrix deposition and matrix turnover during the steps of 
growing the tissue substitute, integrating the substitute with host tissue and maintaining 
mature tissue in vivo will be critical to therapeutic success.  An understanding of cell-cell 
communication is fundamental to developing tissue substitutes because the links between 
cells are what transforms individual cellular responses into a unified tissue response.  
Connexins and gap junctions are also very involved in the differentiation and 
development of tissues in normal physiology thus modulation of these properties could be 
key in growing an engineered tissue.  Gap junctions have special applicability in the 
development of cardiovascular tissue substitutes.  Homocellular connections between 
endothelial cells and smooth muscle cells along with heterocellular connections between 
the two cell types are responsible for movement of signals critical to controlling vascular 
tone.  Normal connexin expression and gap junction function will be required in a tissue 
engineered vascular graft if it is to be vasoactive and integrate with the host vessel.  Gap 
junctions are also critical to electrical conduction in the heart and by controlling 
connections using extracellular matrix, multiple cell types, and mechanical or electrical 
stimuli, a myocardial patch can be developed which possesses the appropriate conduction 
pathways. 
 In conclusion, this dissertation demonstrates the sensitivity of endothelial cell 
phenotype to substrate and mechanical environment.  Results presented here provide 
novel scientific insight into cell functions modulated by these stimuli and demonstrate a 
complex regulation of endothelial cell gap junctions.  Furthermore, this work underlines 
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the importance of including more physiologic in vitro models into studies of basic cell 
biology.  Finally, the use of engineered tissues to probe fundamental scientific questions 
results in novel conclusions which contribute to biological knowledge of endothelial 
cells, clinical understanding of disease, and development of advanced tissue engineered 
substitutes. 
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CHAPTER EIGHT: Recommendations for Future Work 
 
 Conclusions drawn and questions raised in this dissertation lay the foundation of 
recommendations for future work.  These recommendations include next steps for the 
specific lines of experiments conducted here from the expansive microarray study to the 
knockdown of individual connexin isotypes.  Suggestions are also made regarding the 
next steps in a broader sense for basic biology studies, atherosclerosis investigations, and 
tissue engineered substitute development. 
 With respect to the transcriptional profiling of endothelial cells using a more 
physiologic substrate and mechanical environment, analysis presented here barely 
scratches the surface.  The microarray data sets are a significant source of potential 
insight and areas of new investigation.  As new software analysis tools are developed and 
new literature evolves, substrate and shear stress will be shown to influence multiple 
areas of endothelial cell function.  Of particular interest with respect to atherosclerosis 
and development of tissue engineered vascular grafts, experiments should be pursued in 
evaluating changes identified in the reduction-oxidation balance as well as the 
coagulation balance. 
 While demonstrating in detail the complexity of response to substrate and shear 
stress, the case study on endothelial gap junctions also provides numerous opportunities 
for future work in cell-cell communication.  Connexins have traditionally been a major 
focus of cancer biology but less prominent in other fields.  Even within the 
cardiovascular arena, the primary gap junction focus has been on myocardium and the 
important roles in electrical conduction.  Only recently have cardiovascular gap junctions 
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been emphasized and momentum focused on communication in the vascular wall.  While 
data presented here establish an endothelial sensitivity to substrate and mechanical 
environment, the next step is to pursue the specific components inducing these changes. 
Formation of myoendothelial gap junctions and the communication of 
information in a third dimension of the vessel wall deserve primary focus.  Determining 
the potential influence of smooth muscle cell presence on endothelial gap junctions could 
have significant impact on understanding clinical diseases such as atherosclerosis and 
restenosis where connections are lost between the two cell types.  Furthermore, 
investigating of the flow of information between endothelial and smooth muscle cells and 
how this connection could alter endothelial-endothelial or smooth muscle-smooth muscle 
communication pathways could be critical to the understanding of vascular tone and 
hypertension.  In addition to influence of smooth muscle cells, the question arises if gap 
junctions are sensitive to composition and structure of extracellular matrix.  If so, do 
alterations in matrix structure and gap junctions play a role in atherosclerotic plaque 
development or angiogenesis?  Is there a connection between integrin signaling and the 
connexin family which controls the cell-cell communication in different matrix 
environments? 
Interaction amongst environmental components has been demonstrated at multiple 
points in this dissertation.  Thus an investigation of smooth muscle cell or extracellular 
matrix influence on endothelial cells would not be complete without the concurrent 
presence of shear stress.  In this context, experiments could be conducted to determine if 
mechanical environment alters communication from endothelial cells to smooth muscle 
cells and vice versa.  With additional information regarding the components inducing 
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change in endothelial cell gap junctions, experiments should be conducted to determine 
the mechanisms of influence.  Advanced techniques should be employed to investigate 
impact on levels of transcription, efficiency of translation, mRNA stability and protein 
stability, which have all been previously shown as points of regulation for gap junctions. 
As this dissertation is the first study to systematically investigate all three 
endothelial connexin isotypes and in doing so, establish a pattern of interacting 
expression and individual roles in cell function, it is truly the beginning of an area of 
work rather than an ending.  Experiments conducted using the knockdown approach in 
native cells are an excellent complement to other studies using transfected model cell 
lines and knockout animal models.  Initial studies should focus on a multiple knockdown 
strategy to isolate roles of individual connexins and further detail the pattern of effects on 
non-ablated connexins.  An in depth characterization of isotype properties using single 
and multiple knockdowns will provide fundamental information about endothelial 
connexins which is currently unknown.  Evaluation of gap junction chemical 
permeability, electrical conductance and gating in channels composed of each connexin 
will determine a communication profile for each isotype.  Furthermore, potential gap 
junction independent functions of hemichannels or connexin proteins can be evaluated.  
Use of advanced techniques can also be used to determine how the isotypes may interact 
and thus explain the effects on non-ablated connexins.  Information on regulation would 
also provide additional data on conductivity and stability of heterotypic and heteromeric 
channels. 
Specific to endothelial cell functions, additional experiments should be conducted 
to investigate the role of Cx40 in morphology and the role of Cx43 in gap junction 
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communication.  A starting point for Cx40 morphology studies would be interactions 
with cytoskeletal proteins and how these interactions are different from relationships 
between the cytoskeleton and the Cx37 and Cx43 isotypes.  While experiments indicate 
that Cx43 is the major player in endothelial gap junction communication, multiple 
questions remain.  Where, how and when do Cx37 and Cx40 contribute to endothelial 
gap junction communication?  Furthermore, is the mechanism behind shear-induced 
changes in gap junction communication due to modulation of Cx43 gating, channel 
number, or open/close probability? 
Broader recommendations drawn from the overall dissertation conclusions can be 
applied to the scientific and clinical motivations behind this work.  In the field of vascular 
biology, endothelial-smooth muscle and endothelial-extracellular matrix interactions are 
ripe for exploration.  While work is ongoing in some of these areas, there is greater 
applicability of these interactions.  Understanding of human vascular disease, vessel 
development and vessel stabilization would all benefit from experiments into these 
interactions.  Moreover, a combined smooth muscle-extracellular matrix environment 
could provide key insight not possible when only one stimulus is present. 
Towards understanding and treating atherosclerosis, creation of human tissue in 
vitro provides unique opportunities to study normal and diseased vessels.  Comparison of 
healthy and diseased human engineered tissues provides a novel test bed for drug and 
device development.  For example, how does a pharmacologic agent delivered via drug 
eluting stent behave when tested on a human vessel substitute rather than on a single cell 
type of in an animal model?  In the development of next generation tissue engineered 
vascular grafts, data presented here provide insight into important characteristics needed 
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such as control of proliferation for endothelialization and control of blood coagulation.  
Understanding of gap junctions in the tissue engineered blood vessel environment aids in 
the progression towards vasoactive grafts.  Finally, experimental iterations using tissue 
engineered blood vessels in vitro and evaluation of cellular response will demonstrate 
modifications needed to achieve successful clinical application. 
Through large scale endothelial transcriptional profiling and a case study focused 
on cell-cell communication, this dissertation generates novel insight into vascular biology 
through the use of a tissue engineering model in vitro.  By combining the efforts to 
understand and treat the clinical crisis of cardiovascular disease, we demonstrate that 
much remains to be learned regarding endothelial cell function and vascular tissue 
engineering.  The challenges which remain can be addresses through novel strategies 
such as using tissue engineered substitutes for studies of basic human biology thus 
significant scientific and clinical advancements are within our reach. 
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TLJ-P01: Culture Medium for Human Aortic Endothelial Cells (HAEC) 
 
Reagents: 
MCDB 131     Mediatech Cellgro, Cat No. 15-100-CV 
L-Glutamine     Mediatech Cellgro, Cat No 25-005-C1 
HyQ Penicillin-Streptomyocin   Mediatech Cellgro, Cat No SV30010 
Hydrocortizone    Sigma, Cat No H-4001 
hFGF-basic     PeproTech, Cat No 100-18B 
hEGF      Gibco, Cat No 13247-051 
IGF-1      Gibco, Cat No 13245-063 
VEGF      Sigma, Cat No V-7259 
Ascorbic Acid     Sigma, Cat No A-4034 
Fetal Bovine Serum (FBS)      
 
Procedure: 
1. Place the following reagents in the warm water bath until they have completely 
warmed: 
1) 2 x 500 mL MCDB-131 
2) 50 mL FBS 
3) 10 mL Pen-Strep 
4) 10 mL L-Glutamine 
5) 1 mg hydrocortizone aliquoted in 1 mL ethanol 
6) 2 µg FGF aliquoted in 1 mL tissue culture water 
7) 10 µg EGF aliquoted in 1 mL tissue culture water 
8) 2 µg IGF-1 aliquoted in 1 mL tissue culture water 
9) 1 µg VEGF aliquoted in 1 mL tissue culture water 
10)  50mg Ascorbic Acid aliquoted in 1 mL tissue culture water 
 
2. Using a 1 Liter glass bottle and filter top, add all reagents and filter using vacuum 
suction 
3. Label bottle with cell type, initials and date 
4. Place bottle in cold room for storage or tissue culture fridge for immediate use 
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TLJ-P02: Culture Medium for Human Aortic Smooth Muscle Cells (HASMC) 
 
Reagents: 
MCDB 131     Mediatech Cellgro, Cat No. 15-100-CV 
L-Glutamine     Mediatech Cellgro, Cat No 25-005-C1 
HyQ Penicillin-Streptomyocin   Mediatech Cellgro, Cat No SV30010 
Insulin      Gibco Cat No 12585-014 
hFGF-basic     PeproTech, Cat No 100-18B 
hEGF      Gibco, Cat No 13247-051 
Fetal Bovine Serum (FBS)      
 
Procedure: 
1. Place the following reagents in the warm water bath until they have completely 
warmed: 
1) 2 x 500 mL MCDB-131 
2) 50 mL FBS 
3) 10 mL Pen-Strep 
4) 10 mL L-Glutamine 
5) 5 mg insulin aliquoted in 1 mL tissue culture water 
6) 2 µg FGF aliquoted in 1 mL tissue culture water 
7) 0.5 µg EGF aliquoted in 1 mL tissue culture water 
 
2. Using a 1 Liter glass bottle and filter top, add all reagents and filter using vacuum 
suction 
3. Label bottle with cell type, initials and date 




TLJ-P03: Medium for HAEC/HASMC Co-Culture and Flow Experiments 
 
Reagents: 
MCDB 131     Mediatech Cellgro, Cat No. 15-100-CV 
L-Glutamine     Mediatech Cellgro, Cat No 25-005-C1 
HyQ Penicillin-Streptomyocin   Mediatech Cellgro, Cat No SV30010 
hFGF-basic     PeproTech, Cat No 100-18B 
hEGF      Gibco, Cat No 13247-051 
Fetal Bovine Serum (FBS)      
 
Procedure: 
1. Place the following reagents in the warm water bath until they have completely 
warmed: 
1) 2 x 500 mL MCDB-131 
2) 50 mL FBS 
3) 10 mL Pen-Strep 
4) 10 mL L-Glutamine 
5) 2 µg FGF aliquoted in 1 mL tissue culture water 
6) 0.5 µg EGF aliquoted in 1 mL tissue culture water 
 
2. Using a 1 Liter glass bottle and filter top, add all reagents and filter using vacuum 
suction 
3. Label bottle with cell type, initials and date 








Sterile PBS (-Mg, -Ca) 
Co-culture medium (TLJ-P03) 
 
Solutions: 
50 µg/mL Collagen type I Solution 
Using Rat tail type I collagen (BD Biosciences), calculate for 50 µg/mL and 
dilute accordingly with sterile tissue culture water 
 
Procedure: 
Coating Slides with Collagen 
1. Autoclave glass slide and tweezers. 
2. Place slide into square dish with tweezers. 
3. Add 1mL of collagen solution and spread evenly with cell scraper. 
4. Incubate for 1 hour to allow passive adsorption of protein. 
 
Adding Cells to Slide 
1. Remove flasks with endothelial cells from incubator and place in cell culture hood.  
Aspirate spent medium, rinse culture surface with PBS and aspirate, add trypsin to 
detach cells, neutralize trypsin with media and collect cell suspension. 
2. Centrifuge at 1000 rpm for 5 min and aspirate supernatant.  Resuspend in fresh 
culture media and count using Coulter Counter. 
3. Cells will be seeded at a density of 40,000/cm2 with each slide having dimensions of 
3.8 x 7.5 cm for a total area of 28.5 cm2  
4. Centrifuge appropriate number of cells for number of slides at 1000 rpm for 5 min 
and remove supernatant.  Resuspend in media so that 1 mL of cell suspension will be 
added to each slide. 
5. Add 1 mL of cell suspension to surface of slides and spread gently using cell scraper 
if necessary. 




TLJ-P05: Embedding Tubular Constructs and Seeding HAEC on TEWM 
 
 
Reagents:       
3.5% Agar  
 3.5g Agar (Sigma A-9915) in 100ml DI water      
Co-culture Medium (TLJ-P03)  
Trypsin 
PBS -Mg -Ca 
 
Instruments: 
Instrument tray:       New glass slides 
Mandrel grabbers       Used glass slides 
Section lifter (spatula)      Embedding molds 
Smooth angled forceps 
Serrated angled forceps 
Flat tweezers 
Angled scissors 
Scalpel with No.20 blade 
 
Procedure: 
Preparation of Materials and Instruments 
1. Make up 3.5% agar solution in a 100ml glass bottle. 
2. Prepare tray of instruments on paper towel.  Autoclave new glass slides, used 
glass slides, molds and tray of instruments in advance. 
3. Right before embedding procedure, autoclave agar to melt and place immediately 
in hot water bath at 48°C to keep liquid. 
 
Preparation of Constructs 
Steps can be done to all constructs at once. 
1. Place one autoclaved new glass slide in each square cell culture dish and set aside. 
2. Remove dish of constructs from incubator and place in sterile cell culture hood.  
Remove rubber stopper from mandrel end and slide constructs on sleeves off the 
mandrel.  Remove mandrels and rubber stoppers from dish. 
3. Holding silicone sleeve with angled forceps, slowly cut sleeve and construct along 
the long axis with angled scissors.  Then grab silicone sleeves at each end with 
forceps, stretch and free from construct. 
 
Embedding Procedure 
Steps should be done to only two constructs at a time to prevent drying and cell death. 
1. Using smooth angled forceps, grab one corner of the construct and slide onto 
spatula with the lumen down.  Transfer construct onto new glass slide in square 
dish keeping the lumen down. 
2. Using scalpel, cut away ragged ends of construct and remove excess material.  
Center the construct on the glass slide with forceps. 
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3. Aspirate excess fluid off the slide being careful not to aspirate the construct but 
remove all fluid from around it to ensure a good agar seal. 
4. Place mold over slide with hole over construct.  Quickly remove agar from hot 
water bath and add 7 mL over construct.  Quickly place used glass slide over agar 
and press hard with mandrel grabbers and flat tweezers until the agar solidifies to 
ensure a good seal. 
5. After the agar has cooled, remove excess from the sides of the mold and discard.  
Add 30 mL of flow media to the dish.  Using flat tweezers, flip the 
slide/mold/slide combination over and carefully slide off the top slide to expose 
the lumen. 
6. Place the dishes of embedded construct into the incubator at 37°C and 5% CO2.  
Growing and Seeding HAEC 
1. Remove flasks with endothelial cells from incubator and place in cell culture 
hood.  Aspirate spent medium, rinse culture surface with PBS and aspirate, add 
trypsin to detach cells, neutralize trypsin with media and collect cell suspension. 
2. Centrifuge at 1000 rpm for 5 min and aspirate supernatant.  Resuspend in fresh 
culture media and count using Coulter Counter. 
3. Cells will be seeded at a density of 40,000/cm2 with each mold having dimensions 
of 3.8 x 7.5 cm for a total area of 28.5 cm2  
4. Centrifuge appropriate number of cells for number of slides at 1000 rpm for 5 min 
and remove supernatant.  Resuspend in media so that 200ul of cell suspension will 
be added to each construct.  
5. Allow cells to attach for 10 min in the hood, then transfer to the incubator for 20 
min.  Remove from incubator and add 30 mL of warm co-culture media 
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TLJ-P06: Separation of Endothelial Cells from Smooth Muscle Cells 
 
Reagents: 
PBS –Mg –Ca          Mediatech 21-031-CV 
PECAM-1 antibody (PE or FITC conjugate) Microbeads 
 Anti-FITC:      Miltenyi Biotech  120-000-293 
 Anti-PE:       Miltenyi Biotech   120-000-294 
600 U/ml collagenase 
MCDB 131 base       Mediatech 15-100-CV 
Collagenase        Worthington #4176 
Co-culture medium (TLJ-P03) 
MACS Buffer (0.5% BSA, 1mM EDTA in PBS) 
 PBS –Mg –Ca         Mediatech 21-031-CV 
 0.5 M EDTA     Gibco  15575-020 
 Bovine Albumin    Sigma A-1470  
 
Procedure: 
Removal of EC from SMC-seeded collagen gels 
1) Cut away excess agar and place in 30mm dish then rinse construct in PBS 
2) Add 3 mL of 600 U/ml collagenase to surface 
3) Wait 4 min and scrape once 
4) Add 2 mL media to neutralize and remove 
5) Rinse with 4 mL PBS and remove 
6) Centrifuge at 1000rpm for 5 min and remove supernatant 
 
Removal of EC from EC/SMC Contact Monolayer Co-culture 
1) Rinse slides in PBS then add 1ml of 600 U/ml collagenase to surface 
2) Wait for cells to lift off and neutralize with 3ml media 
3) Collect cell suspension in centrifuge tube, rinse slide with PBS and remove 
4) Centrifuge at 1000rpm for 5 min and remove supernatant 
 
Labeling with Antibody and Microbead 
1) Resuspend in PBS and transfer to 15 mL centrifuge tube if necessary 
2) Centrifuge at 1000rpm for 5 min and remove supernatant 
3) Add 10µL CD31 antibody (PE or FITC conjugate) and vortex to mix solution 
4) Place in fridge for 5 min 
5) Add 10 mL PBS, centrifuge at 1000rpm for 5min and remove supernatant 
6) Add 90 µL MACS buffer and resuspend cells 
7) Add 20 µL Anti-FITC or Anti-PE microbeads, vortex and incubate for 15 min in 
fridge 
8) Add 5 mL MACS buffer, centrifuge at 1000rpm for 5 min and remove 
supernatant 




1) Attach miniMACS separation unit to stand and place MS separation column in the 
unit 
2) Place a collection tube under the column and apply 500µL of MACS buffer to the 
top of the column and let the buffer run through 
3) Discard effluent and change collection tube 
4) Pipet labeled cell suspension onto column and allow to run through 
5) Collect effluent as negative fraction 
6) Wash column 3 x 500 µL and collect total effluent as negative fraction 
7) Remove column from separator and place column on a new collection tube 
8) Apply 1 mL buffer to the reservoir of the column and firmly flush out cells using 





Use collagenase rather than trypsin to preserve EC surface markers for antibody labeling 
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TLJ-P07: RNA Interference of Endothelial Connexins on Slides 
 
Reagents: 
OptiMEM medium       Invitrogen 31985-070 
Oligofectamine reagent      Invitrogen 12252-011 
Cy3 labeled negative control #1 siRNA (5nmole)   Ambion 4621 
Pre-designed siRNA, Cx37 siRNA, ID=7185 (5nmole)  Ambion 16708 
Pre-designed siRNA, Cx40 siRNA, ID=145161 (5nmole)  Ambion 16708 
Pre-designed siRNA, Cx43 siRNA, ID=144485 (5nmole)  Ambion 16708 
 
Experimental medium (TLJ-P03) 
FBS 
Sterile, RNase-free microcentrifuge tubes 




Seeding Endothelial Cells on Slides 
1. Adhere silicone gaskets to perimeter of glass slides to create well for culture and 
transfection (reduces slide area from 28 cm2 to 25cm2) 
2. Autoclave slides then coat with 50 ug/ml collagen type I for 1 hour 
3. Trypsinize and pellet endothelial cells from flask 
4. Remove collagen solution from surface of slide and seed endothelial cells at 
40,000/cm2 in 2ml of HAEC culture media 
5. Allow cells to adhere for 1 hour then add 1ml additional culture media to each 
slide and place in incubator. 
 
Initial Preparation of siRNA stocks 
1. siRNA is lyophilized upon arrival and therefore must be re-constituted (use 
ONLY sterile, nuclease-free water which is supplied with siRNA sequences) 
2. Dilute 5nmole of siRNA in 250ul of water for stock concentration of 20uM (when 
this 20uM is later diluted in cocktail and samples are transfected, final 
concentration would be 100nM) 
 
Preparation of Transfection Reagents  
Note – transfection volumes are scaleable based on surface area being treated 
For slide surface of 25cm2: 2mL OptiMEM + 500ul cocktail + 750ul flow media with 
22% FBS 
Cocktail = tube #1 + tube #2 
Tube #1 = 12.5ul siRNA + 450ul OptiMEM 
Tube #2 = 10ul oligofectamine + 27.5ul OptiMEM 
 




For 20 slides total (10 static, 10 shear)  4 slides per siRNA treatment 
 
1. Prepare 13 sterile, RNase-free microcentrifuge tubes (4 for siRNA concentrate, 8 
for tube #1 (2 each siRNA treatment due to volume) and 1 for tube #2) 
2. Dilute siRNA from stock concentration so final concentration will be 40nM (4 
tubes – NC, 37, 40, 43) 
22ul stock siRNA + 33ul water  55ul siRNA (will only need 50ul) 
3. Prepare one tube #2 for all samples – multiply tube#2 ratios listed above by 
number of slides plus adjustment for slight pipetting error (oligofectamine can be 
slightly viscous) 
20 slides total (4 are OptiMEM control) therefore 16 slides to be transfected 
 
tube #2 (x16.2) = 162ul oligofectamine + 445.5ul OptiMEM 
 Allow tube #2 to sit at room temperature for 5-10minutes 
4. Prepare tube #1 for each siRNA transfection (2 tubes per condition due to 
volume) 
Each tube #1 = 25ul siRNA (from diluted samples) + 900ul OptiMEM 
5. Add 75ul from tube #2 to each tube #1 and incubate at room temperature for 15-
20min to allow siRNA to complex (no more than 30minutes) 
 
Transfection of Endothelial Cells on Slides 
1. Remove slides from incubator and aspirate to remove culture media 
2. Add 2ml of OptiMEM per slide and remove as wash #1 
3. Add 2ml of OptiMEM per slide and remove as wash #2 
4. Add 2ml of OptiMEM to each slide 
5. In a dropwise manner, add 500ul of cocktail (tube #1 + tube#2 mixture) to each 
slide; to OptiMEM control slides, add 500ul OptiMEM 
6. Carefully return slides to incubator and allow transfection to proceed for 6 hours 
7. After 6 hours, add 750ul of flow media with 22% FBS to restore total FBS 
concentration to normal culture levels (5%).  Do not remove 




1. To adjust final siRNA concentration, create more dilute siRNA prior to creation 
of tube#1.  Do not adjust ratios of siRNA/oligofectamine or siRNA/OptiMEM. 
2. When transfecting other surface areas, adjust volumes of all reagents while 
maintaining ratios. 
3. Always use sterile, RNase-free reagents – water, microcentrifuge tubes, 
micropipette tips to ensure quality of experiment 
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TLJ-P08: Cell Lysis & RNA Isolation 
 
 
Reagents & Supplies: 
RNeasy Mini Isolation kit      Qiagen 74104 
Qiashredders        Qiagen 79654 
RNase-free DNase kit       Qiagen 79254 
RNase/DNase Free Water      Sigma W-4502 
Ethanol – molecular biology      Sigma E702-3 
RNase/DNase free B-mercaptoethanol    Sigma M3148 
RNase/DNase free tubes 





Mix lyophilized DNase powder with water in kit to get DNase stock solution, then 
aliquot 100 µL and store at -20C 
Lysis Buffer  
Mix RLT buffer (10mL) with 100 µL B-ME; protect from light and store at room 
temp for up to  a month (can scale down ie. 5ml RLT + 50µL B-ME) 
70% Ethanol  
Mix 200 proof ethanol for molecular biology with RNase/DNase Free Water and 
store solution at RT 
DNase mix 
Add 10 µL DNase stock to 70 µL RDD (in Qiagen kit) so there is 80 µL mix per 






1. Aspirate media, rinse with PBS and add trypsin.   
2. Quench trypsin with media and place cell/media/trypsin suspension into centrifuge 
tube; rinse flask with PBS and place in centrifuge tube.   
3. Spin 5-10 min at 1000 rpm and 4C.   
4. Completely aspirate supernatant and place tubes with cell pellet on ice. 
 
Prepare Cell Lysate 
1. Add 350 µL of lysis buffer to the tube and mix well; transfer mixture to qiashredder 
homogenizer column and spin in centrifuge at max for 2 minutes.  (Alternative to 
qiashredder: Leave lysate mixture in tube and put 20-gauge needle on 3 mL syringe 
and place in tube.  Pass the lysate 5-10 times through the needle) 




If using frozen samples, allow to warm at 37C for 10 min before adding ethanol 
 
1. Add 350 µL of 70% ethanol and mix well by pipetting 
2. Transfer 700 µL of the sample to the RNeasy mini column placed in a 2mL collection 
tube.  Centrifuge at 10,000 rpm for 30 sec. 
3. Suck up supernatant with micropipette and add to top of column. Centrifuge at 10,000 
rpm for 30 sec then discard effluent.  (If solution remains above column, spin briefly 
to force through column) 
4. Add 350 µL of RW1 solution to the RNeasy column.  Centrifuge at 10,000 rpm for 
30 sec and discard the effluent. 
5. Add 80 µL DNase mix to the column and incubate at room temp for 15 minutes 
6. Add 350 µL of RW1 solution to the RNeasy column.  Centrifuge at 10,000 rpm for 
30 sec and discard the effluent. 
7. Discard the old collection tube and replace with a new collection tube.  Add 500 µL 
of RPE Buffer; centrifuge at 10,000 rpm for 30 sec and discard the effluent 
8. Add 500 µL RPE Buffer and centrifuge at MAX speed for 2 minutes.  If any solution 
remains above the column, spin again for 30-60 seconds to force through column and 
then discard the effluent. 
9. Label 1.5 mL collection tubes (in kit) and aliquot some RNase free water into a 
medium eppendorf tube 
10. Transfer the RNeasy column to the new collection tube; Add 25 µL (or desired 
volume) of RNase free water and incubate for 1 minute.  Centrifuge at MAX speed 
for 1 minute and discard the RNeasy column.  Place collection tube with RNA on ice. 
 
 
Spec Samples to Determine Concentration and Purity 
1. Prepare small tubes (label for each sample) 
2. Aliquot 58ul water into each tube 
3. Put 2ul of sample (after mixing well) into corresponding tube 
4. Read at 260nm and 280nm 
 
Determine sample concentration: 
(avg spec reading at 260nm)*(dilution factor)*(RNA quantification value) = sample conc 
(ug/ml) 
sample conc (ug/ml)*(volume of sample remaining) = quantity of sample 
 
Determine sample purity: 
(Spec reading at 260nm/Spec reading at 280nm) should be 1.8-2.1 for pure RNA 
 
Samples are also now ready for Bioanalyzer analysis. 
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TLJ-P09: RNA Concentration by Precipitation 




Ethanol – molecular biology grade    Sigma Aldrich E702-3 
Sodium acetate – molecular biology grade   Sigma S-2889 
Glycogen solution (20mg/ml) – molecular biology grade Fermentas R0561 





70% Ethanol (ice cold) 
 Ethanol + RNase/DNase Free Water 
3M sodium acetate solution, pH = 5.2 
 Sodium Acetate + RNase/DNase Free Water 
5mg/ml glycogen solution 




1. Add 1/10 volume of 3 M sodium acetate solution and 2.5 volumes 100% ethanol to 
RNA in solution 
 (For 23.7 µl RNA solution; add 2.4 µl NaOAc and 59.25 µl ethanol) 
 (For 21.7 µl RNA solution; add 2.2 µl NaOAc and 54.25 µl ethanol) 
2. Add 0.5 – 1.0 µl of 5 mg/mL glycogen and mix well 
3. Chill at -20°C for at least an hour (or overnight) 
4. Centrifuge at 12,000 rpm for 10 minutes 
5. Remove the supernatant and wash with ice cold 70% ethanol 
6. Pulse vortex and spin again for 5 min 




Glycogen serves as a carrier for low quantities of RNA 
Used when procedures require concentrated RNA from solutions of dilute RNA 
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TLJ-P10: cDNA Synthesis for RT-PCR 
 
Reagents: 
SuperScript III First-Strand Synthesis System for RT-PCR  Invitrogen 18080-051 
RNase/DNase Free Water      Sigma W-4502 
RNase/DNase free tubes 
RNA samples – concentrations known 
 
Procedure: 
Carefully follow ALL steps as detailed in the SuperScript III procedure outline – details 
listed here are meant as a supplement only. 
 
Controls: Several controls are used in RT-PCR reactions.  At this step, be sure to create –
RT controls.  These are samples which contain sample RNA and all reagents for cDNA 
synthesis EXCEPT the reverse transcriptase enzyme (therefore no cDNA will be created 
and these samples will be a control to check for genomic DNA during the PCR 
amplification steps) 
 
Preparing RNA Samples 
1. Determine concentration and quality of RNA samples using spec and bioanalyzer 
prior to cDNA synthesis.  You will need 1µg of RNA in NO MORE than 8µL of 
water for each tube (cDNA tube as well as –RT tube).  If your RNA is more dilute 
than this, concentrate by precipitation (see protocol) 
2. Based on spec readings and concentration calculations, determine volume of RNA 
for each sample which gives 1µg. 
3. Using spreadsheet, calculate appropriate volumes of RNA and water for each 




RNA (1µg) n µL 
Primer (50µM oligo dT) 1 µL 
10mM dNTP mix 1 µL 
RNase/DNase free water 10-(2+n) µL
 
cDNA Synthesis 
Remember to use new tips when moving between reagents and between tubes! 
Before preparing samples, turn on thermal cycler and load program to heat to 65°C. 
 
Denaturation step: 
1. Mix and briefly centrifuge RNA samples, oligodT, and dNTP mix 
2. Label RNase/DNase free tubes for cDNA synthesis (remember –RT controls) 
 236
3. Add correct volume of RNA to each tube, then add correct volume of water to 
each tube (total at this point should be 8µL) 
4. Add 1µL oligodT to each tube 
5. Add 1µL dNTP mix to each tube 
6. Vortex briefly and centrifuge to collect total volume 
7. Place in thermal cycler for 5 minutes at 65°C then place on ice for at least 1 
minute. 
 
Annealing and cDNA synthesis step: 
1. Mix and briefly centrifuge 10X RT buffer, 25mM MgCl2, 0.1M DTT, RNase out 
and Superscript III RT. 
2. Change program on thermal cycler to 50°C if using oligodT. 
3. Prepare enough cDNA mix for all tubes + 0.15 extra for pipetting error 
4. Create one tube for cDNA synthesis reactions and one tube for –RT reactions.   
5. Always mix reagents together into one tube in the following order: 
 
Component 1 cDNA 
rxn 
10 cDNA rxns 1 –RT rxn 10 –RT rxns 
10X RT buffer 2 µL 20.3 µL 2 µL 20.3 µL 
25mM MgCl2 4 µL 40.6 µL 4 µL 40.6 µL 
0.1 M DTT 2 µL 20.3 µL 2 µL 20.3 µL 
RNase Out 1 µL 10.15 µL 1 µL 10.15 µL 
SuperScript III RT 1 µL 10.15 µL 0 0 
Rnase free water 0 0 1 µL 10.15 µL 
 
6. Vortex and centrifuge to collect total volume of mixture 
7. Add 10ul of cDNA mix or –RT mix to each tube, then mix gently and centrifuge 
briefly to collect 
8. If oligo dT was used, incubate at 50°C for 50 minutes. 
 
Terminate Reaction and Remove RNA: 
1. Terminate the reactions at 85°C for 5 minutes and then chill on ice. 
2. Collect reactions by brief centrifugation and then add 1ul of RNase H to each 
tube. 
3. Incubate at 37°C for 20 minutes. 
4. Store cDNA samples at -20°C or use in PCR immediately 
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TLJ-P11: Preparation and Examination of an Agarose Gel 
Reagents: 
Hi-Lo DNA Marker      Minnesota Molecular – store at 4°C 
Bromophenol Blue (for 300bp samples)  Sigma B-8026 
Xylene Cyanol FF (for 4kb samples)   USB 23513 
Ethidium Bromide     IBI/Shelton Scientific IB40075 
Trizma Base      Sigma T-1503 
Glacial Acetic Acid     JT Baker 9508-05 
0.5 M EDTA      Gibco 15575-020 
Agarose (molecular biology grade)   Fisher BP1356-100 
EZNA Gel Extraction kit     Omega Biotek D2501-01 




50X TAE (Tris-Acetate-EDTA Buffer) 
 242g Tris (Trizma) Base 
 57.1 ml glacial acetic acid 
 100ml 0.5M EDTA (ph 8.0) 
 bring up to 1000ml with dH2O 
1X TAE 
 60ml of 50X TAE 
 2940 ml dH2O 
6X Loading Dye 
 0.25% bromophenol blue (for 300bp) – use 0.25% xylene cyanol FF for 4kb 
 30% glycerol in water 
for 1ml: add 300ul glycerol 
  2.5 mg bromophenol blue 
 bring up to 1ml with water 
 store at 4°C 
EtBr Staining Solution 
25 ul 1% EtBr solution 
250 ml TAE 
 enough for small gels, make more for larger gels 
Use tip box for soaking small gels, tupperware for larger gels 




Setup Gel Casting System 
1. Choose appropriate comb for samples and tighten tray in gel casting system to avoid 
leaks 
2. Balance feet of casting system and check for balance with balance bubble 
3. Note comb is offset – put teeth inward 
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Make Agarose Solution 
1. For small gel, need 50ml; for large gel, need 125ml agarose solution 
2. Size of DNA fragment will dictate concentration of agarose gel 
 Rule of thumb: 1% agarose gel = 125ml TAE + 1.25g agarose or 50ml TAE + 
0.5g agarose 
3. For amplicons 60-80bp in length, make 2% agarose gel (125ml TAE + 2.5g agarose).  
Shake TAE to mix, then add to flask and add agarose powder.  Swirl to mix 
4. Microwave flask – start with 2 minutes (HEAT but DON’T BOIL) 
5. Watch in microwave – wearing orange autoclave gloves - remove every 15-20sec and 
swirl.  Look for refractive crystals indicating that agarose is not totally dissolved.  
Total microwaving time ~ 3min. 
 
Casting Agarose Gel 
1. When agarose solution is completely dissolved, pour slowly into casting tray – avoid 
bubbles! 
2. Let gel cool (takes 30-45 min) but do not let dry out.  Once solidified, gel will have a 
bluish tint and you can add some 1X TAE to the top to prevent drying 
3. When gel is completely solid, carefully remove the comb and mount the gel in the 
electrophoresis tank.  Be sure that the wells are oriented so that the DNA (which is 
neg) can migrate from the cathode (black) to the anode (red). 
4. Add just enough 1X TAE buffer to the tank to cover the gel by about 1mm. 
 
Add Samples to Gel 
When dispensing into wells, brace dispensing hand with other hand, have NO bubbles in 
micropipette tip, dispense slowly  - moving hand back and forth in well 
1. Add 10ul of Hi-Lo DNA ladder to first lane 
2. Rip caps off PCR tubes and add 4ul of 6X loading buffer to each tube 
3. Mix each sample thoroughly and slowly add to each well – volume of sample+buffer 
loaded will depend on the size of the well (number of teeth on comb) 
 
Running Gel 
1. Close the lid of the tank and attach the electrical leads. 
2. Turn on the power supply and set to 75 volts for 90 minutes.  Bubbles should be 
generated at the anode and cathode and the bromophenol blue should begin migrating 
towards the anode. 
3. When the bromophenol blue has run through about 75% of gel (should take 80-
90min), turn off the power supply and remove the lid. 
 
Examining the Gel 
When working with EtBr, ALWAYS double glove to avoid contact 
1. Soak gel in 1ug/ml EtBr staining solution for 30-45 min. 
2. Visualize the gel on a UV box.  ALWAYS use protection with the UV box – face 
shield and goggles. Have razor blade, ruler and timer ready at UV box. 
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3. Use the ladder to focus your attention to the expected area, quickly turn on the UV 
box and make simple cuts with a razor blade.  Note: DNA exposed to UV rays for 
more than 30seconds will be degraded. 
4. Using simple cuts as a guide, cut out your band of interest and remove excess 
agarose. 
 
Storing the Gel 
1. The entire gel can be stored overnight – in saran wrap to prevent drying or a little 
TAE.  Can also cut out area of interest and store at 4°C overnight.   
 
Extracting Amplicons from Gel 
1. Turn on hot water bath prior to preparing gel pieces in solutions. 
2. Use gel extraction kit exactly according to directions 
3. Carefully monitor complete melting of gel pieces 
4. Following extraction, spec cDNA samples to determine concentration 
5. Dilute to desired concentration for stock solution (30nM), aliquot and store standards. 
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TLJ-P12: Gel Electrophoresis and Western Blotting 
 
Reagents: 
Name Supplier Cat. No. 
12% Novex Tris-Glycine Gels, 1.0mm, 10 well Invitrogen EC6005 
10x Tris/Glycine/SDS Buffer Bio-Rad 161-0732 
10x Tris/Glycine Buffer Bio-Rad 161-0734 
SeeBlue Plus2 Pre-stained standard Invitrogen LC5925 
Magic Mark XP Western Protein Standard Invitrogen LC5602 
Tris Base (trizma base) Sigma T-1503 
Tween-20 Sigma P-5927 
Sodium Chloride (NaCl) Sigma S-7653 
Beta-mercaptoethanol Sigma M3148 
SDS (sodium dodecyl sulfate) USB 21651 
Bromophenol Blue Bio-Rad M3978 
Glycerol Sigma G8773 
Tris HCl Sigma T3253 
Nonfat dry milk powder grocery store ☺  
BCA Protein Assay Kit Pierce Biotechnology 23225 
RIPA Buffer Sigma R-0278 
Proteinase Inhibitor Cocktail Sigma P2714 
ECL Plus Western Blotting Detection Reagents Amersham RPN 2132 
Methanol Sigma 494437 
PVDF Membrane Bio-Rad 162-0177 
Filter Paper Bio-Rad 1704085 
Blotting Pads Bio-Rad 1703914 
Film Phenix Research Products F-BX57 






 10x Tris/Glycine/SDS Buffer  100ml 
 Deionized water   900ml 
 
Transfer Buffer 
 10x Tris/Glycine Buffer  100ml 
 Methanol    200ml 
 Deionized water   700ml 
 
5x Sample Buffer 
 Deionized water   3.0ml 
 0.5M Tris-HCl, pH=6.8  1.0ml 
 Glycerol    1.6ml 
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 10% SDS    1.6ml 
 0.5% Bromophenol blue  0.4ml 
  immediately prior to use: add 0.2ml B-ME per 1ml 5x sample buffer 
 
10x TBS (pH = 7.6) 
 Tris base    2.42g 
 NaCl     8.0g 
 Deionized water    100ml 
 Use pH paper and adjust pH to 7.6 
 
1x T-TBS 
 10x TBS    100ml 
 Tween-20    1ml 
 Deionized water   900ml 
 
5% Milk 
 Nonfat dry milk powder  5g 
 1x T-TBS    100ml 
 Aliquot milk into 50ml conical tubes and centrifuge at 3000rpm for 10min. 
 Collect supernatant with pipet and discard pellet. 
 
 
Cell Lysis and Protein Isolation 
Lysis Buffer: Add proteinase inhibitor to RIPA Buffer immediately before use 
Adherent cells can be lysed in dish or in cell pellet following trypsinization and 
centrifugation.  Lysis as a pellet may allow smaller volumes of lysis buffer to be used.  
Either way, be sure to wash with PBS to remove all media as serum proteins will reduce 
yield of cellular proteins. 
 
1) Wash, trypsinize and collect cells in centrifuge tube. 
2) Carefully remove ALL supernatant and add lysis buffer to pellet.  Repeatedly 
pipet cell lysate to break apart cellular structures. 
3) Collect cell lysate and place in microcentrifuge tube on ice for 5-10min. 
4) Centrifuge cell lysate at 12,000g for 10min. 
5) Carefully collect supernatant (containing protein) and place in new microfuge 
tube.  Discard pellet containing DNA. 




Use BCA Protein Assay Kit to measure protein content of samples.  Keep protein 
samples on ice at all times to prevent degradation. 
1) Make serial dilutions of the BSA standard provided (2mg/ml) by diluting in PBS: 
2 mg/ml, 1 mg/ml, 0.5 mg/ml, 0.25 mg/ml, 0 mg/ml 
2) Aliquot 10ul of standards into a 96 well plate 
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3) Dilute protein samples in PBS (start with 1:2, or if concentrated sample use 1:5) 
in small microcentrifuge tubes then add 10ul of each (same volume as standards) 
to 96 well plate 
4) Combine Reagent A and Reagent B in a 50:1 ratio (ie. 2ml A + 40ul B) then add 
200ul of mixture to each well 
5) Incubate plate at 37C for 30min to allow colorimetric reaction to proceed 
6) Turn on absorbance spectrophotometer and allow to warm up for 30min 
7) Scan plate at 562nm and export readings. 





1) Determine layout of samples in gel – including blotting standard, western 
standard and samples 
2) 10-well gels have a maximum capacity of 25ul per well 
3) Each lane will have 5x sample buffer, plus sample and water.  Load an equal 
amount of protein in each lane based on protein assay calculations and bring total 
volume up with water. 
4) Turn on hot plate to 95, add B-ME to 5x sample, and place the following items on 
ice: See Blue Plus 2 standard, Magic Mark Western standard, protein samples 
5) Prepare fresh microcentrifuge tubes for each lane and add volume of water, 
protein and 5xSB 
6) Heat tubes on hot plate at 95C for 5min 
 
Prepare Gel: 
1) Cut open package of Novex gel (other gel types can be used for other 
applications) and rinse off excess acrylamide with deionized water. 
2) Remove white tape along bottom of gel and in one smooth motion, remove comb 
from wells. 
3) Using micropipette, rinse wells with running buffer 2-3x – remove all bubbles 
with last rinse. 
 
Assemble Gel and Load Samples: 
1) Place the white buffer core in the mini-cell so that the gold electrode is in the 
notch on the left side. 
2) Lower gel into front side of buffer core with the wells facing inside, then load 
plastic buffer dam (or second gel) into back side of buffer core. 
3) Place gel tension wedge behind buffer core and lock into place. 
4) Fill area between gel cassette and plastic buffer dam with running buffer to above 
level of wells and look for leaks into outer chamber.  If there are leaks, remove 
pieces and buffer, readjust and test again until tight. 
5) Using gel loading tips, carefully load lanes – be careful to avoid bubble and 
volcanoes! 
6) Fill the outer buffer chamber with running buffer to help dissipate heat generated. 
7) Attach lid to mini-cell and plug into power pack (red to red; black to black) 
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8) Turn on power pack, program to hold voltage constant at 125V and set timer for 
90min. 
 
Gel to Membrane – Protein Transfer 
Preparing Transfer Pieces: 
1) Fold piece of filter paper in half and cut along center line resulting in two 
identically sized pieces. 
2) Pour some transfer buffer into Bio-Rad dishes and soak blotting pads. 
3) Remove roll of PVDF membrane from tube – be sure to keep protective plastic on 
either side of membrane.  Cut a piece just slightly smaller that the filter paper and 
carefully remove plastic pieces – only handle membrane by edges! 
4) Pre-wet membrane in methanol for 30sec and dispose of methanol waste properly.  




1) Turn off power pack, disconnect electrodes and remove lid from mini-cell. 
2) Place gel cassette on edge of benchtop with notched (well) side up.  Using gel 
knife, carefully crack open gel cassette on three edges and remove top plate. 
3) Remove wells with gel knife and pour some transfer buffer over the gel to keep 
moist. 
4) Wet one piece of filter paper and place over gel with edge just above “foot” of 
gel.  Add more transfer buffer and make sure there are no bubbles (bubble will 
interfere with transfer). 
5) Turn the plate over in your gloved hand and use the gel knife to push foot of gel 
through slot so you are left with filter paper and gel in your hand. 
6) Lay on flat surface and cut off foot of gel with gel knife. 
7) Wet surface of gel with transfer buffer, then carefully lay pre-soaked membrane 
on surface of gel ensuring there are no bubbles. 




1) Place two soaked blotting pads in the base of the blot module (no bubbles in 
pads!). 
2) Place sandwich of filter paper, gel, membrane, filter paper on top of blotting pads. 
3) Add more blotting pads (2-3) so that they rise 0.5cm above the rim of the blot 
module base. 
4) Place top of blot module over the pads and hold together securely.  Slide blot 
module into mini-cell ensuring that gold electrode fits into slot on right. 
5) Put gel tension wedge behind blot module and lock into place. 
6) Fill blot module with transfer buffer until gel/membrane sandwich is covered but 
do not fill to top. 
7) Fill the outer buffer chamber with deionized water until the level is 2cm below the 
blot module edge. 
8) Attach lid to mini-cell and plug into power pack (red to red; black to black) 
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9) Turn on power pack, program to hold voltage constant at 25V and set timer for 2 














Staining Western Blot 
 
1) Carefully place blot in staining dish and rinse blot briefly in TTBS. 
2) Block overnight at 4C in 5% milk to reduce non-specific binding.  Cover with 
saran wrap to prevent evaporation. 
3) Dilute primary antibody in milk and add to staining dish.  Place on orbital shaker 
at room temperature for 1 hour. 
4) Rinse 3x in TTBS on orbital shaker for 5min each to remove excess primary 
antibody. 
5) Dilute HRP secondary antibody in milk and add to staining dish.  Magic Mark 
Western standard will react to any IgG secondary antibody.  Note that actin 
control has an IgM secondary antibody. 
6) Rinse 3x in TTBS on orbital shaker for 5min each to remove excess secondary 
antibody. 
 
Apply Substrate and Develop Image 
 
1) Sign up for developer on door to dark room – usually need 30min – and turn on 
machine to warm up. 
2) Lay saran wrap on benchtop and carefully place blot onto saran wrap. 
3) With lights off, prepare ECL solution: mix 2.5ml A with 62.5ul B and carefully 
pipet onto membrane.  Allow reaction to proceed for 5min. 
4) Prepare film cassette by laying down saran wrap in base of cassette. 
5) When substrate reaction is complete, use forceps to lift blot and drip off excess 
substrate solution onto tissue. 
6) Lay blot on saran wrap in cassette and cover with a second piece of saran wrap 
(no wrinkles!) 
7) Take the following items to the developer: film cassette, film, scissors, timer 
 
In the dark room… 










2) Set timer for desired exposure time. 
3) With red light on (NO WHITE LIGHT), carefully open the box of film and 
remove the bag. 
4) Take one piece of film (handle with dry gloves) and cut one corner for 
orientation. 
5) Open cassette and lay film with cut edge in upper left corner. 
6) Close cassette and start timer. 
7) Refold bag of film and place into box with folded side down then put lid on box.  
NEVER turn on lights with film out – will ruin all pieces. 
8) When exposure is complete, open cassette and place film in tray of developer, 
then close developer lid. 
9) Developer will develop, wash, fix and dry film.  When film exits developer, turn 
on white lights. 
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TLJ-P13: Proliferation by BrdU Incorporation 
 
Reagents: 
BrdU (5-bromo-2’-deoxyuridine)  ICN Biomedicals 100171 
Anti-BrdU antibody (mouse)    Sigma B2531 
Cy3 Donkey Anti-mouse   Jackson ImmunoResearch 
 
Solutions: 
4% Formaldehyde in PBS 
 
2N HCL 
 100ml 37.3% HCl 
 400ml water 
 
Neutralizing Buffer 
 50mM NaCl 
 100mM Tris-HCl 
 in water and adjust pH to 7.4 
 
BrdU stock solution 
 10mg/ml BrdU in DMSO 
 
Procedure: 
1. Add appropriate amount of BrdU stock solution to samples such that final 
concentration is 20µg/ml and incubate for 6 hours.  For flow experiments with 
110ml media, add 220µl of stock solution. 
2. Remove slides from flow chamber or static dishes, rinse with PBS and fix in 4% 
formaldehyde for 10minutes. 
3. Rinse with PBS and move to glass dishes 
4. Permeabilize with ice cold acetone for 10 minutes, then remove and rinse twice in 
PBS 
5. Incubate with 2N HCl for 15 minutes at 37C to denature the DNA 
6. Remove and rinse in neutralizing buffer, then rinse twice in PBS to ensure 
restoration of neutral pH 
7. Block in 4% Donkey serum in PBS for 30minutes at room temperature 
8. Incubate with Anti-BrdU antibody for 2 hours at 37C 
9. Rinse twice in PBS to remove primary antibody 
10. Incubate with Cy3 Donkey Anti-Mouse and 20µg/ml Hoechst dye to label all 
non-proliferating nuclei for 30minutes at room temperature 









 Work presented in this dissertation to address specific aims one and two 
compared the adsorbed collagen slide substrate to the tissue engineered blood vessel wall 
model substrate.  The purpose of this comparison was to elucidate differences in 
endothelial cell behavior when presented with a traditional in vitro substrate (Slide) or a 
more physiologic in vitro model (TEWM).  Data presented met this goal of 
demonstrating significant differences in cell function between the two substrates, 
however further questions also arose.  Differences between the Slide and TEWM 
substrates are primarily in three areas: i) absence or presence of smooth muscle cells, ii) 
monomer or fibrillar collagen I, iii) two-dimensional or three-dimensional extracellular 
matrix.  Thus the question which emerged from comparisons of the Slide and TEWM 
was: which difference was responsible for the changes seen in endothelial cell function?  
The answer is likely to be that each difference contributed uniquely to different areas of 
cell function and moreover, that the synergistic presence of these components is what 
shapes the endothelial phenotype.  In the interest of pursuing mechanisms behind the 
differences seen in endothelial cells on the Slide versus TEWM, we decided to focus on 
the presence or absence of smooth muscle cells as a likely candidate for significant 
endothelial influence.  Furthermore, the central hypothesis of this dissertation also 
includes investigation of shear stress effects on endothelial cells.  Thus we hypothesized 
that the interactions of endothelial cells and smooth muscle cells would also be 
modulated by the mechanical environment.  Pursuing this hypothesis, several strategies 
were taken and are outlined in the sections to follow. 
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Endothelial-Smooth Muscle Cell Direct Contact Co-Culture 
 The initial strategy taken was to directly co-culture endothelial cells on top of 
smooth muscle cells.  In this way, contact and interactions between the two cell types 
could be maximized.  Additionally, the model would be similar to the TEWM except for 
the presence of a bulk extracellular matrix and no artificial components would be added. 
The direct contact co-culture model was based on combining the attributes of the 
Slide and TEWM substrates whereby a glass slide was coated with collagen I, then 
smooth muscle cells were seeded on the surface and cultured for 24 hours, followed by 
seeding of endothelial cells on top of the smooth muscle cells.  A protocol was developed 
(see below) to achieve both a confluent smooth muscle cell layer and a confluent 
endothelial cell layer.  This cellular bilayer on a glass slide was then inserted into the 
parallel plate flow chamber for exposure to shear stress.  Thus endothelial cell and 
smooth muscle cell interactions were isolated from effects of extracellular matrix present 
in the TEWM, and endothelial cells could be concurrently exposed to shear stress and 
underlying smooth muscle cells.  Figure B.1 shows depicts the endothelial-smooth 
muscle cell direct contact co-culture model both schematically and pictorially.  Panel A 
demonstrates the confluent culture of smooth muscle cells on the glass slide and the 
confluent layer of endothelial cells on the surface.  Panel B is a confocal microscope 
image taken of the direct contact co-culture model following exposure to shear stress (15 
dynes/cm2) for 24 hours.  Prior to seeding onto the smooth muscle cells, endothelial cells 
were incubated with cell tracker orange to stain the cytoplasm and allow them to be 
distinguished from smooth muscle cells.  The fixed cells were then stained for actin 
filaments (green) and nuclei (blue).  Smooth muscle cell nuclei appear blue and 
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endothelial cell nuclei appear pink due to the overlay of orange cytoplasm and blue 
nucleus. 
Work with this model continued with a focus on endothelial cell gap junctions 
and expression of Connexins 37, 40 and 43.  Endothelial cells were separated from 
smooth muscle cells in the direct contact co-culture model using the same magnetic 
separation procedure which was used in analysis of endothelial cells on the TEWM.  Pure 
endothelial cells were then lysed, RNA isolated, cDNA generated and analyzed using real 
time RT-PCR to determine connexin mRNA expression.  Figure B.2 shows connexin 
mRNA expression in endothelial cells of the direct contact co-culture model under static 
and shear stress conditions.  Figure B.3 compares the data from endothelial connexin 
expression in the direct contact co-culture model (from Figure B.2) to the data from 
chapter five of connexin mRNA expression in the Slide model under static and shear 
conditions.  Statistics have not been conducted on this data because it is preliminary and 
following collection of the data, problems in the model were identified. 
Achieving a confluent endothelial cell monolayer is critical to experimental 
analysis since endothelial cells exhibit very different behavior when subconfluent 
compared to confluent.  Confluence was especially critical with our interest in gap 
junctions, which require cell-cell contact, and for comparison to previous data on the 
Slide and TEWM substrates which had confluent endothelial monolayers.  Although the 
protocol for the direct contact co-culture model was carefully developed to ensure smooth 
muscle cell and endothelial cell confluence, subconfluent regions in the endothelium 
were detected as experiments progressed.  While confluent initially, it appeared that due 
to movement or proliferation of underlying smooth muscle cells, gaps in the endothelial 
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monolayer would develop during the course of experiments.  Additionally, another 
research group who was developing a similar model at the same time also began to 
encounter similar problems. (213) 
Data presented in this section using the endothelial-smooth muscle cell direct 
contact co-culture model must then be examined with a critical eye since the authors felt 
a confluent endothelial monolayer was achieved prior to conducting these experiments, 
yet in retrospect cannot be assured that gaps on the endothelium did not develop.  In 
continuing to pursue the effect of smooth muscle cells and shear stress on endothelial 
cells, an additional strategy for co-culture was investigated. 
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Sterile PBS (-Mg, -Ca) 
Complete HASMC medium 
Co-culture medium 
50 µg/mL Collagen type I Solution 
 
Procedure: 
Coating Slides with Collagen 
1. Autoclave glass slide and tweezers. 
2. Place slide into square dish with tweezers. 
3. Add 1mL of collagen solution and spread evenly with cell scraper. 
4. Allow to coat for 1hour at room temperature. 
 
Adding SMC to Slide 
1. Remove flasks with smooth muscle cells from incubator and place in cell culture hood.  Aspirate 
spent medium, rinse culture surface with PBS and aspirate, add trypsin to detach cells, neutralize 
trypsin with media and collect cell suspension. 
2. Centrifuge at 1000 rpm for 5 min and aspirate supernatant.  Resuspend in fresh culture media and 
count using Coulter Counter. 
3. Cells will be seeded at a density of 20,000/cm2 with each slide having dimensions of 3.8 x 7.5 cm 
for a total area of 28.5 cm2  
4. Centrifuge appropriate number of cells for number of slides at 1000 rpm for 5 min and remove 
supernatant.  Resuspend in media so that 1 mL of cell suspension will be added to each slide. 
5. Add 1 mL of cell suspension to surface of slides and spread gently using cell scraper if necessary. 
6. Cover dish and allow to adhere for 1 hour in hood at room temperature.  
7. Add approximately 30 ml of complete HASMC medium, cover dish and place in incubator for 24 
hours 
 
Adding EC to SMC Slide 
1. Remove flasks with endothelial cells from incubator and place in cell culture hood.  Aspirate spent 
medium, rinse culture surface with PBS and aspirate, add trypsin to detach cells, neutralize trypsin 
with media and collect cell suspension. 
2. Centrifuge at 1000 rpm for 5 min and aspirate supernatant.  Resuspend in fresh culture media and 
count using Coulter Counter. 
3. Seeding efficiency of EC on SMC is low thus a high seeding concentration is required to achieve a 
confluent EC monolayer.  Seed EC corresponding to 90,000/cm2 or a concentration of 3.4M 
cells/ml. 
4. Centrifuge appropriate number of cells for number of slides at 1000 rpm for 5 min and remove 
supernatant.   
5. Remove HASMC media from slide dishes and rinse with one wash of PBS. 
6. Using sterile forceps, remove SMC slide from dish and place in fresh (dry) dish. 
7. Resuspend EC in co-culture media (750 µl for 28cm2 slide) and gently drip onto SMC slide. 
8. Cover dish and allow to adhere for 1 hour in hood at room temperature.  
























Figure B.1 Endothelial-Smooth Muscle Cell Direct Co-Culture Model 
Panel A shows a schematic of the direct co-culture model where smooth muscle cells are seeded at 
confluence on a collagen type I coated glass slide and endothelial cells are seeded at confluence on their 
surface.  Panel B shows a microscope image of the direct co-culture model following exposure to shear 
stress for 24 hours.  Endothelial cells were prelabeled with cell tracker orange and the co-culture was then 













Figure B.2 Connexin mRNA Expression in the EC-SMC Direct Contact Model 
Endothelial cells removed from the EC-SMC direct contact co-culture model following exposure to static 


























Figure B.3 Comparison of Cx mRNA Expression in Slide and Co-Culture Model 
Endothelial cell connexin mRNA expression is compared amongst the slide and direct co-culture models 
following exposure to static and shear stress. 
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Endothelial-Smooth Muscle Cell Transwell Co-Culture 
The second strategy taken was to develop a co-culture model which had the 
properties of the direct contact system in that endothelial cells and smooth muscle cells 
would be in physical contact with each other and additionally, endothelial cells could be 
exposed to shear stress.  However, to address the problems encountered in the direct 
contact co-culture model, there would need to be an intermediary between the endothelial 
and smooth muscle cell layers to prevent gaps from developing in the confluent 
monolayer. 
In numerous previous literature reports, a Transwell system is used to co-culture 
cells of different types and evaluate their effects on each other.  This is achieved using a 
permeable membrane with defined pore size and pore density to separate the two cell 
types of interest.  In a recent study, one group used this system to co-culture endothelial 
cells and smooth muscle cells and also modified a parallel plate flow chamber to expose 
only the endothelium to shear stress. (111)  In our laboratory, we chose to use Transwell 
filters for co-culture with a pore size of 0.4µm which would be large enough to allow for 
heterocellular contact yet too small for cell migration.  A protocol was developed (see 
below) to wet the membranes with culture medium, then seed one side of the membrane 
with endothelial cells and the other side of the membrane with smooth muscle cells.  
Figure B.4 depicts the endothelial-smooth muscle cell Transwell co-culture model.  Panel 
A shows the control treatment of endothelial cells only on the membrane and Panel B 
should the co-culture of endothelial and smooth muscle cells on opposite sides of the 
membrane.  With the endothelial cell monolayer on the outer surface of the cup, the flow 
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block in the parallel plate flow chamber could be modified to allow for insertion of the 
Transwell such that endothelial cells would be exposed to shear stress. 
Prior to modification of the flow chamber, endothelial cell connexin mRNA 
expression was evaluated in static Transwells of endothelial cells in monoculture or in 
co-culture with smooth muscle cells.  Due to the presence of the membrane between the 
endothelial and smooth muscle cells, endothelial cells could be removed for lysis and 
RNA isolation without the need for a separation process to purify them from the smooth 
muscle cells.  Figure B.5 shows endothelial cell connexin expression in monoculture and 
co-culture on the Transwells under static condition.  While there appears to be an effect 
of smooth muscle cell presence, the data suggests that it is isotype dependent. 
Drawings were developed for modification of the polycarbonate flow block which 
would allow for insertion of the Transwell filter and exposure of the endothelium to shear 
stress.  However, several questions arose in anticipation of these modifications.  These 
included concerns regarding the ability to maintain a laminar flow profile, the possibility 
of fluid leak around the Transwell, and the loss of integrity of the flow block if a central 
hole was created.  Due to these concerns and the interest in pursuing the differences 
between connexin isotypes and response to shear stress, the work on co-culture of 
endothelial cells and smooth muscle cells was not pursued further. 
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EC-SMC Transwell Co-Culture Protocol 
 
Reagents & Supplies: 
Transwell filters 0.4µm pore size PET membrane (BD 353090) 
Transwell 6-well companion plates (BD 353502) 
Sterile PBS (-Mg, -Ca)   
Trypsin 
Forceps 
Co-culture medium    
      
Procedure: 
Pre-wet Transwell membrane 
1. Place transwell filters into 6-well companion plate carefully using forceps 
2. Add 3ml of coculture media to lower compartment and 1.5ml coculture media to inner 
compartment of transwell cup. 
3. Soak overnight in incubator to fully prewet membrane (cells do not adhere well if seeded on dry 
membrane) 
 
Seeding Outer Surface of Transwell 
1. Remove flasks with endothelial cells from incubator and place in cell culture hood.  Aspirate spent 
medium, rinse culture surface with PBS and aspirate, add trypsin to detach cells, neutralize trypsin 
with media and collect cell suspension. 
2. Centrifuge at 1000 rpm for 5 min and aspirate supernatant.  Resuspend in fresh culture media and 
count using Coulter Counter. 
3. Cells will be seeded at a density of 250,000/cm2 with each transwell having a surface area of 4.2 
cm2.  Centrifuge appropriate number of cells for number of slides at 1000 rpm for 5 min and 
remove supernatant.   
4. Aspirate media from upper and lower compartments of transwell plate.  Using forceps, remove 
each transwell filter from the plate and place upside-down in Petri dish so lower filter surface is 
now accessible. 
5. Resuspend in media so that 400µL of cell suspension will be added to each surface. 
6. Carefully drip cell suspension on each filter, cover dish and allow to adhere for 2 hours in 
incubator.  Set 6-well plates aside for later use.  
 
Seeding Inner Surface of Transwell 
1. Remove flasks with smooth muscle cells from incubator and place in cell culture hood.  Aspirate 
spent medium, rinse culture surface with PBS and aspirate, add trypsin to detach cells, neutralize 
trypsin with media and collect cell suspension. 
2. Centrifuge at 1000 rpm for 5 min and aspirate supernatant.  Resuspend in fresh culture media and 
count using Coulter Counter. 
3. Cells will be seeded at a density of 100,000/cm2 with each transwell having a surface area of 4.2 
cm2.  Centrifuge appropriate number of cells for number of slides at 1000 rpm for 5 min and 
remove supernatant.   
4. Remove Petri dish of transwells from incubator and using forceps, carefully plate transwells back 
into 6-well plate being careful not to damage EC monolayer.  Add 3ml media to lower 
compartment. 
5. Resuspend SMC in final media volume of 1.5ml and add to inner compartment of transwell filters. 
 
NOTES: 
• Seeding densities and efficiencies should be evaluated for each cell type used in this system 
(HAEC @ 250,000/cm2 and HASMC @ 100,000/cm2 was shown to work well here) 
• Multiple types of transwell filters are available (pore size, membrane type) and experimental goals 



































Figure B.4 Endothelial-Smooth Muscle Cell Transwell Co-Culture Model 
Transwell filters with 0.4µm porous membrane are used for monoculture of endothelial cells (Panel A) or 





















Figure B.5 Connexin mRNA Expression in the EC-SMC Transwell Model 
Endothelial cells were removed from the monoculture and co-culture Transwell models and analyzed by 
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